[{"entities":{"urls":[{"start":278,"end":301,"url":"https://t.co/guk5PZ4ABt","expanded_url":"https://twitter.com/EMA_News/status/1476478917900791810/video/1","display_url":"pic.twitter.com/guk5PZ4ABt"}],"hashtags":[{"start":41,"end":57,"tag":"COVID19vaccines"},{"start":193,"end":202,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":41,"reply_count":11,"like_count":58,"quote_count":2},"attachments":{"media_keys":["7_1473317404226822150"],"poll_ids":{}},"conversation_id":"1476478917900791810","possibly_sensitive":false,"created_at":"2021-12-30T09:03:00.000Z","id":"1476478917900791810","text":"Do you have concerns about the safety of #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º? \n\nTake your information from trusted public health authorities!\n\nWatch this video now to learn how the safety of #vaccines is monitored so they will protect you against death &amp; hospitalization. https://t.co/guk5PZ4ABt","referenced_tweets":{}},{"entities":{"urls":[{"start":229,"end":252,"url":"https://t.co/zb9wY5UmGs","expanded_url":"https://europa.eu/!vB6wBq","display_url":"europa.eu/!vB6wBq"},{"start":253,"end":276,"url":"https://t.co/ODP3a8swaE","expanded_url":"https://twitter.com/EMA_News/status/1476146012796370947/photo/1","display_url":"pic.twitter.com/ODP3a8swaE"}],"hashtags":[{"start":56,"end":74,"tag":"RealWorldEvidence"},{"start":81,"end":101,"tag":"MedicinesRegulation"}],"mentions":[{"start":205,"end":213,"username":"DKMA_dk","id":"826788051175211010"},{"start":218,"end":227,"username":"bfarm_de","id":"803246507688394752"}],"annotations":[{"start":125,"end":127,"probability":0.5361,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":48,"quote_count":0},"attachments":{"media_keys":["3_1476145998141571075"],"poll_ids":{}},"conversation_id":"1476146012796370947","possibly_sensitive":false,"created_at":"2021-12-29T11:00:09.000Z","id":"1476146012796370947","text":"Read more about European regulators'views on the use of #RealWorldEvidence in EU #MedicinesRegulation in this article by the EMA's Head of Data Analysis and EMAâ€™s Executive Director, in collaboration with @DKMA_dk and @bfarm_de: https://t.co/zb9wY5UmGs https://t.co/ODP3a8swaE","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":25,"end":38,"tag":"EUCancerPlan"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Android","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1476126248573321221","possibly_sensitive":false,"created_at":"2021-12-29T09:41:37.000Z","id":"1476126248573321221","text":"RT @EU_Commission: ğŸ”¬ğŸ§¬Our #EUCancerPlan is our political commitment to turn the tide against cancer.  \n \nThis year, we gave another steppingâ€¦","referenced_tweets":[{"type":"retweeted","id":"1475787785676247040"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Android","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1476126113776685058","possibly_sensitive":false,"created_at":"2021-12-29T09:41:05.000Z","id":"1476126113776685058","text":"RT @EU_Health: Each safety measure is important, but they work best when combined!  \n\nKeep yourself and others safe by getting vaccinated aâ€¦","referenced_tweets":[{"type":"retweeted","id":"1473927428842086406"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Android","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1476125486535299074","possibly_sensitive":false,"created_at":"2021-12-29T09:38:35.000Z","id":"1476125486535299074","text":"RT @EU_Health: As COVID-19 case numbers are rising again across the EU, full vaccination is vital \n\nAnd to get the best protection, combineâ€¦","referenced_tweets":[{"type":"retweeted","id":"1476093126867570693"}]},{"entities":{"urls":[{"start":259,"end":282,"url":"https://t.co/kEpC7jEgfS","expanded_url":"https://europa.eu/!bj74WN","display_url":"europa.eu/!bj74WN"},{"start":283,"end":306,"url":"https://t.co/ENqfPh6CjE","expanded_url":"https://twitter.com/EMA_News/status/1475738339588419590/photo/1","display_url":"pic.twitter.com/ENqfPh6CjE"}],"hashtags":[{"start":20,"end":36,"tag":"COVID19vaccines"},{"start":178,"end":187,"tag":"vaccines"},{"start":195,"end":202,"tag":"safety"},{"start":229,"end":238,"tag":"boosters"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":24,"reply_count":2,"like_count":48,"quote_count":2},"attachments":{"media_keys":["3_1475738333431185409"],"poll_ids":{}},"conversation_id":"1475738339588419590","possibly_sensitive":false,"created_at":"2021-12-28T08:00:12.000Z","id":"1475738339588419590","text":"Stay informed about #COVID19vaccines!\n\nVisit the COVID-19 vaccines Key Facts page to learn more on how EMA evaluates data and makes recommendations on the protection provided by #vaccines, their #safety, vaccination in children, #boosters &amp; other topics: https://t.co/kEpC7jEgfS https://t.co/ENqfPh6CjE","referenced_tweets":{}},{"entities":{"urls":[{"start":226,"end":249,"url":"https://t.co/uVHrPNNFkY","expanded_url":"https://www.ema.europa.eu/en/news/ema-ecdc-recommendations-heterologous-vaccination-courses-against-covid-19","display_url":"ema.europa.eu/en/news/ema-ecâ€¦"},{"start":250,"end":273,"url":"https://t.co/bzELab0tpp","expanded_url":"https://twitter.com/EMA_News/status/1474303920382095360/photo/1","display_url":"pic.twitter.com/bzELab0tpp"}],"hashtags":{},"mentions":[{"start":113,"end":121,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":32,"reply_count":12,"like_count":79,"quote_count":6},"attachments":{"media_keys":["3_1474303897644810240"],"poll_ids":{}},"conversation_id":"1474303920382095360","possibly_sensitive":false,"created_at":"2021-12-24T09:00:20.000Z","id":"1474303920382095360","text":"Vaccines ğŸ’‰ are continuing to prevent many millions of EU citizens from becoming very ill or dying. Together with @ECDC_EU, we urge all EU citizens to get fully vaccinated and follow the recommendations on booster vaccination. https://t.co/uVHrPNNFkY https://t.co/bzELab0tpp","referenced_tweets":{}},{"entities":{"urls":[{"start":215,"end":238,"url":"https://t.co/bX1DSvoYzl","expanded_url":"https://www.ema.europa.eu/en/news/emer-cookes-end-year-message","display_url":"ema.europa.eu/en/news/emer-câ€¦"},{"start":239,"end":262,"url":"https://t.co/MYHRjD9D1k","expanded_url":"https://twitter.com/EMA_News/status/1473686121330749455/photo/1","display_url":"pic.twitter.com/MYHRjD9D1k"}],"hashtags":[{"start":114,"end":122,"tag":"COVID19"}],"mentions":{},"annotations":[{"start":33,"end":42,"probability":0.951,"type":"Person","normalized_text":"Emer Cooke"},{"start":45,"end":47,"probability":0.484,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":11,"like_count":51,"quote_count":2},"attachments":{"media_keys":["3_1473683827230924805"],"poll_ids":{}},"conversation_id":"1473686121330749455","possibly_sensitive":false,"created_at":"2021-12-22T16:05:25.000Z","id":"1473686121330749455","text":"See the end-of-year message from Emer Cooke, EMAâ€™s Executive Director, giving an overview of our efforts to fight #COVID19 in 2021. \n\nAn infographic also highlights the milestones of our response to the pandemic. \n\nhttps://t.co/bX1DSvoYzl https://t.co/MYHRjD9D1k","referenced_tweets":{}},{"entities":{"urls":[{"start":215,"end":238,"url":"https://t.co/ihEhf3nq9c","expanded_url":"https://twitter.com/EMA_News/status/1473637320041680898/photo/1","display_url":"pic.twitter.com/ihEhf3nq9c"}],"hashtags":[{"start":0,"end":16,"tag":"COVID19vaccines"},{"start":108,"end":116,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":80,"reply_count":33,"like_count":202,"quote_count":11},"attachments":{"media_keys":["3_1473637132883443715"],"poll_ids":{}},"conversation_id":"1473637320041680898","possibly_sensitive":false,"created_at":"2021-12-22T12:51:30.000Z","id":"1473637320041680898","text":"#COVID19vaccines: Where do we stand? \n\nWith 5âƒ£ vaccines approved in the EU, we are better prepared to fight #COVID19 than last winter. \n\nWe now have a range of technologies: mRNA, protein-based and vector vaccines. https://t.co/ihEhf3nq9c","referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/cQovBwcPgL","expanded_url":"https://twitter.com/i/events/1473291222370242562","display_url":"twitter.com/i/events/14732â€¦","images":[{"url":"https://pbs.twimg.com/news_img/1476586085669085189/Wh__kpkY?format=jpg&name=orig","width":1200,"height":675},{"url":"https://pbs.twimg.com/news_img/1476586085669085189/Wh__kpkY?format=jpg&name=150x150","width":150,"height":150}],"status":200,"title":"EMA's Press Briefing 21 December 2021","description":"See the live tweets posted during EMA's technical press briefing held on 21 December 2021. #EMAPresser","unwound_url":"https://twitter.com/i/events/1473291222370242562"}],"hashtags":[{"start":104,"end":115,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":9,"reply_count":4,"like_count":23,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473291945296474121","possibly_sensitive":false,"created_at":"2021-12-21T13:59:06.000Z","id":"1473291945296474121","text":"See the live tweets shared during our press briefing held on 21 December 2021: https://t.co/cQovBwcPgL \n#EMAPresser","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Novavax"},{"start":172,"end":178,"tag":"COVAX"},{"start":264,"end":275,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":53,"reply_count":16,"like_count":183,"quote_count":21},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:46:57.000Z","id":"1473273784840896516","text":"#Novavax vaccine is easier to handle, as it can be stored at normal fridge temperatures. This vaccine will deliver very large amount of doses, up to 1 billion/year, to the #COVAX programme. This will help ensuring that the world is vaccinated as soon as possible. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473272452457316356"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":70,"end":81,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":15,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:41:39.000Z","id":"1473272452457316356","text":"In the veterinary area, we recommended 12 new medicines for approval. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473272185456316424"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":4,"end":13,"tag":"pandemic"},{"start":113,"end":124,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":12,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:40:35.000Z","id":"1473272185456316424","text":"The #pandemic hasn't affected EMA's priority areas. This year we have recommended 9âƒ£2âƒ£ medicines ğŸ’Š for approval. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473271706445877258"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Omicron"},{"start":166,"end":182,"tag":"COVID19vaccines"},{"start":184,"end":195,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":4,"like_count":21,"quote_count":7},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:38:41.000Z","id":"1473271706445877258","text":"#Omicron: We will not have to start from scratch with updated vaccine composition because what we might need will not necessarily be very different from the existing #COVID19vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473271539332222976"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Omicron"},{"start":230,"end":241,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":2,"like_count":21,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:38:01.000Z","id":"1473271539332222976","text":"#Omicron: There is no answer yet on whether we will need an adapted vaccine with a different composition. The scientific community needs to see more data on the impact of the variant on the effectiveness of the approved vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473271251208708102"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":115,"end":123,"tag":"COVID19"},{"start":158,"end":167,"tag":"patients"},{"start":169,"end":180,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":11,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:36:53.000Z","id":"1473271251208708102","text":"We now have 6âƒ£ treatments for COVID-19 in the ğŸ‡ªğŸ‡º. Every single one is an important addition to our toolbox against #COVID19 and gives hope and possibility to #patients. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473271181063172105"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":159,"end":170,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":11,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:36:36.000Z","id":"1473271181063172105","text":"3âƒ£0âƒ£0âƒ£ million vaccine doses are manufactured in the ğŸ‡ªğŸ‡º every month. Increasing supply means that we can support global access in addition to European access. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473271112054329347"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":238,"end":249,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":9,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:36:19.000Z","id":"1473271112054329347","text":"We have worked tirelessly to help companies to increase their manufacturing capacity, which led to the distribution of almost 1âƒ£ billion doses of vaccine within the ğŸ‡ªğŸ‡º and the export of more than 1âƒ£.3âƒ£billion to countries outside the ğŸ‡ªğŸ‡º. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473270733941977092"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":9,"tag":"Boosters"},{"start":68,"end":84,"tag":"COVID19vaccines"},{"start":197,"end":208,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":4,"like_count":10,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:34:49.000Z","id":"1473270733941977092","text":"#Boosters are important. Studies show that the use of two different #COVID19vaccines for initial courses and boosters confers, in some cases, even more protection as when the same vaccine is used. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473270347898277896"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":194,"end":202,"tag":"COVID19"},{"start":267,"end":278,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":2,"like_count":13,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:33:17.000Z","id":"1473270347898277896","text":"Vaccines protect from death &amp; hospitalisation. The priority now must be to increase vaccine uptake, increase booster uptake and continue to increase supply â€¼ï¸\nWe now have 5 vaccines against #COVID19 authorised in the ğŸ‡ªğŸ‡º. 4 more vaccines are under rolling review. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1473270239118901252"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":195,"end":206,"tag":"EMAPresser"},{"start":207,"end":215,"tag":"COVID19"}],"mentions":{},"annotations":[{"start":49,"end":54,"probability":0.9905,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":3,"like_count":16,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:32:51.000Z","id":"1473270239118901252","text":"The epidemiological situation is worrying across Europe, but with 5âƒ£ vaccines and 6âƒ£ treatments, we are in a stronger position than this time last year â€“ we have many more tools at our disposal. #EMAPresser #COVID19","referenced_tweets":[{"type":"replied_to","id":"1473269730244968456"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":171,"end":194,"url":"https://t.co/6CglwwUsrb","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-10","display_url":"ema.europa.eu/en/events/ema-â€¦"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":7,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:30:50.000Z","id":"1473269730244968456","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser. \nğŸ‘‰https://t.co/6CglwwUsrb","referenced_tweets":[{"type":"replied_to","id":"1473263534851203074"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":151,"end":174,"url":"https://t.co/6CglwwUsrb","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-10","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":175,"end":198,"url":"https://t.co/ljVq7bsbXI","expanded_url":"https://twitter.com/EMA_News/status/1473263534851203074/photo/1","display_url":"pic.twitter.com/ljVq7bsbXI"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":138,"end":149,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":36,"reply_count":5,"like_count":73,"quote_count":5},"attachments":{"media_keys":["3_1473263405494587401"],"poll_ids":{}},"conversation_id":"1473263534851203074","possibly_sensitive":false,"created_at":"2021-12-21T12:06:13.000Z","id":"1473263534851203074","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 21 December, from 13:30 to 14:15 CET. #EMAPresser\nğŸ‘‰https://t.co/6CglwwUsrb https://t.co/ljVq7bsbXI","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"VaccinesWork"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1473211328265392128","possibly_sensitive":false,"created_at":"2021-12-21T08:38:46.000Z","id":"1473211328265392128","text":"RT @EU_Health: #VaccinesWork","referenced_tweets":[{"type":"retweeted","id":"1473201180193042433"}]},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/C0CrY8Jhih","expanded_url":"https://www.ema.europa.eu/en/news/ema-recommends-nuvaxovid-authorisation-eu","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":196,"end":219,"url":"https://t.co/bFDwTnh4Zf","expanded_url":"https://twitter.com/EMA_News/status/1472922370335993859/photo/1","display_url":"pic.twitter.com/bFDwTnh4Zf"}],"hashtags":[{"start":33,"end":48,"tag":"COVID19vaccine"},{"start":62,"end":70,"tag":"Novavax"},{"start":112,"end":120,"tag":"COVID19"},{"start":155,"end":167,"tag":"HealthUnion"}],"mentions":{},"annotations":[{"start":18,"end":26,"probability":0.4093,"type":"Person","normalized_text":"Nuvaxovid"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":403,"reply_count":85,"like_count":875,"quote_count":130},"attachments":{"media_keys":["3_1472921390454128644"],"poll_ids":{}},"conversation_id":"1472922370335993859","possibly_sensitive":false,"created_at":"2021-12-20T13:30:33.000Z","id":"1472922370335993859","text":"â€¼ï¸ EMA recommends Nuvaxovid, the #COVID19vaccine developed by #Novavax, for authorisation in the ğŸ‡ªğŸ‡º, to prevent #COVID19 in people from 18 years of age. \n\n#HealthUnion \n\nğŸ‘‰ https://t.co/C0CrY8Jhih https://t.co/bFDwTnh4Zf","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":25,"end":29,"probability":0.5255,"type":"Organization","normalized_text":"Delta"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1472876735582638081","possibly_sensitive":false,"created_at":"2021-12-20T10:29:13.000Z","id":"1472876735582638081","text":"RT @EU_Health: With both Delta and Omicron in circulation, everyone needs to make informed choices in order to keep us all safe\n\nğŸ©¹Get vacciâ€¦","referenced_tweets":[{"type":"retweeted","id":"1471454367890952196"}]},{"entities":{"urls":[{"start":187,"end":210,"url":"https://t.co/kcqAJAZx18","expanded_url":"https://www.ema.europa.eu/en/news/ema-management-board-highlights-december-2021-meeting","display_url":"ema.europa.eu/en/news/ema-maâ€¦"},{"start":211,"end":234,"url":"https://t.co/gEoyUI2Gw9","expanded_url":"https://twitter.com/EMA_News/status/1471890707803684872/photo/1","display_url":"pic.twitter.com/gEoyUI2Gw9"}],"hashtags":[{"start":78,"end":86,"tag":"COVID19"},{"start":123,"end":137,"tag":"ClinicalTrial"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":6,"like_count":14,"quote_count":1},"attachments":{"media_keys":["3_1471890687201366018"],"poll_ids":{}},"conversation_id":"1471890707803684872","possibly_sensitive":false,"created_at":"2021-12-17T17:11:05.000Z","id":"1471890707803684872","text":"Highlights of the December meeting of our Management Board: EMA's response to #COVID19, preparation for the go-live of the #ClinicalTrial information system and the EMA budget for 2022.\nğŸ‘‰https://t.co/kcqAJAZx18 https://t.co/gEoyUI2Gw9","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":120,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1471839986903396355","possibly_sensitive":false,"created_at":"2021-12-17T13:49:32.000Z","id":"1471839986903396355","text":"RT @EU_Commission: Each safety measure is important, but they work best when combined!  \n\nKeep yourself and others safe by getting vaccinatâ€¦","referenced_tweets":[{"type":"retweeted","id":"1471791444562268160"}]},{"entities":{"urls":[{"start":170,"end":193,"url":"https://t.co/8ylM10PyD9","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-december-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"}],"hashtags":[{"start":4,"end":9,"tag":"CHMP"},{"start":42,"end":53,"tag":"remdesivir"},{"start":158,"end":166,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":29,"reply_count":6,"like_count":37,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1471801959455891457","possibly_sensitive":false,"created_at":"2021-12-17T11:18:26.000Z","id":"1471801959455891457","text":"The #CHMP recommends extending the use of #remdesivir to adults who do not require supplemental oxygen and who are at increased risk of progressing to severe #COVID19. \nğŸ‘‰https://t.co/8ylM10PyD9","referenced_tweets":{}},{"entities":{"urls":[{"start":122,"end":145,"url":"https://t.co/8Px2Rowioz","expanded_url":"https://www.ema.europa.eu/en/news/new-treatment-sickle-cell-disease","display_url":"ema.europa.eu/en/news/new-trâ€¦"}],"hashtags":[{"start":35,"end":40,"tag":"CHMP"},{"start":101,"end":119,"tag":"SickleCellDisease"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":16,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1471801241181335554","possibly_sensitive":false,"created_at":"2021-12-17T11:15:35.000Z","id":"1471801241181335554","text":"Our human medicines committee, the #CHMP, recommends for marketing authorisation a new treatment for #SickleCellDisease.\nğŸ‘‰https://t.co/8Px2Rowioz","referenced_tweets":{}},{"entities":{"urls":[{"start":206,"end":229,"url":"https://t.co/8ylM10PyD9","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-december-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":230,"end":253,"url":"https://t.co/bXUZTb0gzt","expanded_url":"https://twitter.com/EMA_News/status/1471800831787905024/photo/1","display_url":"pic.twitter.com/bXUZTb0gzt"}],"hashtags":[{"start":37,"end":42,"tag":"CHMP"},{"start":194,"end":202,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":2,"like_count":37,"quote_count":0},"attachments":{"media_keys":["3_1471800748753178633"],"poll_ids":{}},"conversation_id":"1471800831787905024","possibly_sensitive":false,"created_at":"2021-12-17T11:13:57.000Z","id":"1471800831787905024","text":"EMA's human medicines committee, the #CHMP, recommends 13 new ğŸ’Š for approval at its Dec meeting, 91 ğŸ’Š in total in 2021 so far. Read the press release for more info, including updates related to #COVID19. \nğŸ‘‰https://t.co/8ylM10PyD9 https://t.co/bXUZTb0gzt","referenced_tweets":{}},{"entities":{"urls":[{"start":225,"end":248,"url":"https://t.co/vmmOOU52PK","expanded_url":"https://www.ema.europa.eu/en/news/increase-manufacturing-capacity-covid-19-vaccines-janssen-moderna-biontech-pfizer","display_url":"ema.europa.eu/en/news/increaâ€¦","status":200,"title":"Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer - European Medicines Agency","description":"Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer","unwound_url":"https://www.ema.europa.eu/en/news/increase-manufacturing-capacity-covid-19-vaccines-janssen-moderna-biontech-pfizer"},{"start":249,"end":272,"url":"https://t.co/0acQ8Rohuf","expanded_url":"https://twitter.com/EMA_News/status/1471519599900303361/photo/1","display_url":"pic.twitter.com/0acQ8Rohuf"}],"hashtags":[{"start":41,"end":57,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":21,"like_count":113,"quote_count":7},"attachments":{"media_keys":["3_1471518967357313026"],"poll_ids":{}},"conversation_id":"1471519599900303361","possibly_sensitive":false,"created_at":"2021-12-16T16:36:26.000Z","id":"1471519599900303361","text":"Increase in manufacturing capacity for 3 #COVID19vaccines. ğŸ’‰ğŸ’‰ğŸ’‰\n\nEMA approves an additional manufacturing site for COVID-19 vaccine Janssen, and scale-up of processes for Spikevax (Moderna) and Comirnaty (BioNTech/Pfizer).\n\nğŸ‘‰ https://t.co/vmmOOU52PK https://t.co/0acQ8Rohuf","referenced_tweets":{}},{"entities":{"urls":[{"start":223,"end":246,"url":"https://t.co/c8iqfTDYvq","expanded_url":"https://www.ema.europa.eu/en/news/ema-issues-advice-use-paxlovid-pf-07321332-ritonavir-treatment-covid-19","display_url":"ema.europa.eu/en/news/ema-isâ€¦"},{"start":247,"end":270,"url":"https://t.co/R6j0U0Lv5f","expanded_url":"https://twitter.com/EMA_News/status/1471502104468492294/photo/1","display_url":"pic.twitter.com/R6j0U0Lv5f"}],"hashtags":[{"start":177,"end":191,"tag":"RollingReview"},{"start":201,"end":218,"tag":"COVID19treatment"}],"mentions":{},"annotations":[{"start":109,"end":114,"probability":0.6913,"type":"Organization","normalized_text":"Pfizer"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":67,"reply_count":20,"like_count":116,"quote_count":19},"attachments":{"media_keys":["3_1471501618524798979"],"poll_ids":{}},"conversation_id":"1471502104468492294","possibly_sensitive":false,"created_at":"2021-12-16T15:26:55.000Z","id":"1471502104468492294","text":"We have just issued advice for ğŸ‡ªğŸ‡º countries who may decide on early use of the oral antiviral developed by Pfizer, before marketing authorisation. \n\nIn parallel, we started the #RollingReview for this #COVID19treatment.\n\nğŸ‘‰ https://t.co/c8iqfTDYvq https://t.co/R6j0U0Lv5f","referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/N5Cz0VKkMm","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-ema-recommends-authorisation-antibody-medicine-xevudy","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":141,"end":164,"url":"https://t.co/mRZtJ55ml4","expanded_url":"https://twitter.com/EMA_News/status/1471480973116198916/photo/1","display_url":"pic.twitter.com/mRZtJ55ml4"}],"hashtags":[{"start":31,"end":50,"tag":"monoclonalantibody"},{"start":79,"end":87,"tag":"COVID19"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3797,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":69,"reply_count":10,"like_count":148,"quote_count":11},"attachments":{"media_keys":["3_1471480939524018195"],"poll_ids":{}},"conversation_id":"1471480973116198916","possibly_sensitive":false,"created_at":"2021-12-16T14:02:57.000Z","id":"1471480973116198916","text":"EMA recommends authorising the #monoclonalantibody Xevudy for the treatment of #COVID19 in adults and adolescents. \nğŸ‘‰https://t.co/N5Cz0VKkMm https://t.co/mRZtJ55ml4","referenced_tweets":{}},{"entities":{"urls":[{"start":189,"end":212,"url":"https://t.co/Wl6i7Lz6jA","expanded_url":"https://www.ema.europa.eu/en/news/ema-recommends-approval-use-kineret-adults-covid-19","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":213,"end":236,"url":"https://t.co/qHQdETjeVN","expanded_url":"https://twitter.com/EMA_News/status/1471480552041689091/photo/1","display_url":"pic.twitter.com/qHQdETjeVN"}],"hashtags":[{"start":80,"end":88,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":32,"reply_count":3,"like_count":60,"quote_count":7},"attachments":{"media_keys":["3_1471480437633605636"],"poll_ids":{}},"conversation_id":"1471480552041689091","possibly_sensitive":false,"created_at":"2021-12-16T14:01:17.000Z","id":"1471480552041689091","text":"EMA recommends approval for use of Kineret, an immunosuppressive medicine ğŸ’Š, in #COVID19 adult patients requiring supplemental oxygen and at risk of developing severe respiratory failure.\nğŸ‘‰https://t.co/Wl6i7Lz6jA https://t.co/qHQdETjeVN","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":112,"end":127,"tag":"COVID19vaccine"},{"start":141,"end":149,"tag":"Novavax"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":221,"reply_count":93,"like_count":715,"quote_count":76},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1471425962189500422","possibly_sensitive":false,"created_at":"2021-12-16T10:24:21.000Z","id":"1471425962189500422","text":"â€¼ï¸ Our human medicines committee will hold an extraordinary meeting on 20 Dec to review the application for the #COVID19vaccine developed by #Novavax. \nWe will communicate the outcome of this scientific discussion.","referenced_tweets":{}},{"entities":{"urls":[{"start":254,"end":277,"url":"https://t.co/Thi2TVe6xV","expanded_url":"https://europa.eu/!VkXCtU","display_url":"europa.eu/!VkXCtU"},{"start":278,"end":301,"url":"https://t.co/bRB0fevOKu","expanded_url":"https://twitter.com/EMA_News/status/1471123697457152010/photo/1","display_url":"pic.twitter.com/bRB0fevOKu"}],"hashtags":[{"start":59,"end":83,"tag":"HealthcareProfessionals"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":17,"like_count":34,"quote_count":6},"attachments":{"media_keys":["3_1471123279691800583"],"poll_ids":{}},"conversation_id":"1471123697457152010","possibly_sensitive":false,"created_at":"2021-12-15T14:23:16.000Z","id":"1471123697457152010","text":"In December, letâ€™s celebrate 10 years of interactions with #HealthcareProfessionals and their organisations!\n\nA decade ago, EMA endorsed a framework for interaction to support access to expertise in clinical practice and enhance targeted communication.\n\nhttps://t.co/Thi2TVe6xV https://t.co/bRB0fevOKu","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"JustPublished"},{"start":72,"end":81,"tag":"SARSCoV2"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":114,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1471121938483458063","possibly_sensitive":false,"created_at":"2021-12-15T14:16:16.000Z","id":"1471121938483458063","text":"RT @ECDC_EU: #JustPublished!\nAssessment of the further emergence of the #SARSCoV2 Omicron variant of concern in the context of the ongoingâ€¦","referenced_tweets":[{"type":"retweeted","id":"1471118984498094083"}]},{"entities":{"urls":[{"start":254,"end":277,"url":"https://t.co/8mHUGEwnJP","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-vaccine-janssen-ema-recommendation-booster-dose","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":278,"end":301,"url":"https://t.co/zYZPPq65jg","expanded_url":"https://twitter.com/EMA_News/status/1471067461965565957/photo/1","display_url":"pic.twitter.com/zYZPPq65jg"}],"hashtags":[{"start":22,"end":34,"tag":"BoosterDose"},{"start":42,"end":57,"tag":"COVID19vaccine"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":64,"reply_count":48,"like_count":95,"quote_count":21},"attachments":{"media_keys":["3_1471067129357217796"],"poll_ids":{}},"conversation_id":"1471067461965565957","possibly_sensitive":false,"created_at":"2021-12-15T10:39:48.000Z","id":"1471067461965565957","text":"ğŸ“¢EMA concludes that a #BoosterDose of the #COVID19vaccine Janssen may be considered at least 2 months after the 1st dose in 18+ \n\nIn addition, a booster dose with this vaccine may be given after 2 doses of one of the mRNA vaccines authorised in the ğŸ‡ªğŸ‡º\n\nğŸ‘‰https://t.co/8mHUGEwnJP https://t.co/zYZPPq65jg","referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/VYe6X2KyMh","expanded_url":"https://www.ema.europa.eu/en/committees/chmp/chmp-agendas-minutes-highlights#agendas-section","display_url":"ema.europa.eu/en/committees/â€¦"}],"hashtags":[{"start":85,"end":90,"tag":"CHMP"}],"mentions":{},"annotations":[{"start":48,"end":50,"probability":0.3805,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":42,"like_count":35,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1470330903712911363","possibly_sensitive":false,"created_at":"2021-12-13T09:52:59.000Z","id":"1470330903712911363","text":"What's on the agenda of the December meeting of EMA's human medicines committee, the #CHMPâ“\n\nSee here: ğŸ‘‡https://t.co/VYe6X2KyMh","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/Yva3H2mipE","expanded_url":"https://twitter.com/EMA_News/status/1469330912118779911/video/1","display_url":"pic.twitter.com/Yva3H2mipE"}],"hashtags":[{"start":52,"end":60,"tag":"COVID19"},{"start":218,"end":230,"tag":"szczepionek"}],"mentions":{},"annotations":{}},"lang":"pl","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":30,"reply_count":47,"like_count":72,"quote_count":3},"attachments":{"media_keys":["13_1469324424574820362"],"poll_ids":{}},"conversation_id":"1469330912118779911","possibly_sensitive":false,"created_at":"2021-12-10T15:39:22.000Z","id":"1469330912118779911","text":"Czy majÄ… PaÅ„stwo obawy o bezpieczeÅ„stwo szczepionek #COVID19 zatwierdzonych w UE?\n\nProszÄ™ zbieraÄ‡ informacje od organÃ³w ds. zdrowia publicznego i obejrzeÄ‡ film, aby dowiedzieÄ‡ siÄ™, jak monitorowane jest bezpieczeÅ„stwo #szczepionek, aby chroniÄ‡ siÄ™ przed Å›mierciÄ… i hospitalizacjÄ…. https://t.co/Yva3H2mipE","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/sPiKxABBgB","expanded_url":"https://twitter.com/EMA_News/status/1469329146169942021/video/1","display_url":"pic.twitter.com/sPiKxABBgB"}],"hashtags":[{"start":17,"end":23,"tag":"COVID"}],"mentions":{},"annotations":{}},"lang":"sl","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":46,"reply_count":42,"like_count":122,"quote_count":4},"attachments":{"media_keys":["13_1469324441415000070"],"poll_ids":{}},"conversation_id":"1469329146169942021","possibly_sensitive":false,"created_at":"2021-12-10T15:32:21.000Z","id":"1469329146169942021","text":"Te skrbi varnost #COVID-19 cepiv odobrenih za uporabo v EU? Spremljaj informacije, ki so dostopne preko zaupanja vrednih javnozdravstvenih ustanov!\n\nV videu izveÅ¡, kako se varnost cepiv nadzoruje, da nas ta zaÅ¡Äitijo pred smrtjo in hospitalizacijo v primeru okuÅ¾be s koronavirusom https://t.co/sPiKxABBgB","referenced_tweets":{}},{"entities":{"urls":[{"start":257,"end":280,"url":"https://t.co/DauvyG1aL1","expanded_url":"https://twitter.com/EMA_News/status/1469328684393844748/video/1","display_url":"pic.twitter.com/DauvyG1aL1"}],"hashtags":[{"start":24,"end":32,"tag":"COVID19"},{"start":199,"end":206,"tag":"vakcÃ­n"}],"mentions":{},"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":16,"reply_count":29,"like_count":148,"quote_count":2},"attachments":{"media_keys":["13_1469324437212307456"],"poll_ids":{}},"conversation_id":"1469328684393844748","possibly_sensitive":false,"created_at":"2021-12-10T15:30:31.000Z","id":"1469328684393844748","text":"MÃ¡te obavy o bezpeÄnosÅ¥ #COVID19 vakcÃ­n povolenÃ½ch v ğŸ‡ªğŸ‡º? \n\nZÃ­skajte svoje informÃ¡cie od dÃ´veryhodnÃ½ch orgÃ¡nov verejnÃ©ho zdravotnÃ­ctva! \n\nPozrite si toto video a zistite, ako sa monitoruje bezpeÄnosÅ¥ #vakcÃ­n, aby vÃ¡s ochrÃ¡nili pred smrÅ¥ou a hospitalizÃ¡ciou. https://t.co/DauvyG1aL1","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/zzMcUWtXNp","expanded_url":"https://twitter.com/EMA_News/status/1469328162190508036/video/1","display_url":"pic.twitter.com/zzMcUWtXNp"}],"hashtags":[{"start":52,"end":60,"tag":"COVID19"},{"start":219,"end":231,"tag":"szczepionek"}],"mentions":{},"annotations":{}},"lang":"pl","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1469324424574820362"],"poll_ids":{}},"conversation_id":"1469328162190508036","possibly_sensitive":false,"created_at":"2021-12-10T15:28:27.000Z","id":"1469328162190508036","text":"Czy majÄ… PaÅ„stwo obawy o bezpieczeÅ„stwo szczepionek #COVID19 zatwierdzonych w UE?\n\nProszÄ™ zbieraÄ‡ informacje od organÃ³w ds. zdrowia publicznego i obejrzeÄ‡ film, aby dowiedzieÄ‡ siÄ™, jak monitorowane jest  bezpieczeÅ„stwo #szczepionek, aby chroniÄ‡ siÄ™ przed Å›mierciÄ… i hospitalizacjÄ… https://t.co/zzMcUWtXNp","referenced_tweets":{}},{"entities":{"urls":[{"start":256,"end":279,"url":"https://t.co/PtzhXUHmac","expanded_url":"https://twitter.com/EMA_News/status/1469327475817816076/video/1","display_url":"pic.twitter.com/PtzhXUHmac"}],"hashtags":[{"start":36,"end":44,"tag":"COVID19"},{"start":173,"end":181,"tag":"vakcÄ«nu"}],"mentions":{},"annotations":{}},"lang":"lv","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":13,"reply_count":26,"like_count":66,"quote_count":4},"attachments":{"media_keys":["13_1469324416173629443"],"poll_ids":{}},"conversation_id":"1469327475817816076","possibly_sensitive":false,"created_at":"2021-12-10T15:25:43.000Z","id":"1469327475817816076","text":"Vai esat noraizÄ“jies par ES atÄ¼auto #COVID19 vakcÄ«nu droÅ¡Ä«bu?\n\nSazinieties ar sabiedrÄ«bas veselÄ«bas iestÄdÄ“m! \n\nNoskatieties Å¡o videoklipu, lai saprastu, kÄ tiek uzraudzÄ«ta #vakcÄ«nu droÅ¡Ä«ba, lai tÄs pasargÄtu JÅ«s no hospitalizÄcijas vai nÄves no COVID-19. https://t.co/PtzhXUHmac","referenced_tweets":{}},{"entities":{"urls":[{"start":271,"end":294,"url":"https://t.co/iLFuGI5IrB","expanded_url":"https://twitter.com/EMA_News/status/1469327283165016064/video/1","display_url":"pic.twitter.com/iLFuGI5IrB"}],"hashtags":[{"start":35,"end":51,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"lt","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":0,"reply_count":3,"like_count":10,"quote_count":0},"attachments":{"media_keys":["13_1469324258283294727"],"poll_ids":{}},"conversation_id":"1469327283165016064","possibly_sensitive":false,"created_at":"2021-12-10T15:24:57.000Z","id":"1469327283165016064","text":"Turite abejoniÅ³ dÄ—l ES patvirtintÅ³ #COVID19vaccines vakcinÅ³ saugumo?    \n\nPasisemkite informacijos iÅ¡ patikimÅ³ sveikatos apsaugos Å¡altiniÅ³! \n\nPerÅ¾iÅ«rÄ—kite video ir suÅ¾inokite kaip yra stebimas vakcinÅ³ saugumas tam, kad jos apsaugotÅ³ Jus nuo mirties ir gydymo ligoninÄ—se. https://t.co/iLFuGI5IrB","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/7jAxm0QFhD","expanded_url":"https://twitter.com/EMA_News/status/1469326871703793675/video/1","display_url":"pic.twitter.com/7jAxm0QFhD"}],"hashtags":[{"start":39,"end":47,"tag":"COVID19"},{"start":197,"end":206,"tag":"vakcinÃ¡k"}],"mentions":{},"annotations":{}},"lang":"hu","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":9,"reply_count":23,"like_count":65,"quote_count":1},"attachments":{"media_keys":["13_1469324262259499020"],"poll_ids":{}},"conversation_id":"1469326871703793675","possibly_sensitive":false,"created_at":"2021-12-10T15:23:19.000Z","id":"1469326871703793675","text":"AggÃ¡lyai vannak a ğŸ‡ªğŸ‡º-ban engedÃ©lyezett #COVID19 vakcinÃ¡k biztonsÃ¡gossÃ¡gÃ¡val kapcsolatban? InformÃ¡ciÃ³Ã©rt forduljon a kÃ¶zegÃ©szsÃ©gÃ¼gyi hatÃ³sÃ¡gokhoz!\n\nEbbÅ‘l a videÃ³bÃ³l megtudhatja, hogyan ellenÅ‘rzik a #vakcinÃ¡k biztonsÃ¡gossÃ¡gÃ¡t, hogy megvÃ©djÃ©k Ã–nt a halÃ¡ltÃ³l Ã©s a kÃ³rhÃ¡zba kerÃ¼lÃ©stÅ‘l. https://t.co/7jAxm0QFhD","referenced_tweets":{}},{"entities":{"urls":[{"start":247,"end":270,"url":"https://t.co/fsgCTWY8K6","expanded_url":"https://twitter.com/EMA_News/status/1469326569177063430/video/1","display_url":"pic.twitter.com/fsgCTWY8K6"}],"hashtags":[{"start":23,"end":38,"tag":"COVID19cjepiva"}],"mentions":{},"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":22,"reply_count":62,"like_count":136,"quote_count":5},"attachments":{"media_keys":["13_1469324245092163586"],"poll_ids":{}},"conversation_id":"1469326569177063430","possibly_sensitive":false,"created_at":"2021-12-10T15:22:07.000Z","id":"1469326569177063430","text":"Brine li Vas sigurnost #COVID19cjepiva odobrenih u EU? \n\nInformirajte se od strane pouzdanih javnozdravstvenih ustanova!\n\nPogledajte ovaj video i nauÄite kako se prati sigurnost cjepiva, kako bi Vas ona mogla zaÅ¡tititi od smrti i hospitalizacije. https://t.co/fsgCTWY8K6","referenced_tweets":{}},{"entities":{"urls":[{"start":262,"end":285,"url":"https://t.co/49BAJ6vnE7","expanded_url":"https://twitter.com/EMA_News/status/1469326406807134217/video/1","display_url":"pic.twitter.com/49BAJ6vnE7"}],"hashtags":[{"start":16,"end":24,"tag":"COVID19"},{"start":163,"end":175,"tag":"vaktsiinide"}],"mentions":{},"annotations":{}},"lang":"et","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":6,"reply_count":18,"like_count":55,"quote_count":0},"attachments":{"media_keys":["13_1469324244198830082"],"poll_ids":{}},"conversation_id":"1469326406807134217","possibly_sensitive":false,"created_at":"2021-12-10T15:21:28.000Z","id":"1469326406807134217","text":"Kas olete mures #COVID19 vaktsiinide ohutuse pÃ¤rast?\n\nTutvuge informatsiooniga mida esitavad usaldusvÃ¤Ã¤rsed rahvatervise asutused! \n\nVaadake videot sellest kuidas #vaktsiinide ohutust jÃ¤lgitakse selleks et nad kaitsekstid sind surma ja haiglasse sattumise eest. https://t.co/49BAJ6vnE7","referenced_tweets":{}},{"entities":{"urls":[{"start":277,"end":300,"url":"https://t.co/3w1J0SBMn9","expanded_url":"https://twitter.com/EMA_News/status/1469326130448637958/video/1","display_url":"pic.twitter.com/3w1J0SBMn9"}],"hashtags":[{"start":32,"end":47,"tag":"COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"},{"start":206,"end":214,"tag":"ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"}],"mentions":{},"annotations":{}},"lang":"el","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":122,"reply_count":39,"like_count":291,"quote_count":14},"attachments":{"media_keys":["13_1469324078666457098"],"poll_ids":{}},"conversation_id":"1469326130448637958","possibly_sensitive":false,"created_at":"2021-12-10T15:20:22.000Z","id":"1469326130448637958","text":"Î‘Î½Î·ÏƒÏ…Ï‡ÎµÎ¯Ï„Îµ Î³Î¹Î± Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€Î¿Ï… ÎµÎ³ÎºÏÎ¯Î¸Î·ÎºÎ±Î½ ÏƒÏ„Î·Î½ Î•E; \n\nÎ•Î½Î·Î¼ÎµÏÏ‰Î¸ÎµÎ¯Ï„Îµ Î±Ï€ÏŒ Î±Î¾Î¹ÏŒÏ€Î¹ÏƒÏ„ÎµÏ‚ Ï…Ï€Î·ÏÎµÏƒÎ¯ÎµÏ‚ Î´Î·Î¼ÏŒÏƒÎ¹Î±Ï‚ Ï…Î³ÎµÎ¯Î±Ï‚! \n\nÎ Î±ÏÎ±ÎºÎ¿Î»Î¿Ï…Î¸Î®ÏƒÏ„Îµ Î±Ï…Ï„ÏŒ Ï„Î¿ Î²Î¯Î½Ï„ÎµÎ¿ Î³Î¹Î± Î½Î± Î¼Î¬Î¸ÎµÏ„Îµ Ï€ÏÏ‚ ÎµÏ€Î¹Î²Î»Î­Ï€ÎµÏ„Î±Î¹ Î· Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î­Ï„ÏƒÎ¹ ÏÏƒÏ„Îµ Î½Î± Ï€ÏÎ¿ÏƒÏ„Î±Ï„Î­ÏˆÎ¿Ï…Î½ Î±Ï€ÏŒ Î¸Î¬Î½Î±Ï„Î¿ Î® Î±Î½Î¬Î³ÎºÎ· Î³Î¹Î± Î½Î¿ÏƒÎ¿ÎºÎ¿Î¼ÎµÎ¯Î¿. https://t.co/3w1J0SBMn9","referenced_tweets":{}},{"entities":{"urls":[{"start":280,"end":303,"url":"https://t.co/uy6BfIQ9KB","expanded_url":"https://twitter.com/EMA_News/status/1469325739325632522/video/1","display_url":"pic.twitter.com/uy6BfIQ9KB"}],"hashtags":[{"start":45,"end":53,"tag":"COVID19"},{"start":195,"end":207,"tag":"Impfstoffen"}],"mentions":{},"annotations":{}},"lang":"de","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":44,"reply_count":48,"like_count":147,"quote_count":7},"attachments":{"media_keys":["13_1469324078385356809"],"poll_ids":{}},"conversation_id":"1469325739325632522","possibly_sensitive":false,"created_at":"2021-12-10T15:18:49.000Z","id":"1469325739325632522","text":"Sind Sie in Sorge Ã¼ber in der EU zugelassene #COVID19-Impfstoffe?\n\nInformationen Sie sich bei GesundheitsaufsichtsbehÃ¶rden!\n\nSchauen Sie dieses Video, um zu verstehen, wie wir die Sicherheit von #Impfstoffen Ã¼berwachen, damit diese Sie vor Tod und Krankenhausaufenthalt schÃ¼tzen. https://t.co/uy6BfIQ9KB","referenced_tweets":{}},{"entities":{"urls":[{"start":262,"end":285,"url":"https://t.co/1WXZkzRJDw","expanded_url":"https://twitter.com/EMA_News/status/1469325580621565953/video/1","display_url":"pic.twitter.com/1WXZkzRJDw"}],"hashtags":[{"start":37,"end":45,"tag":"COVID19"},{"start":189,"end":197,"tag":"vakcÃ­ny"}],"mentions":{},"annotations":{}},"lang":"cs","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":13,"reply_count":19,"like_count":76,"quote_count":1},"attachments":{"media_keys":["13_1469324077924069380"],"poll_ids":{}},"conversation_id":"1469325580621565953","possibly_sensitive":false,"created_at":"2021-12-10T15:18:11.000Z","id":"1469325580621565953","text":"MÃ¡te obavy o bezpeÄnost vakcÃ­n proti #COVID19 autorizovanÃ½ch v EU? \n\nHledejte informace u dÅ¯vÄ›ryhodnÃ½ch orgÃ¡nÅ¯ ochrany veÅ™ejnÃ©ho zdravÃ­! \n\nSledujte video, kde se dozvÃ­te, jak je bezpeÄnost #vakcÃ­ny monitorovÃ¡na tak, aby vÃ¡s ochrÃ¡nila pÅ™ed smrtÃ­ a hospitalizacÃ­. https://t.co/1WXZkzRJDw","referenced_tweets":{}},{"entities":{"urls":[{"start":268,"end":291,"url":"https://t.co/EelNFSRvkM","expanded_url":"https://twitter.com/EMA_News/status/1469325262395424780/video/1","display_url":"pic.twitter.com/EelNFSRvkM"}],"hashtags":[{"start":47,"end":55,"tag":"COVID19"},{"start":210,"end":220,"tag":"Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ"}],"mentions":{},"annotations":{}},"lang":"bg","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":34,"reply_count":51,"like_count":150,"quote_count":8},"attachments":{"media_keys":["13_1469324077940756485"],"poll_ids":{}},"conversation_id":"1469325262395424780","possibly_sensitive":false,"created_at":"2021-12-10T15:16:55.000Z","id":"1469325262395424780","text":"Ğ˜Ğ¼Ğ°Ñ‚Ğµ Ğ»Ğ¸ Ğ¿Ñ€Ğ¸Ñ‚ĞµÑĞ½ĞµĞ½Ğ¸Ñ Ğ¾Ñ‚Ğ½Ğ¾ÑĞ½Ğ¾ Ğ±ĞµĞ·Ğ¾Ğ¿Ğ°ÑĞ½Ğ¾ÑÑ‚Ñ‚Ğ° Ğ½Ğ°  #COVID19 Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ, Ñ€Ğ°Ğ·Ñ€ĞµÑˆĞµĞ½Ğ¸ Ğ² ğŸ‡ªğŸ‡º?\n\nĞ˜Ğ½Ñ„Ğ¾Ñ€Ğ¼Ğ¸Ñ€Ğ°Ğ¹Ñ‚Ğµ ÑĞµ Ğ¾Ñ‚ Ğ´Ğ¾Ğ²ĞµÑ€ĞµĞ½Ğ¸ Ğ¾Ñ€Ğ³Ğ°Ğ½Ğ¸ Ğ·Ğ° Ğ¾Ğ±Ñ‰ĞµÑÑ‚Ğ²ĞµĞ½Ğ¾ Ğ·Ğ´Ñ€Ğ°Ğ²ĞµĞ¾Ğ¿Ğ°Ğ·Ğ²Ğ°Ğ½Ğµ!\n\nĞ“Ğ»ĞµĞ´Ğ°Ğ¹Ñ‚Ğµ Ñ‚Ğ¾Ğ²Ğ° Ğ²Ğ¸Ğ´ĞµĞ¾ Ğ¸ Ğ½Ğ°ÑƒÑ‡ĞµÑ‚Ğµ ĞºĞ°Ğº ÑĞµ ÑĞ»ĞµĞ´Ğ¸ Ğ±ĞµĞ·Ğ¾Ğ¿Ğ°ÑĞ½Ğ¾ÑÑ‚Ñ‚Ğ° Ğ½Ğ° #Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ, Ğ·Ğ° Ğ´Ğ° Ğ²Ğ¸ Ğ¿Ñ€ĞµĞ´Ğ¿Ğ°Ğ·ÑÑ‚ Ğ¾Ñ‚ ÑĞ¼ÑŠÑ€Ñ‚ Ğ¸ Ñ…Ğ¾ÑĞ¿Ğ¸Ñ‚Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ. https://t.co/EelNFSRvkM","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":27,"end":35,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":63,"end":64,"probability":0.4694,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1469268678499835905","possibly_sensitive":false,"created_at":"2021-12-10T11:32:05.000Z","id":"1469268678499835905","text":"RT @ECDC_EU: Update on the #COVID19 vaccination rollout in the EU/EEA. See below and in our weekly reports!\nâ¬‡ï¸â¬‡ï¸â¬‡ï¸","referenced_tweets":[{"type":"retweeted","id":"1469245877554495491"}]},{"entities":{"urls":[{"start":238,"end":261,"url":"https://t.co/BQGeDELrMD","expanded_url":"https://www.ema.europa.eu/en/news/international-regulators-stress-continued-need-covid-19-therapeutics","display_url":"ema.europa.eu/en/news/internâ€¦"},{"start":269,"end":292,"url":"https://t.co/W1rJlXXrBG","expanded_url":"https://twitter.com/EMA_News/status/1469240355929436163/photo/1","display_url":"pic.twitter.com/W1rJlXXrBG"}],"hashtags":[{"start":36,"end":51,"tag":"pharmaceutical"},{"start":187,"end":195,"tag":"COVID19"},{"start":213,"end":222,"tag":"patients"},{"start":262,"end":268,"tag":"ICMRA"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":15,"like_count":26,"quote_count":1},"attachments":{"media_keys":["3_1469240212257751040"],"poll_ids":{}},"conversation_id":"1469240355929436163","possibly_sensitive":false,"created_at":"2021-12-10T09:39:32.000Z","id":"1469240355929436163","text":"Global regulators urge researchers, #pharmaceutical industry, healthcare professionals, health research funding agencies &amp; research institutions to continue their focus on developing #COVID19 therapeutics for #patients around theğŸŒ. \nğŸ‘‰https://t.co/BQGeDELrMD #ICMRA https://t.co/W1rJlXXrBG","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":29,"end":51,"tag":"VaccinationAcceptance"},{"start":69,"end":74,"tag":"ECDC"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468985131025240073","possibly_sensitive":false,"created_at":"2021-12-09T16:45:22.000Z","id":"1468985131025240073","text":"RT @ECDC_EU: How to increase #VaccinationAcceptance &amp; uptake?\nAn #ECDC online course based on the \"5C Model\" will help you to:\n-understandâ€¦","referenced_tweets":[{"type":"retweeted","id":"1468981155273785344"}]},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/Pc2pOhGOfN","expanded_url":"https://twitter.com/i/events/1468939879220277250","display_url":"twitter.com/i/events/14689â€¦"}],"hashtags":[{"start":72,"end":83,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":5,"like_count":11,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468941069865918467","possibly_sensitive":false,"created_at":"2021-12-09T13:50:17.000Z","id":"1468941069865918467","text":"See the live tweets posted during our press briefing today, 9 December. #EMAPresser https://t.co/Pc2pOhGOfN","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":125,"end":133,"tag":"COVID19"},{"start":134,"end":143,"tag":"patients"},{"start":235,"end":246,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":6,"like_count":38,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:15:28.000Z","id":"1468932307109257221","text":"Xevudy, an antiviral monoclonal antibody, will be considered by our human medicines committee next week for the treatment of #COVID19 #patients who do not require additional oxygen and who are at increased risk of disease progression. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468931664789319684"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Novavax"},{"start":202,"end":213,"tag":"EMAPresser"},{"start":214,"end":230,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":75,"reply_count":75,"like_count":211,"quote_count":39},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:12:54.000Z","id":"1468931664789319684","text":"#Novavaxâ€™s COVID-19 vaccine: We could possibly conclude its evaluation before the end of the year. When authorised, this vaccine will provide a new option for vaccinating people in the EU and globally.\n#EMAPresser #COVID19vaccines","referenced_tweets":[{"type":"replied_to","id":"1468931540432441357"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":10,"end":26,"tag":"COVID19vaccines"},{"start":196,"end":207,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":4,"like_count":26,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:12:25.000Z","id":"1468931540432441357","text":"Safety of #COVID19vaccines continues to be supported by their large-scale use worldwide. This is the largest vaccination campaign ever, with more than 6âƒ£0âƒ£0âƒ£ million doses administered in the ğŸ‡ªğŸ‡º. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468931272408027142"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":165,"end":173,"tag":"COVID19"},{"start":269,"end":280,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":49,"reply_count":5,"like_count":97,"quote_count":21},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:11:21.000Z","id":"1468931272408027142","text":"Epidemiological data show that infections &amp; hospitalisation of children aged 5-11 years have been on the rise in recent months. While children at risk of severe #COVID19 should be given priority, all children in this age group should be considered for vaccination. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468931098281447426"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":16,"end":32,"tag":"COVID19vaccines"},{"start":188,"end":199,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":37,"reply_count":8,"like_count":72,"quote_count":11},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:10:39.000Z","id":"1468931098281447426","text":"Pfizer/BioNTech #COVID19vaccines in children aged 5-11 years: Safety data are reassuring. So far, no safety concerns have emerged from large vaccination campaigns in this group in the ğŸ‡ºğŸ‡¸. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468930670386946058"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":40,"end":49,"tag":"boosters"},{"start":215,"end":226,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":40,"reply_count":11,"like_count":57,"quote_count":30},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:08:57.000Z","id":"1468930670386946058","text":"Current recommendation is to administer #boosters preferably after 6âƒ£ months. Available data support safe and effective administration of a booster dose as early as 3âƒ£ months from completion of primary vaccination. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468930471031672838"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":128,"end":140,"tag":"coronavirus"},{"start":189,"end":197,"tag":"booster"},{"start":199,"end":210,"tag":"EMApresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":3,"like_count":26,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:08:10.000Z","id":"1468930471031672838","text":"Studies show that the combination of vector viral vaccines followed by mRNA vaccines produces high levels of antibodies against #coronavirus when used either as primary vaccination or as a #booster. #EMApresser","referenced_tweets":[{"type":"replied_to","id":"1468930229620158468"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":215,"end":226,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.6771,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":8,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:07:12.000Z","id":"1468930229620158468","text":"EMA has been working with vaccines manufacturers on contingency plans to define requirements for advancing potential variant vaccines. It is too early to say whether the vaccine composition will need to be changed. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468930064855310340"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":26,"end":42,"tag":"COVID19vaccines"},{"start":143,"end":151,"tag":"Omicron"},{"start":204,"end":215,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":2,"like_count":19,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:06:53.000Z","id":"1468930149529829378","text":"The companies that market #COVID19vaccines are required to submit the results of laboratory tests to determine the level of neutralisation for #Omicron. \nWe are prepared to take rapid action when needed. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468930064855310340"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":59,"end":74,"tag":"OmicronVariant"},{"start":112,"end":128,"tag":"COVID19vaccines"},{"start":194,"end":205,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":4,"like_count":40,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:06:33.000Z","id":"1468930064855310340","text":"At this stage, we do not have enough data on the impact of #OmicronVariant on the effectiveness of the approved #COVID19vaccines but we are continuously scanning the horizon to gather evidence. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468929710717607937"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":13,"tag":"DeltaVariant"},{"start":114,"end":122,"tag":"COVID19"},{"start":191,"end":202,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":3,"like_count":23,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:05:09.000Z","id":"1468929710717607937","text":"#DeltaVariant should remain the main concern. We are reiterating a call to all citizens to complete their primary #COVID19 vaccination and, for those who are eligible, to get a booster shot. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1468929181601861634"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":171,"end":194,"url":"https://t.co/ifVDEHDEXz","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-9","display_url":"ema.europa.eu/en/events/ema-â€¦"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":17,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T13:03:02.000Z","id":"1468929181601861634","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser. \nğŸ‘‰https://t.co/ifVDEHDEXz","referenced_tweets":[{"type":"replied_to","id":"1468920745485086724"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":150,"end":173,"url":"https://t.co/ifVDEHm461","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-9","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":174,"end":197,"url":"https://t.co/Onfx67dsYg","expanded_url":"https://twitter.com/EMA_News/status/1468920745485086724/photo/1","display_url":"pic.twitter.com/Onfx67dsYg"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":137,"end":148,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":41,"reply_count":22,"like_count":72,"quote_count":5},"attachments":{"media_keys":["3_1468920385878085636"],"poll_ids":{}},"conversation_id":"1468920745485086724","possibly_sensitive":false,"created_at":"2021-12-09T12:29:31.000Z","id":"1468920745485086724","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 9 December, from 14:00 to 14:30 CET. #EMAPresser\nğŸ‘‰https://t.co/ifVDEHm461 https://t.co/Onfx67dsYg","referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/IyvnlenB7S","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-9-december-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":157,"end":180,"url":"https://t.co/zZimN3VBsO","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-covid-19-vaccine-janssen-9-december-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-covid-19-vaccine-janssen-9-december-2021_en.pdf"},{"start":194,"end":217,"url":"https://t.co/7oNUti19aM","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-spikevax-previously-covid-19-vaccine-moderna-9-december-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":232,"end":255,"url":"https://t.co/LHoyMqTohK","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-9-december-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":275,"end":298,"url":"https://t.co/sRK8SLMEAe","expanded_url":"https://twitter.com/EMA_News/status/1468900745831452673/photo/1","display_url":"pic.twitter.com/sRK8SLMEAe"}],"hashtags":[{"start":50,"end":66,"tag":"COVID19vaccines"},{"start":257,"end":274,"tag":"SafetyOfVaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":32,"reply_count":16,"like_count":59,"quote_count":6},"attachments":{"media_keys":["3_1468900681360850948"],"poll_ids":{}},"conversation_id":"1468900745831452673","possibly_sensitive":false,"created_at":"2021-12-09T11:10:03.000Z","id":"1468900745831452673","text":"Check out our latest updates on the safety of all #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º:\n\nâ˜‘ï¸ Comirnaty: https://t.co/IyvnlenB7S\nâ˜‘ï¸ COVID-19 Vaccine Janssen: https://t.co/zZimN3VBsO\nâ˜‘ï¸ Spikevax: https://t.co/7oNUti19aM\nâ˜‘ï¸ Vaxzevria: https://t.co/LHoyMqTohK\n\n#SafetyOfVaccines https://t.co/sRK8SLMEAe","referenced_tweets":{}},{"entities":{"urls":[{"start":274,"end":297,"url":"https://t.co/Z8KQmrGfOO","expanded_url":"https://twitter.com/EMA_News/status/1468888258369183746/video/1","display_url":"pic.twitter.com/Z8KQmrGfOO"}],"hashtags":[{"start":32,"end":47,"tag":"COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"},{"start":203,"end":211,"tag":"ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"}],"mentions":{},"annotations":{}},"lang":"el","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":34,"reply_count":29,"like_count":82,"quote_count":6},"attachments":{"media_keys":["13_1468615149036527617"],"poll_ids":{}},"conversation_id":"1468888258369183746","possibly_sensitive":false,"created_at":"2021-12-09T10:20:26.000Z","id":"1468888258369183746","text":"Î‘Î½Î·ÏƒÏ…Ï‡ÎµÎ¯Ï„Îµ Î³Î¹Î± Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€Î¿Ï… ÎµÎ³ÎºÏÎ¯Î¸Î·ÎºÎ±Î½ ÏƒÏ„Î·Î½ Î•E;\n\nÎ•Î½Î·Î¼ÎµÏÏ‰Î¸ÎµÎ¯Ï„Îµ Î±Ï€ÏŒ Î±Î¾Î¹ÏŒÏ€Î¹ÏƒÏ„ÎµÏ‚ Ï…Ï€Î·ÏÎµÏƒÎ¯ÎµÏ‚ Î´Î·Î¼ÏŒÏƒÎ¹Î±Ï‚ Ï…Î³ÎµÎ¯Î±Ï‚! Î Î±ÏÎ±ÎºÎ¿Î»Î¿Ï…Î¸Î®ÏƒÏ„Îµ Î±Ï…Ï„ÏŒ Ï„Î¿ Î²Î¯Î½Ï„ÎµÎ¿ Î³Î¹Î± Î½Î± Î¼Î¬Î¸ÎµÏ„Îµ Ï€ÏÏ‚ ÎµÏ€Î¹Î²Î»Î­Ï€ÎµÏ„Î±Î¹ Î· Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î­Ï„ÏƒÎ¹ ÏÏƒÏ„Îµ Î½Î± Ï€ÏÎ¿ÏƒÏ„Î±Ï„Î­ÏˆÎ¿Ï…Î½ Î±Ï€ÏŒ Î¸Î¬Î½Î±Ï„Î¿ Î® Î±Î½Î¬Î³ÎºÎ· Î³Î¹Î± Î½Î¿ÏƒÎ¿ÎºÎ¿Î¼ÎµÎ¯Î¿. https://t.co/Z8KQmrGfOO","referenced_tweets":{}},{"entities":{"urls":[{"start":277,"end":300,"url":"https://t.co/cnVijQFOsY","expanded_url":"https://twitter.com/EMA_News/status/1468629912470769667/video/1","display_url":"pic.twitter.com/cnVijQFOsY"}],"hashtags":[{"start":48,"end":56,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"ro","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":31,"reply_count":51,"like_count":164,"quote_count":6},"attachments":{"media_keys":["13_1468628460666904579"],"poll_ids":{}},"conversation_id":"1468629912470769667","possibly_sensitive":false,"created_at":"2021-12-08T17:13:51.000Z","id":"1468629912470769667","text":"Te intereseazÄƒ siguranÅ£a vaccinurilor Ã®mpotriva #COVID19 autorizate Ã®n UE?\n\nInformeazÄƒ-te de la autoritÄƒÅ£ile de sÄƒnÄƒtate publicÄƒ!\n\nUrmÄƒreÅŸte acest video pentru a afla cum monitorizÄƒm siguranÅ£a vaccinurilor, astfel Ã®ncÃ¢t ele sÄƒ te protejeze Ã®mpotriva spitalizÄƒrii ÅŸi decesului. https://t.co/cnVijQFOsY","referenced_tweets":{}},{"entities":{"urls":[{"start":274,"end":297,"url":"https://t.co/isE2sT548P","expanded_url":"https://twitter.com/EMA_News/status/1468629785173626884/video/1","display_url":"pic.twitter.com/isE2sT548P"}],"hashtags":[{"start":34,"end":42,"tag":"COVID19"},{"start":189,"end":197,"tag":"vaccins"}],"mentions":{},"annotations":{}},"lang":"fr","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":56,"reply_count":83,"like_count":86,"quote_count":14},"attachments":{"media_keys":["13_1468628460260057091"],"poll_ids":{}},"conversation_id":"1468629785173626884","possibly_sensitive":false,"created_at":"2021-12-08T17:13:21.000Z","id":"1468629785173626884","text":"La sÃ©curitÃ© des vaccins contre la #COVID19 autorisÃ©s dans l'UE vous inquiÃ¨te ?\n\nRenseignez-vous auprÃ¨s des autoritÃ©s de santÃ© ! Regardez cette vidÃ©o pour comprendre comment la sÃ©curitÃ© des #vaccins est assurÃ©e afin qu'ils vous protÃ¨gent d'une hospitalisation ou d'un dÃ©cÃ¨s. https://t.co/isE2sT548P","referenced_tweets":{}},{"entities":{"urls":[{"start":277,"end":300,"url":"https://t.co/CHE05MaHNk","expanded_url":"https://twitter.com/EMA_News/status/1468629640671481857/video/1","display_url":"pic.twitter.com/CHE05MaHNk"}],"hashtags":[{"start":41,"end":57,"tag":"COVID19vaccines"},{"start":192,"end":201,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":18,"reply_count":55,"like_count":43,"quote_count":9},"attachments":{"media_keys":["13_1468628460252065793"],"poll_ids":{}},"conversation_id":"1468629640671481857","possibly_sensitive":false,"created_at":"2021-12-08T17:12:46.000Z","id":"1468629640671481857","text":"Do you have concerns about the safety of #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º? \n\nTake your information from trusted public health authorities!\nWatch this video now to learn how the safety of #vaccines is monitored so they will protect you against death &amp; hospitalization. https://t.co/CHE05MaHNk","referenced_tweets":{}},{"entities":{"urls":[{"start":232,"end":255,"url":"https://t.co/L9UKzyfsFj","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines?pk_source=twitter&pk_medium=link&pk_campaign=ema_safety_reports_animation","display_url":"ema.europa.eu/en/human-regulâ€¦"},{"start":256,"end":279,"url":"https://t.co/CZd7iOZDBj","expanded_url":"https://twitter.com/EMA_News/status/1468625592631373836/video/1","display_url":"pic.twitter.com/CZd7iOZDBj"}],"hashtags":[{"start":0,"end":4,"tag":"DYK"},{"start":44,"end":52,"tag":"COVID19"},{"start":145,"end":154,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":75,"reply_count":44,"like_count":109,"quote_count":11},"attachments":{"media_keys":["7_1468625077163991046"],"poll_ids":{}},"conversation_id":"1468625592631373836","possibly_sensitive":false,"created_at":"2021-12-08T16:56:41.000Z","id":"1468625592631373836","text":"#DYK that most suspected side effects after #COVID19 vaccination are not caused by the vaccine?\n\nWatch this video now to learn how the safety of #vaccines is monitored so they will protect you against death &amp; hospitalization. \nğŸ‘‰https://t.co/L9UKzyfsFj https://t.co/CZd7iOZDBj","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/awhr1GWTOK","expanded_url":"https://twitter.com/EMA_News/status/1468621380015255552/video/1","display_url":"pic.twitter.com/awhr1GWTOK"}],"hashtags":[{"start":17,"end":23,"tag":"COVID"}],"mentions":{},"annotations":{}},"lang":"sl","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":17,"reply_count":18,"like_count":36,"quote_count":2},"attachments":{"media_keys":["13_1468616717630799872"],"poll_ids":{}},"conversation_id":"1468621380015255552","possibly_sensitive":false,"created_at":"2021-12-08T16:39:57.000Z","id":"1468621380015255552","text":"Te skrbi varnost #COVID-19 cepiv odobrenih za uporabo v EU?\nSpremljaj informacije, ki so dostopne preko zaupanja vrednih javnozdravstvenih ustanov! V videu izveÅ¡, kako se varnost cepiv nadzoruje, da nas ta zaÅ¡Äitijo pred smrtjo in hospitalizacijo v primeru okuÅ¾be s koronavirusom. https://t.co/awhr1GWTOK","referenced_tweets":{}},{"entities":{"urls":[{"start":255,"end":278,"url":"https://t.co/SsFDmY9bkX","expanded_url":"https://twitter.com/EMA_News/status/1468621089542590468/video/1","display_url":"pic.twitter.com/SsFDmY9bkX"}],"hashtags":[{"start":24,"end":32,"tag":"COVID19"},{"start":197,"end":204,"tag":"vakcÃ­n"}],"mentions":{},"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":15,"quote_count":0},"attachments":{"media_keys":["13_1468616592615370754"],"poll_ids":{}},"conversation_id":"1468621089542590468","possibly_sensitive":false,"created_at":"2021-12-08T16:38:48.000Z","id":"1468621089542590468","text":"MÃ¡te obavy o bezpeÄnosÅ¥ #COVID19 vakcÃ­n povolenÃ½ch v ğŸ‡ªğŸ‡º? \n\nZÃ­skajte svoje informÃ¡cie od dÃ´veryhodnÃ½ch orgÃ¡nov verejnÃ©ho zdravotnÃ­ctva! Pozrite si toto video a zistite, ako sa monitoruje bezpeÄnosÅ¥ #vakcÃ­n, aby vÃ¡s ochrÃ¡nili pred smrÅ¥ou a hospitalizÃ¡ciou. https://t.co/SsFDmY9bkX","referenced_tweets":{}},{"entities":{"urls":[{"start":276,"end":299,"url":"https://t.co/6tuIvXwL64","expanded_url":"https://twitter.com/EMA_News/status/1468620967954219009/video/1","display_url":"pic.twitter.com/6tuIvXwL64"}],"hashtags":[{"start":48,"end":56,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"ro","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468616529939894272"],"poll_ids":{}},"conversation_id":"1468620967954219009","possibly_sensitive":false,"created_at":"2021-12-08T16:38:19.000Z","id":"1468620967954219009","text":"Te intereseazÄƒ siguranÅ£a vaccinurilor Ã®mpotriva #COVID19 autorizate Ã®n UE?\n\nInformeazÄƒ-te de la autoritÄƒÅ£ile de sÄƒnÄƒtate publicÄƒ!\nUrmÄƒreÅŸte acest video pentru a afla cum monitorizÄƒm siguranÅ£a vaccinurilor, astfel Ã®ncÃ¢t ele sÄƒ te protejeze Ã®mpotriva spitalizÄƒrii ÅŸi decesului. https://t.co/6tuIvXwL64","referenced_tweets":{}},{"entities":{"urls":[{"start":277,"end":300,"url":"https://t.co/C8F7gsQbJf","expanded_url":"https://twitter.com/EMA_News/status/1468620829940346882/video/1","display_url":"pic.twitter.com/C8F7gsQbJf"}],"hashtags":[{"start":52,"end":60,"tag":"COVID19"},{"start":218,"end":230,"tag":"szczepionek"}],"mentions":{},"annotations":{}},"lang":"pl","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":72,"reply_count":115,"like_count":213,"quote_count":12},"attachments":{"media_keys":["13_1468616082210521090"],"poll_ids":{}},"conversation_id":"1468620829940346882","possibly_sensitive":false,"created_at":"2021-12-08T16:37:46.000Z","id":"1468620829940346882","text":"Czy majÄ… PaÅ„stwo obawy o bezpieczeÅ„stwo szczepionek #COVID19 zatwierdzonych w UE?\n\nProszÄ™ zbieraÄ‡ informacje od organÃ³w ds. drowia publicznego i obejrzeÄ‡ film, aby dowiedzieÄ‡ siÄ™, jak monitorowane jest  bezpieczeÅ„stwo #szczepionek, aby chroniÄ‡ przed Å›mierciÄ… i hospitalizacjÄ…. https://t.co/C8F7gsQbJf","referenced_tweets":{}},{"entities":{"urls":[{"start":271,"end":294,"url":"https://t.co/MAEDVzCbCh","expanded_url":"https://twitter.com/EMA_News/status/1468620691213717509/video/1","display_url":"pic.twitter.com/MAEDVzCbCh"}],"hashtags":[{"start":35,"end":51,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"lt","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":5,"like_count":2,"quote_count":0},"attachments":{"media_keys":["13_1468615917550510085"],"poll_ids":{}},"conversation_id":"1468620691213717509","possibly_sensitive":false,"created_at":"2021-12-08T16:37:13.000Z","id":"1468620691213717509","text":"Turite abejoniÅ³ dÄ—l ES patvirtintÅ³ #COVID19vaccines vakcinÅ³ saugumo?\n\nPasisemkite informacijos iÅ¡ patikimÅ³ sveikatos apsaugos Å¡altiniÅ³!       PerÅ¾iÅ«rÄ—kite video ir suÅ¾inokite kaip yra stebimas vakcinÅ³ saugumas tam, kad jos apsaugotÅ³ Jus nuo mirties ir gydymo ligoninÄ—se. https://t.co/MAEDVzCbCh","referenced_tweets":{}},{"entities":{"urls":[{"start":254,"end":277,"url":"https://t.co/koriHF3AVF","expanded_url":"https://twitter.com/EMA_News/status/1468620436091318274/video/1","display_url":"pic.twitter.com/koriHF3AVF"}],"hashtags":[{"start":36,"end":44,"tag":"COVID19"},{"start":171,"end":179,"tag":"vakcÄ«nu"}],"mentions":{},"annotations":{}},"lang":"lv","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":3,"reply_count":3,"like_count":10,"quote_count":0},"attachments":{"media_keys":["13_1468616033967943681"],"poll_ids":{}},"conversation_id":"1468620436091318274","possibly_sensitive":false,"created_at":"2021-12-08T16:36:12.000Z","id":"1468620436091318274","text":"Vai esat noraizÄ“jies par ES atÄ¼auto #COVID19 vakcÄ«nu droÅ¡Ä«bu?\n\nSazinieties ar sabiedrÄ«bas veselÄ«bas iestÄdÄ“m! Noskatieties Å¡o videoklipu, lai saprastu, kÄ tiek uzraudzÄ«ta #vakcÄ«nu droÅ¡Ä«ba, lai tÄs pasargÄtu JÅ«s no hospitalizÄcijas vai nÄves no COVID-19. https://t.co/koriHF3AVF","referenced_tweets":{}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/3veDSRHFef","expanded_url":"https://twitter.com/EMA_News/status/1468620341732077570/video/1","display_url":"pic.twitter.com/3veDSRHFef"}],"hashtags":[{"start":39,"end":47,"tag":"COVID19"},{"start":197,"end":206,"tag":"vakcinÃ¡k"}],"mentions":{},"annotations":{}},"lang":"hu","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468615834923073537"],"poll_ids":{}},"conversation_id":"1468620341732077570","possibly_sensitive":false,"created_at":"2021-12-08T16:35:49.000Z","id":"1468620341732077570","text":"AggÃ¡lyai vannak a ğŸ‡ªğŸ‡º-ban engedÃ©lyezett #COVID19 vakcinÃ¡k biztonsÃ¡gossÃ¡gÃ¡val kapcsolatban?\n\nInformÃ¡ciÃ³Ã©rt forduljon a kÃ¶zegÃ©szsÃ©gÃ¼gyi hatÃ³sÃ¡gokhoz!\nEbbÅ‘l a videÃ³bÃ³l megtudhatja, hogyan ellenÅ‘rzik a #vakcinÃ¡k biztonsÃ¡gossÃ¡gÃ¡t, hogy megvÃ©djÃ©k Ã–nt a halÃ¡ltÃ³l Ã©s a kÃ³rhÃ¡zba kerÃ¼lÃ©stÅ‘l. https://t.co/3veDSRHFef","referenced_tweets":{}},{"entities":{"urls":[{"start":274,"end":297,"url":"https://t.co/go5KRNYs6T","expanded_url":"https://twitter.com/EMA_News/status/1468619975262814209/video/1","display_url":"pic.twitter.com/go5KRNYs6T"}],"hashtags":[{"start":32,"end":47,"tag":"COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"},{"start":203,"end":211,"tag":"ÎµÎ¼Î²ÏŒÎ»Î¹Î¿"}],"mentions":{},"annotations":{}},"lang":"el","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468615149036527617"],"poll_ids":{}},"conversation_id":"1468619975262814209","possibly_sensitive":false,"created_at":"2021-12-08T16:34:22.000Z","id":"1468619975262814209","text":"Î‘Î½Î·ÏƒÏ…Ï‡ÎµÎ¯Ï„Îµ Î³Î¹Î± Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #COVID19ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€Î¿Ï… ÎµÎ³ÎºÏÎ¯Î¸Î·ÎºÎ±Î½ ÏƒÏ„Î·Î½ Î•Îˆ;\n\nÎ•Î½Î·Î¼ÎµÏÏ‰Î¸ÎµÎ¯Ï„Îµ Î±Ï€ÏŒ Î±Î¾Î¹ÏŒÏ€Î¹ÏƒÏ„ÎµÏ‚ Ï…Ï€Î·ÏÎµÏƒÎ¯ÎµÏ‚ Î´Î·Î¼ÏŒÏƒÎ¹Î±Ï‚ Ï…Î³ÎµÎ¯Î±Ï‚! Î Î±ÏÎ±ÎºÎ¿Î»Î¿Ï…Î¸Î®ÏƒÏ„Îµ Î±Ï…Ï„ÏŒ Ï„Î¿ Î²Î¯Î½Ï„ÎµÎ¿ Î³Î¹Î± Î½Î± Î¼Î¬Î¸ÎµÏ„Îµ Ï€ÏÏ‚ ÎµÏ€Î¹Î²Î»Î­Ï€ÎµÏ„Î±Î¹ Î· Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Ï‰Î½ #ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î­Ï„ÏƒÎ¹ ÏÏƒÏ„Îµ Î½Î± Ï€ÏÎ¿ÏƒÏ„Î±Ï„Î­ÏˆÎ¿Ï…Î½ Î±Ï€ÏŒ Î¸Î¬Î½Î±Ï„Î¿ Î® Î±Î½Î¬Î³ÎºÎ· Î³Î¹Î± Î½Î¿ÏƒÎ¿ÎºÎ¿Î¼ÎµÎ¯Î¿. https://t.co/go5KRNYs6T","referenced_tweets":{}},{"entities":{"urls":[{"start":279,"end":302,"url":"https://t.co/tKbxLe1kqz","expanded_url":"https://twitter.com/EMA_News/status/1468619777774022658/video/1","display_url":"pic.twitter.com/tKbxLe1kqz"}],"hashtags":[{"start":45,"end":53,"tag":"COVID19"},{"start":194,"end":206,"tag":"Impfstoffen"}],"mentions":{},"annotations":{}},"lang":"de","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":22,"reply_count":25,"like_count":47,"quote_count":5},"attachments":{"media_keys":["13_1468614545313001475"],"poll_ids":{}},"conversation_id":"1468619777774022658","possibly_sensitive":false,"created_at":"2021-12-08T16:33:35.000Z","id":"1468619777774022658","text":"Sind Sie in Sorge Ã¼ber in der EU zugelassene #COVID19-Impfstoffe?\n\nInformationen Sie sich bei GesundheitsaufsichtsbehÃ¶rden!\nSchauen Sie dieses Video, um zu verstehen, wie wir die Sicherheit von #Impfstoffen Ã¼berwachen, damit diese Sie vor Tod und Krankenhausaufenthalt schÃ¼tzen. https://t.co/tKbxLe1kqz","referenced_tweets":{}},{"entities":{"urls":[{"start":260,"end":283,"url":"https://t.co/q4o5bAsnDI","expanded_url":"https://twitter.com/EMA_News/status/1468619602590502915/video/1","display_url":"pic.twitter.com/q4o5bAsnDI"}],"hashtags":[{"start":16,"end":24,"tag":"COVID19"},{"start":161,"end":173,"tag":"vaktsiinide"}],"mentions":{},"annotations":{}},"lang":"et","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":1},"attachments":{"media_keys":["13_1468615246197637124"],"poll_ids":{}},"conversation_id":"1468619602590502915","possibly_sensitive":false,"created_at":"2021-12-08T16:32:53.000Z","id":"1468619602590502915","text":"Kas olete mures #COVID19 vaktsiinide ohutuse pÃ¤rast?\n\nTutvuge informatsiooniga mida esitavad usaldusvÃ¤Ã¤rsed rahvatervise asutused! Vaadake videot sellest kuidas #vaktsiinide ohutust jÃ¤lgitakse selleks et nad kaitsekstid sind surma ja haiglasse sattumise eest. https://t.co/q4o5bAsnDI","referenced_tweets":{}},{"entities":{"urls":[{"start":274,"end":297,"url":"https://t.co/Po88mtHqY7","expanded_url":"https://twitter.com/EMA_News/status/1468619468100149252/video/1","display_url":"pic.twitter.com/Po88mtHqY7"}],"hashtags":[{"start":34,"end":42,"tag":"COVID19"},{"start":189,"end":197,"tag":"vaccins"}],"mentions":{},"annotations":{}},"lang":"fr","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468615334953627651"],"poll_ids":{}},"conversation_id":"1468619468100149252","possibly_sensitive":false,"created_at":"2021-12-08T16:32:21.000Z","id":"1468619468100149252","text":"La sÃ©curitÃ© des vaccins contre la #COVID19 autorisÃ©s dans l'UE vous inquiÃ¨te ?\n\nRenseignez-vous auprÃ¨s des autoritÃ©s de santÃ© ! Regardez cette vidÃ©o pour comprendre comment la sÃ©curitÃ© des #vaccins est assurÃ©e afin qu'ils vous protÃ¨gent d'une hospitalisation ou d'un dÃ©cÃ¨s. https://t.co/Po88mtHqY7","referenced_tweets":{}},{"entities":{"urls":[{"start":260,"end":283,"url":"https://t.co/TmNDYRGD1H","expanded_url":"https://twitter.com/EMA_News/status/1468619240307445760/video/1","display_url":"pic.twitter.com/TmNDYRGD1H"}],"hashtags":[{"start":37,"end":45,"tag":"COVID19"},{"start":187,"end":195,"tag":"vakcÃ­ny"}],"mentions":{},"annotations":{}},"lang":"cs","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":13,"reply_count":16,"like_count":61,"quote_count":4},"attachments":{"media_keys":["13_1468614544746754051"],"poll_ids":{}},"conversation_id":"1468619240307445760","possibly_sensitive":false,"created_at":"2021-12-08T16:31:27.000Z","id":"1468619240307445760","text":"MÃ¡te obavy o bezpeÄnost vakcÃ­n proti #COVID19 autorizovanÃ½ch v EU?\n\nHledejte informace u dÅ¯vÄ›ryhodnÃ½ch orgÃ¡nÅ¯ ochrany veÅ™ejnÃ©ho zdravÃ­! \nSledujte video, kde se dozvÃ­te, jak je bezpeÄnost #vakcÃ­ny monitorovÃ¡na tak, aby vÃ¡s ochrÃ¡nila pÅ™ed smrtÃ­ a hospitalizacÃ­. https://t.co/TmNDYRGD1H","referenced_tweets":{}},{"entities":{"urls":[{"start":245,"end":268,"url":"https://t.co/2tTWO245no","expanded_url":"https://twitter.com/EMA_News/status/1468618983930662916/video/1","display_url":"pic.twitter.com/2tTWO245no"}],"hashtags":[{"start":23,"end":38,"tag":"COVID19cjepiva"}],"mentions":{},"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":2,"reply_count":8,"like_count":13,"quote_count":1},"attachments":{"media_keys":["13_1468615403521798147"],"poll_ids":{}},"conversation_id":"1468618983930662916","possibly_sensitive":false,"created_at":"2021-12-08T16:30:26.000Z","id":"1468618983930662916","text":"Brine li Vas sigurnost #COVID19cjepiva odobrenih u EU? Informirajte se od strane pouzdanih javnozdravstvenih ustanova!\n\nPogledajte ovaj video i nauÄite kako se prati sigurnost cjepiva, kako bi Vas ona mogla zaÅ¡tititi od smrti i hospitalizacije. https://t.co/2tTWO245no","referenced_tweets":{}},{"entities":{"urls":[{"start":267,"end":290,"url":"https://t.co/uDLD7jtlTB","expanded_url":"https://twitter.com/EMA_News/status/1468618747095105537/video/1","display_url":"pic.twitter.com/uDLD7jtlTB"}],"hashtags":[{"start":47,"end":55,"tag":"COVID19"},{"start":209,"end":219,"tag":"Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ"}],"mentions":{},"annotations":{}},"lang":"bg","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":4,"reply_count":7,"like_count":12,"quote_count":0},"attachments":{"media_keys":["13_1468614544003985408"],"poll_ids":{}},"conversation_id":"1468618747095105537","possibly_sensitive":false,"created_at":"2021-12-08T16:29:29.000Z","id":"1468618747095105537","text":"Ğ˜Ğ¼Ğ°Ñ‚Ğµ Ğ»Ğ¸ Ğ¿Ñ€Ğ¸Ñ‚ĞµÑĞ½ĞµĞ½Ğ¸Ñ Ğ¾Ñ‚Ğ½Ğ¾ÑĞ½Ğ¾ Ğ±ĞµĞ·Ğ¾Ğ¿Ğ°ÑĞ½Ğ¾ÑÑ‚Ñ‚Ğ° Ğ½Ğ°  #COVID19 Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ, Ñ€Ğ°Ğ·Ñ€ĞµÑˆĞµĞ½Ğ¸ Ğ² ğŸ‡ªğŸ‡º?\n\nĞ˜Ğ½Ñ„Ğ¾Ñ€Ğ¼Ğ¸Ñ€Ğ°Ğ¹Ñ‚Ğµ ÑĞµ Ğ¾Ñ‚ Ğ´Ğ¾Ğ²ĞµÑ€ĞµĞ½Ğ¸ Ğ¾Ñ€Ğ³Ğ°Ğ½Ğ¸ Ğ·Ğ° Ğ¾Ğ±Ñ‰ĞµÑÑ‚Ğ²ĞµĞ½Ğ¾ Ğ·Ğ´Ñ€Ğ°Ğ²ĞµĞ¾Ğ¿Ğ°Ğ·Ğ²Ğ°Ğ½Ğµ!\nĞ“Ğ»ĞµĞ´Ğ°Ğ¹Ñ‚Ğµ Ñ‚Ğ¾Ğ²Ğ° Ğ²Ğ¸Ğ´ĞµĞ¾ Ğ¸ Ğ½Ğ°ÑƒÑ‡ĞµÑ‚Ğµ ĞºĞ°Ğº ÑĞµ ÑĞ»ĞµĞ´Ğ¸ Ğ±ĞµĞ·Ğ¾Ğ¿Ğ°ÑĞ½Ğ¾ÑÑ‚Ñ‚Ğ° Ğ½Ğ° #Ğ²Ğ°ĞºÑĞ¸Ğ½Ğ¸Ñ‚Ğµ, Ğ·Ğ° Ğ´Ğ° Ğ²Ğ¸ Ğ¿Ñ€ĞµĞ´Ğ¿Ğ°Ğ·ÑÑ‚ Ğ¾Ñ‚ ÑĞ¼ÑŠÑ€Ñ‚ Ğ¸ Ñ…Ğ¾ÑĞ¿Ğ¸Ñ‚Ğ°Ğ»Ğ¸Ğ·Ğ°Ñ†Ğ¸Ñ. https://t.co/uDLD7jtlTB","referenced_tweets":{}},{"entities":{"urls":[{"start":277,"end":300,"url":"https://t.co/8e2WlLjkV5","expanded_url":"https://twitter.com/EMA_News/status/1468618567406919681/video/1","display_url":"pic.twitter.com/8e2WlLjkV5"}],"hashtags":[{"start":41,"end":57,"tag":"COVID19vaccines"},{"start":192,"end":201,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468614517475004422"],"poll_ids":{}},"conversation_id":"1468618567406919681","possibly_sensitive":false,"created_at":"2021-12-08T16:28:46.000Z","id":"1468618567406919681","text":"Do you have concerns about the safety of #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º? \n\nTake your information from trusted public health authorities!\nWatch this video now to learn how the safety of #vaccines is monitored so they will protect you against death &amp; hospitalization. https://t.co/8e2WlLjkV5","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":78,"end":95,"tag":"EUPharmaStrategy"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468584692928688138","possibly_sensitive":false,"created_at":"2021-12-08T14:14:10.000Z","id":"1468584692928688138","text":"RT @EU_Health: Preventing medicine shortages is one of our ambitions with the #EUPharmaStrategy\n\nğŸ“¢ Today's new study provides an overview oâ€¦","referenced_tweets":[{"type":"retweeted","id":"1468581749382914051"}]},{"entities":{"urls":[{"start":21,"end":44,"url":"https://t.co/rGBSJN2whn","expanded_url":"https://twitter.com/EMA_News/status/1468508879587708928/video/1","display_url":"pic.twitter.com/rGBSJN2whn"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1468506608313724940"],"poll_ids":{}},"conversation_id":"1468508879587708928","possibly_sensitive":false,"created_at":"2021-12-08T09:12:55.000Z","id":"1468508879587708928","text":"this is a video test https://t.co/rGBSJN2whn","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":93,"end":107,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":[{"start":120,"end":138,"probability":0.7148,"type":"Organization","normalized_text":"EU Health Ministers"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1468215595162349577","possibly_sensitive":false,"created_at":"2021-12-07T13:47:30.000Z","id":"1468215595162349577","text":"RT @EU_Health: It is imperative that we close the immunisation gap\n\nğŸ“º Listen to Commissioner @SKyriakidesEU calling on EU Health Ministersâ€¦","referenced_tweets":[{"type":"retweeted","id":"1468193573782933504"}]},{"entities":{"urls":[{"start":232,"end":255,"url":"https://t.co/uVHrPNNFkY","expanded_url":"https://www.ema.europa.eu/en/news/ema-ecdc-recommendations-heterologous-vaccination-courses-against-covid-19","display_url":"ema.europa.eu/en/news/ema-ecâ€¦","status":200,"title":"EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: â€˜mix-and-matchâ€™ approach can be used for both initial boosters - European Medicines Agency","description":"EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: â€˜mix-and-matchâ€™ approach can be used for both initial boosters","unwound_url":"https://www.ema.europa.eu/en/news/ema-ecdc-recommendations-heterologous-vaccination-courses-against-covid-19-mix-match-approach-can-be"},{"start":284,"end":307,"url":"https://t.co/n9aMXdi4QI","expanded_url":"https://twitter.com/EMA_News/status/1468189227548651522/photo/1","display_url":"pic.twitter.com/n9aMXdi4QI"}],"hashtags":[{"start":90,"end":106,"tag":"COVID19vaccines"},{"start":219,"end":227,"tag":"booster"},{"start":257,"end":269,"tag":"HealthUnion"},{"start":270,"end":283,"tag":"VaccinesWork"}],"mentions":[{"start":13,"end":21,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":162,"reply_count":44,"like_count":269,"quote_count":38},"attachments":{"media_keys":["3_1468188361210933253"],"poll_ids":{}},"conversation_id":"1468189227548651522","possibly_sensitive":false,"created_at":"2021-12-07T12:02:44.000Z","id":"1468189227548651522","text":"â€¼ï¸ EMA &amp; @ECDC_EU share their recommendations on the possibility of using 2 different #COVID19vaccines, either for the 1st and 2nd doses of a primary course, or using a 3rd dose of a different COVID-19 vaccine as a #booster.\n\nğŸ‘‰ https://t.co/uVHrPNNFkY\n\n#HealthUnion #VaccinesWork https://t.co/n9aMXdi4QI","referenced_tweets":{}},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/OInSXGH3yZ","expanded_url":"https://www.ema.europa.eu/en/news/icmra-high-level-meeting-global-health-emergencies-regulatory-approaches","display_url":"ema.europa.eu/en/news/icmra-â€¦"},{"start":196,"end":219,"url":"https://t.co/wCzczAnQb2","expanded_url":"https://twitter.com/EMA_News/status/1468158397711360005/photo/1","display_url":"pic.twitter.com/wCzczAnQb2"}],"hashtags":[{"start":69,"end":77,"tag":"COVID19"},{"start":97,"end":101,"tag":"AMR"},{"start":119,"end":129,"tag":"pregnancy"},{"start":161,"end":167,"tag":"ICMRA"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":21,"reply_count":14,"like_count":32,"quote_count":0},"attachments":{"media_keys":["3_1468158381164793867"],"poll_ids":{}},"conversation_id":"1468158397711360005","possibly_sensitive":false,"created_at":"2021-12-07T10:00:13.000Z","id":"1468158397711360005","text":"Global regulators met to discuss challenges faced during the ongoing #COVID19 pandemic, but also #AMR and ğŸ’Š for use in #pregnancy. A meeting report will follow. #ICMRA\n\nâ¡ï¸ https://t.co/OInSXGH3yZ https://t.co/wCzczAnQb2","referenced_tweets":{}},{"entities":{"urls":[{"start":168,"end":191,"url":"https://t.co/Ix5H9j1H0j","expanded_url":"https://www.ema.europa.eu/en/events/eu-big-data-stakeholder-forum","display_url":"ema.europa.eu/en/events/eu-bâ€¦"},{"start":214,"end":237,"url":"https://t.co/R3SY3EPGJn","expanded_url":"https://twitter.com/EMA_News/status/1468126892956045317/photo/1","display_url":"pic.twitter.com/R3SY3EPGJn"}],"hashtags":[{"start":56,"end":64,"tag":"BigData"},{"start":193,"end":213,"tag":"MedicinesRegulation"}],"mentions":[{"start":120,"end":134,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":76,"end":78,"probability":0.5104,"type":"Organization","normalized_text":"EMA"},{"start":85,"end":111,"probability":0.6319,"type":"Organization","normalized_text":"Heads of Medicines Agencies"}]},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":15,"reply_count":5,"like_count":28,"quote_count":0},"attachments":{"media_keys":["3_1468126886320648192"],"poll_ids":{}},"conversation_id":"1468126892956045317","possibly_sensitive":false,"created_at":"2021-12-07T07:55:02.000Z","id":"1468126892956045317","text":"Follow live ğŸ”´ the 2nd annual multi-stakeholder forum on #BigData hosted by EMA, the Heads of Medicines Agencies and the @EU_Commission\n\nToday, from 09:00 to 16:20 CET: https://t.co/Ix5H9j1H0j\n\n#MedicinesRegulation https://t.co/R3SY3EPGJn","referenced_tweets":{}},{"entities":{"urls":[{"start":149,"end":172,"url":"https://t.co/4vTBOG82sr","expanded_url":"https://www.ema.europa.eu/en/news/ema-recommends-approval-use-roactemra-adults-severe-covid-19","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":220,"end":243,"url":"https://t.co/lfUCHapQfA","expanded_url":"https://twitter.com/EMA_News/status/1467864620597710849/photo/1","display_url":"pic.twitter.com/lfUCHapQfA"}],"hashtags":[{"start":135,"end":143,"tag":"COVID19"},{"start":174,"end":186,"tag":"HealthUnion"},{"start":187,"end":205,"tag":"COVID19treatments"},{"start":206,"end":219,"tag":"PublicHealth"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":89,"reply_count":26,"like_count":149,"quote_count":16},"attachments":{"media_keys":["3_1467864361259741193"],"poll_ids":{}},"conversation_id":"1467864620597710849","possibly_sensitive":false,"created_at":"2021-12-06T14:32:51.000Z","id":"1467864620597710849","text":"â€¼ï¸ EMA recommends extending the use of the anti-inflammatory medicine RoActemra (tocilizumab) to treat hospitalised adults with severe #COVID19. \n\nğŸ‘‰ https://t.co/4vTBOG82sr\n\n#HealthUnion #COVID19treatments #PublicHealth https://t.co/lfUCHapQfA","referenced_tweets":{}},{"entities":{"urls":[{"start":274,"end":297,"url":"https://t.co/rK9AfoLv7c","expanded_url":"https://twitter.com/EMA_News/status/1467078735425949698/photo/1","display_url":"pic.twitter.com/rK9AfoLv7c"}],"hashtags":[{"start":0,"end":16,"tag":"COVID19vaccines"},{"start":87,"end":101,"tag":"RollingReview"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":147,"reply_count":117,"like_count":415,"quote_count":24},"attachments":{"media_keys":["3_1467078729209982978"],"poll_ids":{}},"conversation_id":"1467078735425949698","possibly_sensitive":false,"created_at":"2021-12-04T10:30:02.000Z","id":"1467078735425949698","text":"#COVID19vaccines: Where are we nowâ“\n\nâ¡ï¸ 5 vaccines under evaluation: for 4 of them the #RollingReview is ongoing; the 5th â€“ the Novavax vaccine - is on the last mile for a recommendation with a formally submitted marketing authorisation application\nâ¡ï¸ 4 vaccines authorised https://t.co/rK9AfoLv7c","referenced_tweets":{}},{"entities":{"urls":[{"start":170,"end":193,"url":"https://t.co/PwBmfymveL","expanded_url":"https://www.ema.europa.eu/en/news/icmra-who-map-out-flexibilities-used-regulators-respond-covid-19-pandemic","display_url":"ema.europa.eu/en/news/icmra-â€¦"},{"start":194,"end":217,"url":"https://t.co/5EwjL32rz5","expanded_url":"https://twitter.com/EMA_News/status/1466806223857139717/photo/1","display_url":"pic.twitter.com/5EwjL32rz5"}],"hashtags":[{"start":26,"end":32,"tag":"ICMRA"},{"start":135,"end":143,"tag":"COVID19"}],"mentions":[{"start":37,"end":41,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":5,"like_count":20,"quote_count":0},"attachments":{"media_keys":["3_1466806162855243781"],"poll_ids":{}},"conversation_id":"1466806223857139717","possibly_sensitive":false,"created_at":"2021-12-03T16:27:10.000Z","id":"1466806223857139717","text":"Global regulators part of #ICMRA and @WHO reviewed some of the practices applied by regulatory authorities worldwide to respond to the #COVID19 challenges. Learn more: \nğŸ‘‰https://t.co/PwBmfymveL https://t.co/5EwjL32rz5","referenced_tweets":{}},{"entities":{"urls":[{"start":173,"end":196,"url":"https://t.co/TQcP9IFN3D","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-29-november-2-december-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":197,"end":220,"url":"https://t.co/Q95oKWmFOU","expanded_url":"https://twitter.com/EMA_News/status/1466733355593052164/photo/1","display_url":"pic.twitter.com/Q95oKWmFOU"}],"hashtags":[{"start":53,"end":58,"tag":"PRAC"},{"start":142,"end":150,"tag":"COVID19"},{"start":151,"end":169,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":22,"reply_count":14,"like_count":41,"quote_count":6},"attachments":{"media_keys":["3_1466733237007536128"],"poll_ids":{}},"conversation_id":"1466733355593052164","possibly_sensitive":false,"created_at":"2021-12-03T11:37:37.000Z","id":"1466733355593052164","text":"ğŸ“¢ At its December meeting, our safety committee, the #PRAC, recommended updates on risk of myocarditis &amp; pericarditis with mRNA vaccines. #COVID19 #pharmacovigilance  \nğŸ‘‰https://t.co/TQcP9IFN3D https://t.co/Q95oKWmFOU","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":20,"end":34,"tag":"JustPublished"},{"start":117,"end":126,"tag":"SARSCoV2"},{"start":127,"end":134,"tag":"B11529"}],"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466403295535284224","possibly_sensitive":false,"created_at":"2021-12-02T13:46:04.000Z","id":"1466403295535284224","text":"RT @ECDC_Outbreaks: #JustPublished:\nThreat Assessment Brief: Implications of the further emergence and spread of the #SARSCoV2 #B11529 variâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466381906086346754"}]},{"entities":{"urls":[{"start":45,"end":68,"url":"https://t.co/CcBVx6B0o5","expanded_url":"http://bit.ly/COVIDWeekly","display_url":"bit.ly/COVIDWeekly"},{"start":78,"end":101,"url":"https://t.co/hX49Par6jx","expanded_url":"https://twitter.com/ECDC_EU/status/1466400179494473731/photo/1","display_url":"pic.twitter.com/hX49Par6jx"}],"hashtags":[{"start":69,"end":77,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_1466399722730659843"],"poll_ids":{}},"conversation_id":"1466403255836196865","possibly_sensitive":false,"created_at":"2021-12-02T13:45:55.000Z","id":"1466403255836196865","text":"RT @ECDC_EU: Color-blind version of the map:\nhttps://t.co/CcBVx6B0o5\n#COVID19 https://t.co/hX49Par6jx","referenced_tweets":[{"type":"retweeted","id":"1466400179494473731"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":145,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466403242565382148","possibly_sensitive":false,"created_at":"2021-12-02T13:45:52.000Z","id":"1466403242565382148","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466399624692912128"}]},{"entities":{"urls":[{"start":186,"end":209,"url":"https://t.co/PSaOYnAyHp","expanded_url":"https://europa.eu/!GRbFUG","display_url":"europa.eu/!GRbFUG"},{"start":210,"end":233,"url":"https://t.co/RKqGkVzw9q","expanded_url":"https://twitter.com/EMA_News/status/1466353370621431815/photo/1","display_url":"pic.twitter.com/RKqGkVzw9q"}],"hashtags":[{"start":14,"end":28,"tag":"RollingReview"},{"start":42,"end":57,"tag":"COVID19vaccine"},{"start":168,"end":180,"tag":"coronavirus"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":96,"reply_count":36,"like_count":246,"quote_count":39},"attachments":{"media_keys":["3_1466352947470741513"],"poll_ids":{}},"conversation_id":"1466353370621431815","possibly_sensitive":false,"created_at":"2021-12-02T10:27:41.000Z","id":"1466353370621431815","text":"â€¼ï¸ EMA starts #RollingReview of Valnevaâ€™s #COVID19vaccine. \n\nStudies in adults show that this inactivated vaccine triggers the production of antibodies that target the #coronavirus. \n\nğŸ‘‰ https://t.co/PSaOYnAyHp https://t.co/RKqGkVzw9q","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":265,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466335487753437184","possibly_sensitive":false,"created_at":"2021-12-02T09:16:38.000Z","id":"1466335487753437184","text":"RT @vonderleyen: About 1 billion doses have been delivered in the EU.\n\nOver 360 million doses of mRNA vaccines will be delivered by the endâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466048087974100997"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466335424243187716","possibly_sensitive":false,"created_at":"2021-12-02T09:16:22.000Z","id":"1466335424243187716","text":"RT @EU_Health: While vaccination offers the best way to end the pandemic, testing is crucial to slow down the spread of the virus\n\nTogetherâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466308653309317121"}]},{"entities":{"urls":[{"start":136,"end":159,"url":"https://t.co/8of0VYthyM","expanded_url":"https://www.ema.europa.eu/en/news/increase-manufacturing-capacity-covid-19-vaccine-astrazeneca","display_url":"ema.europa.eu/en/news/increaâ€¦"},{"start":160,"end":183,"url":"https://t.co/vSX2YsTqoO","expanded_url":"https://twitter.com/EMA_News/status/1466066891911450624/photo/1","display_url":"pic.twitter.com/vSX2YsTqoO"}],"hashtags":[{"start":78,"end":93,"tag":"COVID19vaccine"}],"mentions":{},"annotations":[{"start":3,"end":5,"probability":0.6877,"type":"Organization","normalized_text":"EMA"},{"start":64,"end":72,"probability":0.3435,"type":"Place","normalized_text":"Vaxzevria"},{"start":108,"end":118,"probability":0.4327,"type":"Organization","normalized_text":"AstraZeneca"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":31,"reply_count":21,"like_count":62,"quote_count":3},"attachments":{"media_keys":["3_1466066795069116420"],"poll_ids":{}},"conversation_id":"1466066891911450624","possibly_sensitive":false,"created_at":"2021-12-01T15:29:19.000Z","id":"1466066891911450624","text":"ğŸ“¢ EMA approves one new and one extended manufacturing site for Vaxzevria, the #COVID19vaccine developed by AstraZeneca, in ğŸ‡©ğŸ‡ª and ğŸ‡ºğŸ‡¸.\n\nğŸ‘‰https://t.co/8of0VYthyM https://t.co/vSX2YsTqoO","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"annotations":[{"start":24,"end":25,"probability":0.6869,"type":"Organization","normalized_text":"EU"},{"start":98,"end":107,"probability":0.9895,"type":"Person","normalized_text":"Emer Cooke"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466053313418481672","possibly_sensitive":false,"created_at":"2021-12-01T14:35:22.000Z","id":"1466053313418481672","text":"RT @Europarl_EN: Is the EU prepared for the new variant of Covid-19?\n\nMembers of Parliament asked Emer Cooke, Executive Director of the @EMâ€¦","referenced_tweets":[{"type":"retweeted","id":"1465739502379544586"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466042167286280205","possibly_sensitive":false,"created_at":"2021-12-01T13:51:05.000Z","id":"1466042167286280205","text":"RT @EU_Health: Only sustained, collective &amp; determined action will bring the pandemic under control. \n\nThe ğŸ‡ªğŸ‡º will continue to lead effortsâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466018038650740744"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466042109337772032","possibly_sensitive":false,"created_at":"2021-12-01T13:50:51.000Z","id":"1466042109337772032","text":"RT @EU_Health: We don't know everything about Omicron, but we know enough to be concerned.\nScientists are working day &amp; night to find answeâ€¦","referenced_tweets":[{"type":"retweeted","id":"1466040460300935173"}]},{"entities":{"urls":{},"hashtags":[{"start":15,"end":23,"tag":"COVID19"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1466023593012310021","possibly_sensitive":false,"created_at":"2021-12-01T12:37:16.000Z","id":"1466023593012310021","text":"RT @EU_Health: #COVID19: Rapidly rising case numbers &amp; increasing pressure on our health services, combined with the Omicron variant, are râ€¦","referenced_tweets":[{"type":"retweeted","id":"1466016056133271554"}]},{"entities":{"urls":{},"hashtags":[{"start":27,"end":40,"tag":"WorldAIDSDay"}],"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1465979664594255872","possibly_sensitive":false,"created_at":"2021-12-01T09:42:43.000Z","id":"1465979664594255872","text":"RT @ECDC_HIVAIDS: Today is #WorldAIDSDay !","referenced_tweets":[{"type":"retweeted","id":"1465963865410347008"}]},{"entities":{"urls":{},"hashtags":[{"start":24,"end":37,"tag":"WorldAidsDay"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":81,"end":83,"probability":0.6427,"type":"Other","normalized_text":"HIV"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1465979444288495619","possibly_sensitive":false,"created_at":"2021-12-01T09:41:50.000Z","id":"1465979444288495619","text":"RT @EU_Health: Ahead of #WorldAidsDay we must recognise the pandemic's impact on HIV patients &amp; healthcare systems\n\nTogether, we will put tâ€¦","referenced_tweets":[{"type":"retweeted","id":"1465644113089413121"}]},{"entities":{"urls":[{"start":225,"end":248,"url":"https://t.co/Ix5H9j1H0j","expanded_url":"https://www.ema.europa.eu/en/events/eu-big-data-stakeholder-forum","display_url":"ema.europa.eu/en/events/eu-bâ€¦"},{"start":271,"end":294,"url":"https://t.co/UpfG84istv","expanded_url":"https://twitter.com/EMA_News/status/1465725088930668551/photo/1","display_url":"pic.twitter.com/UpfG84istv"}],"hashtags":[{"start":122,"end":130,"tag":"BigData"},{"start":250,"end":270,"tag":"MedicinesRegulation"}],"mentions":[{"start":64,"end":78,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":5,"like_count":41,"quote_count":4},"attachments":{"media_keys":["3_1465724639880036360"],"poll_ids":{}},"conversation_id":"1465725088930668551","possibly_sensitive":false,"created_at":"2021-11-30T16:51:07.000Z","id":"1465725088930668551","text":"ğŸ—“ï¸Save the date! \n\nEMA, the Heads of Medicines Agencies and the @EU_Commission are hosting a 2nd annual multi-stakeholder #BigData forum to foster collaboration on 7 December 2021.\n\nThe event will be available to watch live: https://t.co/Ix5H9j1H0j\n\n#MedicinesRegulation https://t.co/UpfG84istv","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":87,"end":95,"tag":"Omicron"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":54,"end":57,"username":"G7","id":"3191500397"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1465319125773959180","possibly_sensitive":false,"created_at":"2021-11-29T13:57:58.000Z","id":"1465319125773959180","text":"RT @SKyriakidesEU: ğŸ“Important coordination meeting of @G7 Health Ministers in light of #Omicron variant. \n\nğŸ”¹We must continue to act fast â–¶ï¸â€¦","referenced_tweets":[{"type":"retweeted","id":"1465307617077731333"}]},{"entities":{"urls":{},"hashtags":[{"start":103,"end":120,"tag":"EUPharmaStrategy"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1465319008010391564","possibly_sensitive":false,"created_at":"2021-11-29T13:57:30.000Z","id":"1465319008010391564","text":"RT @EU_Health: Access to medicines is a fundamental European value\n\n1 year ago today we introduced the #EUPharmaStrategy to:\n\nâœ…prevent mediâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463802138459529218"}]},{"entities":{"urls":{},"hashtags":[{"start":83,"end":91,"tag":"COVID19"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":35,"end":50,"username":"EP_Environment","id":"951333319"}],"annotations":[{"start":126,"end":135,"probability":0.9345,"type":"Person","normalized_text":"Emer Cooke"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1465259066662572036","possibly_sensitive":false,"created_at":"2021-11-29T09:59:19.000Z","id":"1465259066662572036","text":"RT @EP_Environment: ğŸ—“ï¸Next week in @EP_Environment \n\n30/11 Debates\n\n9.00ğŸ’‰Latest on #COVID19 vaccination &amp; therapeutics with Emer Cooke @EMAâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463806866572652549"}]},{"entities":{"urls":[{"start":232,"end":255,"url":"https://t.co/AeXUwijDzP","expanded_url":"https://www.ema.europa.eu/en/news/vision-use-real-world-evidence-eu-medicines-regulation","display_url":"ema.europa.eu/en/news/visionâ€¦"},{"start":256,"end":279,"url":"https://t.co/t6bm9Ln4jI","expanded_url":"https://twitter.com/EMA_News/status/1464264539109736450/photo/1","display_url":"pic.twitter.com/t6bm9Ln4jI"}],"hashtags":[{"start":57,"end":75,"tag":"RealWorldEvidence"},{"start":82,"end":102,"tag":"MedicinesRegulation"}],"mentions":[{"start":206,"end":214,"username":"DKMA_dk","id":"826788051175211010"},{"start":219,"end":228,"username":"bfarm_de","id":"803246507688394752"}],"annotations":[{"start":126,"end":128,"probability":0.5308,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":8,"like_count":31,"quote_count":0},"attachments":{"media_keys":["3_1464263287495970817"],"poll_ids":{}},"conversation_id":"1464264539109736450","possibly_sensitive":false,"created_at":"2021-11-26T16:07:25.000Z","id":"1464264539109736450","text":"Read more about European regulators' views on the use of #RealWorldEvidence in EU #MedicinesRegulation in this article by the EMA's Head of Data Analysis and EMAâ€™s Executive Director, in collaboration with @DKMA_dk and @bfarm_de\n ğŸ‘‰ https://t.co/AeXUwijDzP https://t.co/t6bm9Ln4jI","referenced_tweets":{}},{"entities":{"urls":[{"start":127,"end":150,"url":"https://t.co/6ZZlgqpsCW","expanded_url":"https://www.youtube.com/watch?v=_ekituOTevE","display_url":"youtube.com/watch?v=_ekituâ€¦","images":{}},{"start":254,"end":277,"url":"https://t.co/RFgJ6Vutav","expanded_url":"https://twitter.com/i/events/1463891511683256326","display_url":"twitter.com/i/events/14638â€¦","images":[{"url":"https://pbs.twimg.com/news_img/1464229443392753667/HSuRLHsh?format=jpg&name=orig","width":1200,"height":676},{"url":"https://pbs.twimg.com/news_img/1464229443392753667/HSuRLHsh?format=jpg&name=150x150","width":150,"height":150}],"status":200,"title":"The 4th EMA public meeting - 25 November 2021","description":"See the live tweets posted during the 4th EMA public meeting held on 25 November 2021. #EMAPublicMeeting4","unwound_url":"https://twitter.com/i/events/1463891511683256326"}],"hashtags":[{"start":43,"end":59,"tag":"COVID19vaccines"},{"start":64,"end":82,"tag":"COVID19treatments"},{"start":234,"end":252,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":[{"start":110,"end":116,"probability":0.4343,"type":"Product","normalized_text":"YouTube"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":9,"reply_count":5,"like_count":28,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1464229441970839562","possibly_sensitive":false,"created_at":"2021-11-26T13:47:57.000Z","id":"1464229441970839562","text":"Did you miss the 4th EMA public meeting on #COVID19vaccines and #COVID19treatments? You can watch it on EMA's YouTube channel: https://t.co/6ZZlgqpsCW\n\nAnd see the live tweets posted during the meeting yesterday, 25 November 2021. \n \n#EMAPublicMeeting4 \nhttps://t.co/RFgJ6Vutav","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":0,"end":13,"tag":"PublicHealth"},{"start":169,"end":187,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":4,"like_count":33,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T14:10:23.000Z","id":"1463872697029570563","text":"#PublicHealth measures such as social distancing, wearing face masks ğŸ˜· and handwashing should also be followed very carefully so that we protect ourselves and others. \n\n#EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463872173437820934"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":103,"end":111,"tag":"COVID19"},{"start":117,"end":135,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":4,"like_count":30,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T14:08:18.000Z","id":"1463872173437820934","text":"Therapeutics are becoming available and will complement, but not replace vaccines in the fight against #COVID19. ğŸ’ŠğŸ’‰\n\n#EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463871994227793921"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":16,"tag":"COVID19Vaccines"},{"start":93,"end":102,"tag":"pandemic"},{"start":187,"end":205,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":6,"like_count":19,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T14:07:35.000Z","id":"1463871994227793921","text":"#COVID19Vaccines have reduced the impact of the virus and remain the key tools to combat the #pandemic. \n\nPlease get vaccinated! For those who are eligible, please get a booster shot! \n\n #EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463856184386019328"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":185,"end":208,"url":"https://t.co/pbXDKmGZMZ","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":0,"end":8,"tag":"COVID19"},{"start":165,"end":183,"tag":"EMAPublicMeeting4"}],"mentions":[{"start":126,"end":134,"username":"ECDC_EU","id":"204752573"},{"start":136,"end":146,"username":"EU_Health","id":"606325697"},{"start":148,"end":162,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":2,"like_count":33,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T13:04:46.000Z","id":"1463856184386019328","text":"#COVID19 misinformation has serious consequences that we all need to combat â€“ get the facts from public health authorities! \n\n@ECDC_EU \n@EU_Health \n@EU_Commission \n\n#EMAPublicMeeting4\n\nhttps://t.co/pbXDKmGZMZ","referenced_tweets":[{"type":"replied_to","id":"1463853607405723650"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":256,"end":279,"url":"https://t.co/OspLZNSIcR","expanded_url":"https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab","display_url":"vaccinetracker.ecdc.europa.eu/public/extensiâ€¦"}],"hashtags":[{"start":178,"end":186,"tag":"COVID19"},{"start":236,"end":254,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":4,"like_count":25,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:54:31.000Z","id":"1463853607405723650","text":"It is vital that we continue to get vaccinated, especially in those Member States with unacceptably low vaccination rates. Countries should continuously strive to increase their #COVID19 vaccination coverage in all eligible age groups. #EMAPublicMeeting4 \nhttps://t.co/OspLZNSIcR","referenced_tweets":[{"type":"replied_to","id":"1463852434418286601"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":193,"end":216,"url":"https://t.co/bOowmEsihM","expanded_url":"https://www.ecdc.europa.eu/en/covid-19/situation-updates/weekly-maps-coordinated-restriction-free-movement","display_url":"ecdc.europa.eu/en/covid-19/siâ€¦"}],"hashtags":[{"start":43,"end":51,"tag":"COVID19"},{"start":84,"end":97,"tag":"PublicHealth"},{"start":164,"end":182,"tag":"EMAPublicMeeting4"}],"mentions":[{"start":183,"end":191,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":23,"reply_count":3,"like_count":39,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:49:52.000Z","id":"1463852434418286601","text":"Depending on the local epidemiological and #COVID19 vaccination coverage situation, #PublicHealth measures (non-pharmaceutical interventions ğŸ˜·) are still needed. \n\n#EMAPublicMeeting4 @ECDC_EU \nhttps://t.co/bOowmEsihM","referenced_tweets":[{"type":"replied_to","id":"1463851110754570241"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":26,"end":38,"tag":"SideEffects"},{"start":160,"end":167,"tag":"safety"},{"start":171,"end":187,"tag":"COVID19vaccines"},{"start":191,"end":209,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":14,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:44:36.000Z","id":"1463851110754570241","text":"Your feedback on possible #SideEffects helps us all identify risks and find the best measures to mitigate them. \n\nGet involved and support us in monitoring the #safety of #COVID19vaccines! \n\n#EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463849623248846850"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":9,"end":19,"tag":"medicines"},{"start":21,"end":37,"tag":"COVID19vaccines"},{"start":48,"end":60,"tag":"SideEffects"},{"start":225,"end":233,"tag":"COVID19"},{"start":237,"end":255,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":4,"like_count":20,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:38:41.000Z","id":"1463849623248846850","text":"Like all #medicines, #COVID19vaccines can cause #SideEffects. \n\nThe majority are mild and many people will not experience any at all. \n\nSerious side effects are very rare and must be balanced against the prevention of severe #COVID19. \n\n#EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463849235598696452"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":20,"end":32,"tag":"vaccination"},{"start":132,"end":148,"tag":"COVID19vaccines"},{"start":168,"end":186,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":[{"start":95,"end":96,"probability":0.5099,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":5,"like_count":19,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:37:09.000Z","id":"1463849235598696452","text":"This is the largest #vaccination campaign ever with over 550 million doses administered in the EU/EEA and the safety profile of the #COVID19vaccines is very reassuring #EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463848497690689537"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":123,"end":131,"tag":"COVID19"},{"start":150,"end":159,"tag":"boosters"},{"start":270,"end":288,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":21,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:34:13.000Z","id":"1463848497690689537","text":"Numbers of unvaccinated but also some vaccinated patients in hospitals are on the rise in almost all ğŸ‡ªğŸ‡ºMember States. Full #COVID19 vaccination &amp; #boosters are key to staying protected. Get vaccinated &amp; follow advice in your country to keep infection rates low! #EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463846911182614531"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":245,"end":268,"url":"https://t.co/YZCZKoHur0","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-treatments","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":58,"end":66,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":12,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:27:55.000Z","id":"1463846911182614531","text":"While vaccination is the cornerstone of EMA's response to #COVID19, the urgent need for treatments remains at the forefront: 1âƒ£ therapeutic is under rolling review and an additional 5âƒ£ marketing authorisation applications have been submitted. ğŸ’Š\nhttps://t.co/YZCZKoHur0","referenced_tweets":[{"type":"replied_to","id":"1463844070531510282"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":23,"end":39,"tag":"COVID19vaccines"},{"start":96,"end":104,"tag":"COVID19"},{"start":243,"end":261,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":4,"like_count":34,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:16:37.000Z","id":"1463844070531510282","text":"All currently approved #COVID19vaccines ğŸ’‰remain effective against severe disease and death from #COVID19. \n\nTo maintain effectiveness over time people may need to extend their protection with a booster at least 6 months after the second dose. #EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463842892120829957"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":4,"end":20,"tag":"COVID19pandemic"},{"start":108,"end":124,"tag":"COVID19vaccines"},{"start":134,"end":152,"tag":"COVID19treatments"},{"start":175,"end":193,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":[{"start":42,"end":47,"probability":0.9769,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":2,"like_count":19,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:11:57.000Z","id":"1463842892120829957","text":"The #COVID19pandemic is not over yet, but Europe now has more tools to fight it than we had last winter: 4âƒ£ #COVID19vaccines &amp; 3âƒ£ #COVID19treatments authorised in the EU. #EMAPublicMeeting4","referenced_tweets":[{"type":"replied_to","id":"1463840195535687680"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":240,"end":263,"url":"https://t.co/6ZZlgqpsCW","expanded_url":"https://www.youtube.com/watch?v=_ekituOTevE","display_url":"youtube.com/watch?v=_ekituâ€¦"}],"hashtags":[{"start":111,"end":118,"tag":"safety"},{"start":133,"end":149,"tag":"COVID19vaccines"},{"start":219,"end":237,"tag":"EMAPublicMeeting4"}],"mentions":[{"start":0,"end":8,"username":"ECDC_EU","id":"204752573"},{"start":9,"end":19,"username":"EU_Health","id":"606325697"},{"start":20,"end":34,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":3,"like_count":27,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T12:01:14.000Z","id":"1463840195535687680","text":"@ECDC_EU @EU_Health @EU_Commission A 4th public meeting is being held to update the public on the approval and #safety monitoring of #COVID19vaccines &amp; therapeutics in the EU ğŸ‡ªğŸ‡º\n\nFollow and share our live tweets on #EMAPublicMeeting4\n\nğŸ‘‰https://t.co/6ZZlgqpsCW","referenced_tweets":[{"type":"replied_to","id":"1463830354834382850"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":236,"end":259,"url":"https://t.co/uqqBAklVvl","expanded_url":"https://www.ema.europa.eu/en/news/comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11","display_url":"ema.europa.eu/en/news/comirnâ€¦"},{"start":260,"end":283,"url":"https://t.co/NZQhli4SDl","expanded_url":"https://twitter.com/EMA_News/status/1463837597558624264/photo/1","display_url":"pic.twitter.com/NZQhli4SDl"}],"hashtags":[{"start":48,"end":63,"tag":"COVID19vaccine"},{"start":136,"end":146,"tag":"Comirnaty"}],"mentions":{},"annotations":[{"start":30,"end":37,"probability":0.4249,"type":"Organization","normalized_text":"BioNTech"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":1342,"reply_count":222,"like_count":2611,"quote_count":559},"attachments":{"media_keys":["3_1463837383774908426"],"poll_ids":{}},"conversation_id":"1463837597558624264","possibly_sensitive":false,"created_at":"2021-11-25T11:50:54.000Z","id":"1463837597558624264","text":"â€¼ï¸ EMA recommends approval of BioNTech/Pfizerâ€™s #COVID19vaccine, Comirnaty, for children aged 5 to 11.\n\nIn this population, the dose of #Comirnaty will be lower than that used in people aged 12 and above. \n\nRead the full press release: https://t.co/uqqBAklVvl https://t.co/NZQhli4SDl","referenced_tweets":{}},{"entities":{"urls":[{"start":190,"end":213,"url":"https://t.co/4pVRV9uTcq","expanded_url":"https://www.ema.europa.eu/en/events/public-stakeholder-meeting-covid-19-vaccines-therapeutics-eu","display_url":"ema.europa.eu/en/events/publâ€¦"},{"start":214,"end":237,"url":"https://t.co/Jy5dV1jMrI","expanded_url":"https://twitter.com/EMA_News/status/1463830354834382850/photo/1","display_url":"pic.twitter.com/Jy5dV1jMrI"}],"hashtags":[{"start":100,"end":116,"tag":"COVID19vaccines"},{"start":168,"end":186,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":69,"reply_count":17,"like_count":104,"quote_count":12},"attachments":{"media_keys":["3_1463830217127043076"],"poll_ids":{}},"conversation_id":"1463830354834382850","possibly_sensitive":false,"created_at":"2021-11-25T11:22:07.000Z","id":"1463830354834382850","text":"Remember to follow the ğŸ”´ live broadcast of the 4th EMA public meeting on the approval and safety of #COVID19vaccines and therapeutics in the ğŸ‡ªğŸ‡º.\n\nğŸ—“ï¸ Today, 13h00 CET \n\n#EMAPublicMeeting4\n\nğŸ‘‰ https://t.co/4pVRV9uTcq https://t.co/Jy5dV1jMrI","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":47,"end":64,"tag":"EUPharmaStrategy"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463798331721854976","possibly_sensitive":false,"created_at":"2021-11-25T09:14:52.000Z","id":"1463798331721854976","text":"RT @EU_Health: One year ago we've launched the #EUPharmaStrategy to make sure patients have access to innovative &amp; affordable medicines\n\nItâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463769421403484163"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463798095947485189","possibly_sensitive":false,"created_at":"2021-11-25T09:13:56.000Z","id":"1463798095947485189","text":"RT @EU_Commission: â€œBecause vaccines offer high protection against severe outcomes of COVID-19 infection, the forecasts are showing that aâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463596387271155713"}]},{"entities":{"urls":{},"hashtags":[{"start":74,"end":82,"tag":"COVID19"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":128,"end":136,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463797876463747075","possibly_sensitive":false,"created_at":"2021-11-25T09:13:04.000Z","id":"1463797876463747075","text":"RT @SKyriakidesEU: â–¶ï¸This afternoon, the ğŸ‡ªğŸ‡º Scientific Advice Platform on #COVID19 discussed the state of the pandemic based on @ECDC_EU Raâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463595269006581760"}]},{"entities":{"urls":[{"start":255,"end":278,"url":"https://t.co/fewys3DPYx","expanded_url":"https://audiovisual.ec.europa.eu/en/video/I-214515","display_url":"audiovisual.ec.europa.eu/en/video/I-214â€¦","images":[{"url":"https://pbs.twimg.com/news_img/1463552786721873922/Fr0V70K4?format=jpg&name=orig","width":1057,"height":600},{"url":"https://pbs.twimg.com/news_img/1463552786721873922/Fr0V70K4?format=jpg&name=150x150","width":150,"height":150}],"status":200,"title":"EC technical briefing (on the record) on the ECDCâ€™s assessment of the current COVID-19 epidemiological situation","description":"Technical briefing (on the record) by - Andrea AMMON,Â Director of the European Centre for Disease Prevention and Control (ECDC) (ECDC) - Marco CAVALERI, Head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA)","unwound_url":"https://audiovisual.ec.europa.eu/en/video/I-214515"}],"hashtags":[{"start":67,"end":80,"tag":"PublicHealth"},{"start":211,"end":219,"tag":"COVID19"}],"mentions":{},"annotations":[{"start":0,"end":13,"probability":0.9059,"type":"Person","normalized_text":"Marco Cavaleri"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":21,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463501202461806599","possibly_sensitive":false,"created_at":"2021-11-24T16:59:09.000Z","id":"1463552783316045829","text":"Marco Cavaleri: â€˜We should fill the vaccination gap without delay. #PublicHealth measures such as social distancing, hand hygiene and wearing masks should also be followed very closely to minimise the spread of #COVID19. And it's now time for a booster!â€™\nhttps://t.co/fewys3DPYx","referenced_tweets":[{"type":"replied_to","id":"1463505636583477250"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":13,"end":18,"tag":"LIVE"},{"start":66,"end":71,"tag":"ECDC"},{"start":100,"end":108,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":25,"end":39,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463508070039015424","possibly_sensitive":false,"created_at":"2021-11-24T14:01:29.000Z","id":"1463508070039015424","text":"RT @ECDC_EU: #LIVE now:\n\n@EU_Commission technical briefing on the #ECDCâ€™s assessment of the current #COVID19 epidemiological situation. Updâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463503010244575236"}]},{"entities":{"urls":{},"hashtags":[{"start":62,"end":75,"tag":"boosterdoses"},{"start":107,"end":115,"tag":"COVID19"}],"mentions":[{"start":0,"end":14,"username":"EU_Commission","id":"157981564"},{"start":15,"end":23,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":24,"end":37,"probability":0.9549,"type":"Person","normalized_text":"Marco Cavaleri"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":4,"like_count":56,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463501202461806599","possibly_sensitive":false,"created_at":"2021-11-24T13:51:49.000Z","id":"1463505636583477250","text":"@EU_Commission @ECDC_EU Marco Cavaleri: 'Data is showing that #boosterdoses restore protection against the #COVID19 infection and disease.'","referenced_tweets":[{"type":"replied_to","id":"1463501202461806599"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":100,"end":108,"tag":"COVID19"},{"start":127,"end":136,"tag":"boosters"}],"mentions":[{"start":22,"end":36,"username":"EU_Commission","id":"157981564"},{"start":63,"end":71,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":0,"end":13,"probability":0.961,"type":"Person","normalized_text":"Marco Cavaleri"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":47,"reply_count":14,"like_count":120,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463501202461806599","possibly_sensitive":false,"created_at":"2021-11-24T13:34:11.000Z","id":"1463501202461806599","text":"Marco Cavaleri at the @EU_Commission technical briefing on the @ECDC_EU's assessment of the current #COVID19 situation, today: #boosters play an important part in vaccination strategies. For those who are eligible, please get a booster shot!","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"},{"start":21,"end":29,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":204,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463495122335809552","possibly_sensitive":false,"created_at":"2021-11-24T13:10:02.000Z","id":"1463495122335809552","text":"RT @vonderleyen: New @ECDC_EU risk assessment is clear: we must step up vaccination to control the pandemic.â€¨\nWe want to convince people toâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463465055689875456"}]},{"entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"JustPublished"},{"start":56,"end":65,"tag":"SARSCoV2"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463494381411999750","possibly_sensitive":false,"created_at":"2021-11-24T13:07:05.000Z","id":"1463494381411999750","text":"RT @ECDC_EU: #JustPublished:\n\nAssessment of the current #SARSCoV2 epidemiological situation in the EU/EEA, projections for the end-of-yearâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463447955042676736"}]},{"entities":{"urls":[{"start":156,"end":179,"url":"https://t.co/H9eoBm97sJ","expanded_url":"https://twitter.com/EMA_News/status/1463418870627278848/photo/1","display_url":"pic.twitter.com/H9eoBm97sJ"}],"hashtags":[{"start":100,"end":124,"tag":"AntimicrobialResistance"},{"start":128,"end":137,"tag":"WAAW2021"},{"start":138,"end":143,"tag":"WAAW"},{"start":144,"end":148,"tag":"AMR"},{"start":149,"end":155,"tag":"ICMRA"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":12,"reply_count":2,"like_count":32,"quote_count":2},"attachments":{"media_keys":["3_1463418862490329092"],"poll_ids":{}},"conversation_id":"1463418870627278848","possibly_sensitive":false,"created_at":"2021-11-24T08:07:02.000Z","id":"1463418870627278848","text":"Global regulators remind doctors, pharmacists and nurses that they have a critical role in fighting #AntimicrobialResistance! \n\n#WAAW2021 #WAAW #AMR #ICMRA https://t.co/H9eoBm97sJ","referenced_tweets":{}},{"entities":{"urls":[{"start":242,"end":265,"url":"https://t.co/y8yypFooxA","expanded_url":"https://www.ema.europa.eu/en/news/ema-receives-application-marketing-authorisation-lagevrio-molnupiravir-treating-patients-covid-19","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":279,"end":302,"url":"https://t.co/okeAVsRv7x","expanded_url":"https://twitter.com/EMA_News/status/1463178928416346122/photo/1","display_url":"pic.twitter.com/okeAVsRv7x"}],"hashtags":[{"start":132,"end":141,"tag":"medicine"},{"start":175,"end":183,"tag":"COVID19"},{"start":266,"end":278,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":71,"reply_count":11,"like_count":136,"quote_count":13},"attachments":{"media_keys":["3_1463178561653719040"],"poll_ids":{}},"conversation_id":"1463178928416346122","possibly_sensitive":false,"created_at":"2021-11-23T16:13:35.000Z","id":"1463178928416346122","text":"â€¼ï¸ EMA starts evaluating an application for marketing authorisation for Lagevrio, molnupiravirâ€™s ğŸ‡ªğŸ‡ºtradename. \n\nThis oral antiviral #medicine is intended for the treatment of #COVID19 in adults. \n\nAn outcome could be reached within weeks. \n\nğŸ‘‰https://t.co/y8yypFooxA #HealthUnion https://t.co/okeAVsRv7x","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":99,"end":107,"tag":"COVID19"},{"start":108,"end":121,"tag":"VaccinesWork"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7456,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463170623228764160","possibly_sensitive":false,"created_at":"2021-11-23T15:40:35.000Z","id":"1463170623228764160","text":"RT @EU_Commission: Data shows us that the higher the vaccination rate, the lower the death rate. \n\n#COVID19 #VaccinesWork https://t.co/mORrâ€¦","referenced_tweets":[{"type":"retweeted","id":"1463119478099693571"}]},{"entities":{"urls":[{"start":181,"end":204,"url":"https://t.co/NHhuIJ2Ooi","expanded_url":"https://www.ema.europa.eu/en/news/2011-2020-more-40-decrease-sales-antimicrobials-use-animals","display_url":"ema.europa.eu/en/news/2011-2â€¦"},{"start":205,"end":228,"url":"https://t.co/7sZNvwU52a","expanded_url":"https://twitter.com/EMA_News/status/1463139407607775235/photo/1","display_url":"pic.twitter.com/7sZNvwU52a"}],"hashtags":[{"start":73,"end":88,"tag":"antimicrobials"},{"start":154,"end":158,"tag":"AMR"},{"start":159,"end":164,"tag":"WAAW"},{"start":165,"end":178,"tag":"animalhealth"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":5,"like_count":51,"quote_count":5},"attachments":{"media_keys":["3_1463139055584092169"],"poll_ids":{}},"conversation_id":"1463139407607775235","possibly_sensitive":false,"created_at":"2021-11-23T13:36:33.000Z","id":"1463139407607775235","text":"ğŸ“¢ New EMA report shows that there was more than 40% decrease in sales of #antimicrobials for use in animals in 25 European countries, between 2011-2020. \n#AMR #WAAW #animalhealth\nğŸ‘‰ https://t.co/NHhuIJ2Ooi https://t.co/7sZNvwU52a","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":56,"end":69,"tag":"EUCancerPlan"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1463120779520978945","possibly_sensitive":false,"created_at":"2021-11-23T12:22:31.000Z","id":"1463120779520978945","text":"RT @EU_Health: Letâ€™s turn the tide against cancer.\n\nThe #EUCancerPlan sets out a new approach to cancer prevention, diagnosis, treatment &amp;â€¦","referenced_tweets":[{"type":"retweeted","id":"1463054649716531208"}]},{"entities":{"urls":[{"start":202,"end":225,"url":"https://t.co/y8PG1GzrTR","expanded_url":"https://www.ema.europa.eu/en/news/ema-evaluating-data-booster-dose-covid-19-vaccine-janssen","display_url":"ema.europa.eu/en/news/ema-evâ€¦"},{"start":226,"end":249,"url":"https://t.co/mfR5kJHKIp","expanded_url":"https://twitter.com/EMA_News/status/1462799803927117834/photo/1","display_url":"pic.twitter.com/mfR5kJHKIp"}],"hashtags":[{"start":33,"end":48,"tag":"COVID19Vaccine"},{"start":57,"end":69,"tag":"boosterdose"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4624,"type":"Person","normalized_text":"EMA"},{"start":49,"end":55,"probability":0.6655,"type":"Person","normalized_text":"Janssen"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":55,"reply_count":16,"like_count":97,"quote_count":6},"attachments":{"media_keys":["3_1462799698364968967"],"poll_ids":{}},"conversation_id":"1462799803927117834","possibly_sensitive":false,"created_at":"2021-11-22T15:07:05.000Z","id":"1462799803927117834","text":"EMA is now evaluating the use of #COVID19Vaccine Janssen #boosterdose. \n\nIt should be given at least 2âƒ£ months after the first dose to people aged 18 years and older.\n\nOutcome expected within weeks. \nğŸ‘‰ https://t.co/y8PG1GzrTR https://t.co/mfR5kJHKIp","referenced_tweets":{}},{"entities":{"urls":[{"start":220,"end":243,"url":"https://t.co/teNIB8ESS5","expanded_url":"https://twitter.com/EMA_News/status/1462726055228227587/photo/1","display_url":"pic.twitter.com/teNIB8ESS5"}],"hashtags":[{"start":0,"end":8,"tag":"COVID19"},{"start":35,"end":39,"tag":"AMR"},{"start":176,"end":181,"tag":"WAAW"},{"start":182,"end":187,"tag":"EAAD"},{"start":188,"end":194,"tag":"ICMRA"},{"start":195,"end":219,"tag":"AntimicrobialResistance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":28,"reply_count":4,"like_count":48,"quote_count":0},"attachments":{"media_keys":["3_1462726048412581891"],"poll_ids":{}},"conversation_id":"1462726055228227587","possibly_sensitive":false,"created_at":"2021-11-22T10:14:02.000Z","id":"1462726055228227587","text":"#COVID19 is an infectious disease. #AMR is about infectious diseases. \n\nPublic health leaders will build on the work carried out during the pandemic to fight the AMR threat. \n\n#WAAW #EAAD #ICMRA #AntimicrobialResistance https://t.co/teNIB8ESS5","referenced_tweets":{}},{"entities":{"urls":[{"start":200,"end":223,"url":"https://t.co/6NcBAeZt8z","expanded_url":"https://twitter.com/EMA_News/status/1462707334128492549/video/1","display_url":"pic.twitter.com/6NcBAeZt8z"}],"hashtags":[{"start":78,"end":82,"tag":"AMR"},{"start":194,"end":199,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1460234677416042499"],"poll_ids":{}},"conversation_id":"1462707334128492549","possibly_sensitive":false,"created_at":"2021-11-22T08:59:38.000Z","id":"1462707334128492549","text":"World Antimicrobial Awareness Week 2021 is over.\nCompanies, the fight against #AMR needs to continue.\nBoost research and development to create innovative medicines against bacterial infections. #WAAW https://t.co/6NcBAeZt8z","referenced_tweets":{}},{"entities":{"urls":[{"start":173,"end":196,"url":"https://t.co/BmpGY9uslV","expanded_url":"https://twitter.com/EMA_News/status/1462707238804537348/video/1","display_url":"pic.twitter.com/BmpGY9uslV"}],"hashtags":[{"start":82,"end":86,"tag":"AMR"},{"start":167,"end":172,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1460234816532660224"],"poll_ids":{}},"conversation_id":"1462707238804537348","possibly_sensitive":false,"created_at":"2021-11-22T08:59:16.000Z","id":"1462707238804537348","text":"World Antimicrobial Awareness Week 2021 is over.\nVeterinarians, the fight against #AMR needs to continue.\nDo your part and prescribe antibiotics in animals correctly! #WAAW https://t.co/BmpGY9uslV","referenced_tweets":{}},{"entities":{"urls":[{"start":157,"end":180,"url":"https://t.co/zjqhMW6Twi","expanded_url":"https://twitter.com/EMA_News/status/1462707141010239489/video/1","display_url":"pic.twitter.com/zjqhMW6Twi"}],"hashtags":[{"start":71,"end":75,"tag":"AMR"},{"start":151,"end":156,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":5,"quote_count":0},"attachments":{"media_keys":["13_1460235131222994949"],"poll_ids":{}},"conversation_id":"1462707141010239489","possibly_sensitive":false,"created_at":"2021-11-22T08:58:52.000Z","id":"1462707141010239489","text":"World Antimicrobial Awareness Week 2021 is over.\nBut the fight against #AMR needs to continue.\nDo your part and remember to use antibiotics correctly! #WAAW https://t.co/zjqhMW6Twi","referenced_tweets":{}},{"entities":{"urls":[{"start":157,"end":180,"url":"https://t.co/lZG5M7LhIs","expanded_url":"https://twitter.com/EMA_News/status/1462707019106983938/video/1","display_url":"pic.twitter.com/lZG5M7LhIs"}],"hashtags":[{"start":71,"end":75,"tag":"AMR"},{"start":151,"end":156,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1460234950867881986"],"poll_ids":{}},"conversation_id":"1462707019106983938","possibly_sensitive":false,"created_at":"2021-11-22T08:58:23.000Z","id":"1462707019106983938","text":"World Antimicrobial Awareness Week 2021 is over.\nBut the fight against #AMR needs to continue.\nDo your part and remember to use antibiotics correctly! #WAAW https://t.co/lZG5M7LhIs","referenced_tweets":{}},{"entities":{"urls":[{"start":157,"end":180,"url":"https://t.co/K5N5pxOnhk","expanded_url":"https://twitter.com/EMA_News/status/1462706920750473219/video/1","display_url":"pic.twitter.com/K5N5pxOnhk"}],"hashtags":[{"start":71,"end":75,"tag":"AMR"},{"start":151,"end":156,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"attachments":{"media_keys":["13_1460235061358436354"],"poll_ids":{}},"conversation_id":"1462706920750473219","possibly_sensitive":false,"created_at":"2021-11-22T08:58:00.000Z","id":"1462706920750473219","text":"World Antimicrobial Awareness Week 2021 is over.\nBut the fight against #AMR needs to continue.\nDo your part and remember to use antibiotics correctly! #WAAW https://t.co/K5N5pxOnhk","referenced_tweets":{}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/YcJ9KfL4F2","expanded_url":"https://twitter.com/EMA_News/status/1462706634497605633/video/1","display_url":"pic.twitter.com/YcJ9KfL4F2"}],"hashtags":[{"start":77,"end":81,"tag":"AMR"},{"start":157,"end":162,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1460235061358436354"],"poll_ids":{}},"conversation_id":"1462706634497605633","possibly_sensitive":false,"created_at":"2021-11-22T08:56:52.000Z","id":"1462706634497605633","text":"Video World Antimicrobial Awareness Week 2021 is over.\nBut the fight against #AMR needs to continue.\nDo your part and remember to use antibiotics correctly! #WAAW https://t.co/YcJ9KfL4F2","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":59,"end":83,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1462697654287224834","possibly_sensitive":false,"created_at":"2021-11-22T08:21:11.000Z","id":"1462697654287224834","text":"RT @EU_Health: What happens if Antibiotics stop working? \n\n#AntimicrobialResistance already presents a serious social &amp; economic burden inâ€¦","referenced_tweets":[{"type":"retweeted","id":"1462684776071106560"}]},{"entities":{"urls":[{"start":145,"end":168,"url":"https://t.co/Fi9TsdXzJF","expanded_url":"https://twitter.com/EMA_News/status/1461992471907516417/photo/1","display_url":"pic.twitter.com/Fi9TsdXzJF"}],"hashtags":[{"start":46,"end":70,"tag":"AntimicrobialResistance"},{"start":121,"end":125,"tag":"AMR"},{"start":126,"end":131,"tag":"WAAW"},{"start":132,"end":137,"tag":"EAAD"},{"start":138,"end":144,"tag":"ICMRA"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":27,"reply_count":3,"like_count":53,"quote_count":2},"attachments":{"media_keys":["3_1461992464148008962"],"poll_ids":{}},"conversation_id":"1461992471907516417","possibly_sensitive":false,"created_at":"2021-11-20T09:39:02.000Z","id":"1461992471907516417","text":"Letâ€™s educate our children about the risks of #AntimicrobialResistance and include this topic in family conversations! \n\n#AMR #WAAW #EAAD #ICMRA https://t.co/Fi9TsdXzJF","referenced_tweets":{}},{"entities":{"urls":[{"start":255,"end":278,"url":"https://t.co/cx6Bp26uFK","expanded_url":"https://www.ema.europa.eu/en/news/ema-issues-advice-use-lagevrio-molnupiravir-treatment-covid-19","display_url":"ema.europa.eu/en/news/ema-isâ€¦","status":200,"title":"EMA issues advice on use of Lagevrio (molnupiravir) for the treatment COVID-19 - European Medicines Agency","description":"EMA issues advice on use of Lagevrio (molnupiravir) for the treatment COVID-19","unwound_url":"https://www.ema.europa.eu/en/news/ema-issues-advice-use-lagevrio-molnupiravir-treatment-covid-19"},{"start":279,"end":302,"url":"https://t.co/SfkvKvErQG","expanded_url":"https://twitter.com/EMA_News/status/1461717028994224134/photo/1","display_url":"pic.twitter.com/SfkvKvErQG"}],"hashtags":[{"start":114,"end":123,"tag":"medicine"},{"start":157,"end":165,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":74,"reply_count":22,"like_count":118,"quote_count":17},"attachments":{"media_keys":["3_1461715978006503438"],"poll_ids":{}},"conversation_id":"1461717028994224134","possibly_sensitive":false,"created_at":"2021-11-19T15:24:31.000Z","id":"1461717028994224134","text":"â€¼ï¸ EMA issues advice to support ğŸ‡ªğŸ‡º countries who may decide on early use of the oral antiviral molnupiravir.\n\nThe #medicine can be used to treat adults with #COVID19 who donâ€™t require supplemental oxygen and who are at increased risk of severe disease.\n\nğŸ‘‰https://t.co/cx6Bp26uFK https://t.co/SfkvKvErQG","referenced_tweets":{}},{"entities":{"urls":[{"start":179,"end":202,"url":"https://t.co/bORg92JkRv","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-review-paxlovid-treating-patients-covid-19","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":218,"end":241,"url":"https://t.co/2OmcYZlY2S","expanded_url":"https://twitter.com/EMA_News/status/1461705459216359431/photo/1","display_url":"pic.twitter.com/2OmcYZlY2S"}],"hashtags":[{"start":40,"end":48,"tag":"COVID19"},{"start":205,"end":217,"tag":"HealthUnion"}],"mentions":{},"annotations":[{"start":26,"end":33,"probability":0.3858,"type":"Organization","normalized_text":"Paxlovid"},{"start":77,"end":82,"probability":0.7775,"type":"Organization","normalized_text":"Pfizer"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":60,"reply_count":13,"like_count":128,"quote_count":16},"attachments":{"media_keys":["3_1461704765809831944"],"poll_ids":{}},"conversation_id":"1461705459216359431","possibly_sensitive":false,"created_at":"2021-11-19T14:38:33.000Z","id":"1461705459216359431","text":"â€¼ï¸ EMA starts a review of Paxlovid, the #COVID19 oral treatment developed by Pfizer, to support EU countries who may decide on its early use for COVID-19 before authorisation. \n\nğŸ‘‰https://t.co/bORg92JkRv \n\n#HealthUnion https://t.co/2OmcYZlY2S","referenced_tweets":{}},{"entities":{"urls":[{"start":228,"end":251,"url":"https://t.co/aoDgCmXt2o","expanded_url":"https://twitter.com/EMA_News/status/1461682430650241031/photo/1","display_url":"pic.twitter.com/aoDgCmXt2o"}],"hashtags":[{"start":0,"end":24,"tag":"AntimicrobialResistance"},{"start":37,"end":50,"tag":"PublicHealth"},{"start":69,"end":75,"tag":"ICMRA"},{"start":204,"end":208,"tag":"AMR"},{"start":212,"end":221,"tag":"WAAW2021"},{"start":222,"end":227,"tag":"WAAW"}],"mentions":{},"annotations":[{"start":142,"end":175,"probability":0.5505,"type":"Other","normalized_text":"World Antimicrobial Awareness Week"}]},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":22,"quote_count":0},"attachments":{"media_keys":["3_1461682421917749248"],"poll_ids":{}},"conversation_id":"1461682430650241031","possibly_sensitive":false,"created_at":"2021-11-19T13:07:02.000Z","id":"1461682430650241031","text":"#AntimicrobialResistance is a global #PublicHealth threat. \n\nThrough #ICMRA, we have joined the international regulatory community to support World Antimicrobial Awareness Week 2021 and the fight against #AMR. \n\n#WAAW2021 #WAAW https://t.co/aoDgCmXt2o","referenced_tweets":{}},{"entities":{"urls":[{"start":217,"end":240,"url":"https://t.co/TlgX6PzejK","expanded_url":"https://twitter.com/EMA_News/status/1461635378708889601/photo/1","display_url":"pic.twitter.com/TlgX6PzejK"}],"hashtags":[{"start":0,"end":16,"tag":"COVID19vaccines"},{"start":175,"end":183,"tag":"Covid19"},{"start":184,"end":206,"tag":"PublicHealthEmergency"},{"start":207,"end":216,"tag":"Pandemic"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":76,"reply_count":32,"like_count":134,"quote_count":9},"attachments":{"media_keys":["3_1461635371670949890"],"poll_ids":{}},"conversation_id":"1461635378708889601","possibly_sensitive":false,"created_at":"2021-11-19T10:00:04.000Z","id":"1461635378708889601","text":"#COVID19vaccines: Where are we nowâ“\n\n3ï¸âƒ£ Rolling reviews in progress, \n1ï¸âƒ£ new application submitted for a conditional marketing authorisation,\n4ï¸âƒ£ authorisations completed.\n\n#Covid19 #PublicHealthEmergency #Pandemic https://t.co/TlgX6PzejK","referenced_tweets":{}},{"entities":{"urls":[{"start":201,"end":224,"url":"https://t.co/1HWTuvkOTz","expanded_url":"https://twitter.com/EMA_News/status/1457731498497413132","display_url":"twitter.com/EMA_News/statuâ€¦"}],"hashtags":[{"start":50,"end":54,"tag":"AMR"},{"start":126,"end":137,"tag":"veterinary"}],"mentions":{},"annotations":[{"start":68,"end":81,"probability":0.7793,"type":"Person","normalized_text":"Zoltan Kunsagi"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":12,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461620541526360067","possibly_sensitive":false,"created_at":"2021-11-19T09:01:07.000Z","id":"1461620541526360067","text":"Tune in â€¼ï¸ \n\nWe are now starting our live chat on #AMR. Our expert, Zoltan Kunsagi, specialist on antimicrobial resistance in #veterinary medicine, will talk about what EMA does to tackle this threat. https://t.co/1HWTuvkOTz","referenced_tweets":[{"type":"quoted","id":"1457731498497413132"}]},{"entities":{"urls":[{"start":134,"end":157,"url":"https://t.co/E4BWrQP179","expanded_url":"https://twitter.com/EU_Health/status/1457623149206515716","display_url":"twitter.com/EU_Health/statâ€¦"}],"hashtags":[{"start":20,"end":44,"tag":"AntimicrobialResistance"},{"start":101,"end":110,"tag":"pandemic"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":16,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461599340263268352","possibly_sensitive":false,"created_at":"2021-11-19T07:36:52.000Z","id":"1461599340263268352","text":"Join the chat about #AntimicrobialResistance. You will find out what the ğŸ‡ªğŸ‡º does against this silent #pandemic.\n\nğŸ—“ï¸Today at 10:00 AM. https://t.co/E4BWrQP179","referenced_tweets":[{"type":"quoted","id":"1457623149206515716"}]},{"entities":{"urls":[{"start":237,"end":260,"url":"https://t.co/zv5Io93IyJ","expanded_url":"https://twitter.com/EMA_News/status/1461378730509705229/photo/1","display_url":"pic.twitter.com/zv5Io93IyJ"}],"hashtags":[{"start":20,"end":44,"tag":"AntimicrobialResistance"},{"start":61,"end":73,"tag":"antibiotics"},{"start":216,"end":221,"tag":"EAAD"},{"start":222,"end":226,"tag":"AMR"},{"start":227,"end":236,"tag":"WAAW2021"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":32,"reply_count":3,"like_count":77,"quote_count":4},"attachments":{"media_keys":["3_1461378721278050308"],"poll_ids":{}},"conversation_id":"1461378730509705229","possibly_sensitive":false,"created_at":"2021-11-18T17:00:15.000Z","id":"1461378730509705229","text":"We all need to take #AntimicrobialResistance seriously! \n\nIf #antibiotics no longer work to treat or prevent infections, then even simple surgeries that are taken for granted may become a gamble of life and death. \n\n#EAAD #AMR #WAAW2021 https://t.co/zv5Io93IyJ","referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/S6jDKV8OQC","expanded_url":"https://twitter.com/i/events/1461350462335045642","display_url":"twitter.com/i/events/14613â€¦"}],"hashtags":[{"start":91,"end":102,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":34,"end":36,"probability":0.5092,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":9,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461351250407018521","possibly_sensitive":false,"created_at":"2021-11-18T15:11:03.000Z","id":"1461351250407018521","text":"See the live tweets posted during EMA's technical press briefing held on 18 November 2021. #EMAPresser\nhttps://t.co/S6jDKV8OQC","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":32,"end":40,"tag":"COVID19"},{"start":272,"end":283,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":22,"like_count":68,"quote_count":7},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:46:38.000Z","id":"1461345107647500295","text":"â€¼ï¸ There are excessive cases of #COVID19 particularly in unvaccinated people. Many EU countries have large unvaccinated populations. They are the most likely to go to hospitals and suffer from severe disease. We should close the gap between vaccinated &amp; unvaccinated. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461343712357744651"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":47,"end":70,"url":"https://t.co/xPHVm5cmY1","expanded_url":"https://www.youtube.com/watch?v=NBeDXAKKJiE","display_url":"youtube.com/watch?v=NBeDXAâ€¦"}],"hashtags":{},"mentions":{},"annotations":[{"start":38,"end":44,"probability":0.5151,"type":"Product","normalized_text":"YouTube"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":17,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:41:06.000Z","id":"1461343712357744651","text":"The press briefing can be followed on YouTube: https://t.co/xPHVm5cmY1\n\nA recording will be made available.","referenced_tweets":[{"type":"replied_to","id":"1461343528202555399"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":148,"end":152,"tag":"flu"},{"start":190,"end":206,"tag":"COVID19vaccines"},{"start":208,"end":219,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":5,"like_count":47,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:40:22.000Z","id":"1461343528202555399","text":"We encourage everybody who is offered a flu vaccine to get the shot and protect themselves and their family, friends and colleagues. Data show that #flu vaccines can be co-administered with #COVID19vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461343433805627398"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":13,"tag":"PublicHealth"},{"start":168,"end":179,"tag":"EMAPresser"},{"start":180,"end":188,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":3,"like_count":25,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:39:59.000Z","id":"1461343433805627398","text":"#PublicHealth measures such as social distancing, hand hygiene and wearing face masks ğŸ˜· should also be followed very carefully so that we protect ourselves and others. #EMAPresser #COVID19","referenced_tweets":[{"type":"replied_to","id":"1461343230595723269"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":17,"tag":"COVID19treatment"},{"start":31,"end":38,"tag":"Pfizer"},{"start":226,"end":237,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":40,"end":42,"probability":0.4473,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":3,"like_count":20,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:39:11.000Z","id":"1461343230595723269","text":"#COVID19treatment developed by #Pfizer: EMAâ€™s Executive Director has asked our human medicines committee to give advice on its emergency use to EU countries before a marketing authorisation. The procedure will start tomorrow. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461342845621604356"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":20,"end":37,"tag":"COVID19treatment"},{"start":165,"end":176,"tag":"EMAPresser"},{"start":177,"end":185,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":2,"like_count":21,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:37:39.000Z","id":"1461342845621604356","text":"EMA's evaluation of #COVID19treatment Xevudy (sotrovimab): an outcome is expected within 2âƒ£ months, depending on whether the data submitted are sufficiently robust. #EMAPresser #COVID19","referenced_tweets":[{"type":"replied_to","id":"1461342657582546946"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":17,"tag":"COVID19treatment"},{"start":90,"end":98,"tag":"COVID19"},{"start":247,"end":258,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":34,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:36:54.000Z","id":"1461342657582546946","text":"#COVID19treatment Ronapreve: Study shows that it reduces the chance of becoming sick with #COVID19 in people who are in close contact with a household member infected with the virus. This can help people who might not respond well to vaccination. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461342426660962304"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":10,"tag":"Comirnaty"},{"start":106,"end":114,"tag":"COVID19"},{"start":115,"end":126,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":155,"reply_count":15,"like_count":303,"quote_count":57},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:35:59.000Z","id":"1461342426660962304","text":"#Comirnaty for 5-11-year olds: EMA evaluation is ongoing. An outcome is possible by the end of next week. #COVID19 #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461342276316119043"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":39,"end":47,"tag":"booster"},{"start":190,"end":201,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":34,"quote_count":8},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:35:23.000Z","id":"1461342276316119043","text":"Academic studies support mix and match #booster strategies. These studies are also looking into intervals shorter than 6âƒ£ months. We expect to reach a conclusion on this by end of November. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461341900154105862"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":9,"tag":"Boosters"},{"start":87,"end":100,"tag":"boosterdoses"},{"start":132,"end":140,"tag":"COVID19"},{"start":175,"end":188,"tag":"deltavariant"},{"start":200,"end":211,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":29,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:33:54.000Z","id":"1461341900154105862","text":"#Boosters will play an important part in vaccination strategies. \nData is showing that #boosterdoses restore protection against the #COVID19 infection and disease in times of #deltavariant dominance. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461341775239397377"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":127,"end":135,"tag":"COVID19"},{"start":136,"end":147,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":5,"like_count":46,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:33:24.000Z","id":"1461341775239397377","text":"ğŸ“¢ It is vital that we continue to get vaccinated, especially in those Member States with unacceptably low vaccination ratesâ€¼ï¸ \n#COVID19 #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461341709527359506"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":204,"end":215,"tag":"EMAPresser"},{"start":216,"end":224,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":7,"like_count":52,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:33:08.000Z","id":"1461341709527359506","text":"â€¼ï¸ Hospitalisation rates and number of unvaccinated patients in intensive care are on the rise in almost all ğŸ‡ªğŸ‡ºMember States. Please get vaccinated! For those who are eligible, please get a booster shot! #EMAPresser #COVID19","referenced_tweets":[{"type":"replied_to","id":"1461341468396638219"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Novavax"},{"start":102,"end":118,"tag":"COVID19vaccines"},{"start":169,"end":180,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":10,"like_count":78,"quote_count":8},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:32:11.000Z","id":"1461341468396638219","text":"#Novavax COVID-19 vaccine: It is based on a different platform technology than the already authorised #COVID19vaccines. â€¼ï¸ Recommendation could be adopted within weeks.\n#EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1461334138724700160"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":155,"end":178,"url":"https://t.co/YMWHSXZhRu","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-8","display_url":"ema.europa.eu/en/events/ema-â€¦","status":200,"title":"EMA regular press briefing on COVID-19 - European Medicines Agency","description":"EMA regular press briefing on COVID-19","unwound_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-8"},{"start":179,"end":202,"url":"https://t.co/ujiUcnb7uh","expanded_url":"https://twitter.com/EMA_News/status/1461334138724700160/photo/1","display_url":"pic.twitter.com/ujiUcnb7uh"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":140,"end":151,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":8,"like_count":66,"quote_count":9},"attachments":{"media_keys":["3_1461334001214541828"],"poll_ids":{}},"conversation_id":"1461334138724700160","possibly_sensitive":false,"created_at":"2021-11-18T14:03:03.000Z","id":"1461334138724700160","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 18 November, from 15:30 to 16:00 CET. \n\n#EMAPresser\n\nğŸ‘‰ https://t.co/YMWHSXZhRu https://t.co/ujiUcnb7uh","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"UMCGlobalSafety","id":"3173443348"},{"start":87,"end":91,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461332197819011072","possibly_sensitive":false,"created_at":"2021-11-18T13:55:20.000Z","id":"1461332197819011072","text":"RT @UMCGlobalSafety: Itâ€™s World Antimicrobial Awareness Week! \n\nJoin us in this global @WHO campaign to â€œSpread awareness and Stop Resistanâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461293220051230725"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"animalhealthEU","id":"1017044760"},{"start":124,"end":133,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":70,"end":73,"probability":0.9046,"type":"Place","normalized_text":"ğŸ‡ªğŸ‡º"},{"start":108,"end":124,"probability":0.8719,"type":"Person","normalized_text":"Barbara Freischem"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461328744572936195","possibly_sensitive":false,"created_at":"2021-11-18T13:41:37.000Z","id":"1461328744572936195","text":"RT @animalhealthEU: \"The way antibiotics are being used in animals in ğŸ‡ªğŸ‡º is changing for the better\" says Barbara Freischem @EMA_News \n\nâ¡ï¸Tâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461270777123287040"}]},{"entities":{"urls":[{"start":264,"end":287,"url":"https://t.co/TeEOcvTCs5","expanded_url":"https://europa.eu/!9pQjdY","display_url":"europa.eu/!9pQjdY"},{"start":288,"end":311,"url":"https://t.co/60fZibBl2J","expanded_url":"https://twitter.com/EMA_News/status/1461323202907582468/photo/1","display_url":"pic.twitter.com/60fZibBl2J"}],"hashtags":[{"start":123,"end":131,"tag":"COVID19"},{"start":245,"end":262,"tag":"COVID19treatment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":49,"quote_count":3},"attachments":{"media_keys":["3_1461322327078100997"],"poll_ids":{}},"conversation_id":"1461323202907582468","possibly_sensitive":false,"created_at":"2021-11-18T13:19:36.000Z","id":"1461323202907582468","text":"â€¼ï¸ EMA starts evaluating an application to authorise the monoclonal antibody Xevudy to treat adults &amp; adolescents with #COVID19 who do not require supplemental oxygen therapy &amp; who are at increased risk of progressing to severe disease. #COVID19treatment\nğŸ‘‰https://t.co/TeEOcvTCs5 https://t.co/60fZibBl2J","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":22,"end":34,"tag":"antibiotics"},{"start":65,"end":88,"tag":"HealthCareProfessional"},{"start":110,"end":122,"tag":"Pharmacists"}],"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461319528898514945","possibly_sensitive":false,"created_at":"2021-11-18T13:05:00.000Z","id":"1461319528898514945","text":"RT @PGEU: Never share #antibiotics &amp; always seek advice of a #HealthCareProfessional before taking them!\n\n#Pharmacists advise patients on hâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461319353320812555"}]},{"entities":{"urls":{},"hashtags":[{"start":9,"end":41,"tag":"WorldAntimicrobialAwarenessWeek"},{"start":57,"end":81,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":897,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461316722384941064","possibly_sensitive":false,"created_at":"2021-11-18T12:53:51.000Z","id":"1461316722384941064","text":"RT @WHO: #WorldAntimicrobialAwarenessWeek starts today!\n\n#AntimicrobialResistance (AMR) can affect everyone, everywhere, at any age. ğŸ‘€ Watcâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461274608045277184"}]},{"entities":{"urls":[{"start":217,"end":240,"url":"https://t.co/14RrEp0o9i","expanded_url":"https://twitter.com/EMA_News/status/1461288839813738500/photo/1","display_url":"pic.twitter.com/14RrEp0o9i"}],"hashtags":[{"start":174,"end":179,"tag":"SMEs"},{"start":196,"end":201,"tag":"EAAD"},{"start":202,"end":206,"tag":"AMR"},{"start":207,"end":216,"tag":"WAAW2021"}],"mentions":{},"annotations":[{"start":39,"end":41,"probability":0.5224,"type":"Organization","normalized_text":"R&D"}]},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":5,"reply_count":4,"like_count":16,"quote_count":0},"attachments":{"media_keys":["3_1461288832234622978"],"poll_ids":{}},"conversation_id":"1461288839813738500","possibly_sensitive":false,"created_at":"2021-11-18T11:03:03.000Z","id":"1461288839813738500","text":"Pharma companies need to focus more on R&amp;D for innovative medicines against infections. \n\nWe enable early dialogue with developers focused on innovation, especially with #SMEs and academia. \n\n#EAAD #AMR #WAAW2021 https://t.co/14RrEp0o9i","referenced_tweets":{}},{"entities":{"urls":[{"start":180,"end":203,"url":"https://t.co/BEo8jdIIuW","expanded_url":"https://www.ema.europa.eu/en/documents/report/infographic-categorisation-antibiotics-use-animals-prudent-responsible-use_en.pdf","display_url":"ema.europa.eu/en/documents/râ€¦"},{"start":218,"end":241,"url":"https://t.co/Ij6ub7YYiA","expanded_url":"https://twitter.com/EMA_News/status/1461260900757815297/photo/1","display_url":"pic.twitter.com/Ij6ub7YYiA"}],"hashtags":[{"start":15,"end":19,"tag":"DYK"},{"start":102,"end":115,"tag":"PublicHealth"},{"start":152,"end":156,"tag":"AMR"},{"start":206,"end":211,"tag":"EAAD"},{"start":212,"end":217,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":32,"quote_count":1},"attachments":{"media_keys":["3_1461260893514342405"],"poll_ids":{}},"conversation_id":"1461260900757815297","possibly_sensitive":false,"created_at":"2021-11-18T09:12:02.000Z","id":"1461260900757815297","text":"Veterinarians, #DYK that antibiotics are categorised based on the risk their use in animals causes to #PublicHealth through the possible development of #AMR? \n\nRead more about it: https://t.co/BEo8jdIIuW \n\n#EAAD #WAAW https://t.co/Ij6ub7YYiA","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":25,"end":39,"tag":"Antimicrobial"}],"mentions":[{"start":3,"end":12,"username":"EU_HaDEA","id":"1399614058496679936"},{"start":68,"end":79,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461253925068279815","possibly_sensitive":false,"created_at":"2021-11-18T08:44:19.000Z","id":"1461253925068279815","text":"RT @EU_HaDEA: It's World #Antimicrobial Awareness WeekğŸ¦ \n\nThe EU and @WHO_Europe joined forces ğŸ¤- Introducing the Tailoring #AntimicrobialReâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461253366634450949"}]},{"entities":{"urls":{},"hashtags":[{"start":51,"end":56,"tag":"EAAD"},{"start":91,"end":103,"tag":"Antibiotics"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461253076032106498","possibly_sensitive":false,"created_at":"2021-11-18T08:40:56.000Z","id":"1461253076032106498","text":"RT @EU_Health: ğŸ—£European Antibiotics Awareness Day #EAAD\n\nWe cannot get to the point where #Antibiotics no longer work to treat or preventâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461250067017388033"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1461249327196741641","possibly_sensitive":false,"created_at":"2021-11-18T08:26:02.000Z","id":"1461249327196741641","text":"RT @EU_Health: Did you know? ğŸ’Š\n\nUp to 5âƒ£0âƒ£% of all antimicrobial use in European hospitals may be unnecessary or inappropriate, which mightâ€¦","referenced_tweets":[{"type":"retweeted","id":"1461220123868479493"}]},{"entities":{"urls":[{"start":173,"end":196,"url":"https://t.co/IthrvY3Non","expanded_url":"https://twitter.com/EMA_News/status/1461230451838918663/photo/1","display_url":"pic.twitter.com/IthrvY3Non"}],"hashtags":[{"start":0,"end":11,"tag":"DidYouKnow"},{"start":22,"end":34,"tag":"antibiotics"},{"start":156,"end":161,"tag":"EAAD"},{"start":162,"end":167,"tag":"WAAW"},{"start":168,"end":172,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Meltwater Social","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":47,"quote_count":2},"attachments":{"media_keys":["3_1461230444339412995"],"poll_ids":{}},"conversation_id":"1461230451838918663","possibly_sensitive":false,"created_at":"2021-11-18T07:11:02.000Z","id":"1461230451838918663","text":"#DidYouKnow? By using #antibiotics correctly, we can protect those people who are especially vulnerable to infections, such as pregnant ladies and seniors. #EAAD #WAAW #AMR https://t.co/IthrvY3Non","referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/04tiY6InzV","expanded_url":"https://twitter.com/EMA_News/status/1461002145776513035/photo/1","display_url":"pic.twitter.com/04tiY6InzV"}],"hashtags":[{"start":96,"end":100,"tag":"AMR"},{"start":101,"end":106,"tag":"EAAD"},{"start":107,"end":116,"tag":"WAAW2021"}],"mentions":{},"annotations":[{"start":12,"end":44,"probability":0.72,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":5,"like_count":101,"quote_count":5},"attachments":{"media_keys":["3_1461002040172335108"],"poll_ids":{}},"conversation_id":"1461002145776513035","possibly_sensitive":false,"created_at":"2021-11-17T16:03:50.000Z","id":"1461002145776513035","text":"Tomorrow is European Antibiotic Awareness Day! Letâ€™s remember how to use antibiotics correctly! #AMR #EAAD #WAAW2021 https://t.co/04tiY6InzV","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":49,"end":73,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":15,"end":29,"username":"SKyriakidesEU","id":"2476130260"},{"start":30,"end":33,"username":"G7","id":"3191500397"},{"start":34,"end":48,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460997354543329284","possibly_sensitive":false,"created_at":"2021-11-17T15:44:47.000Z","id":"1460997354543329284","text":"RT @EU_Health: @SKyriakidesEU @G7 @EU_Commission #AntimicrobialResistance is a major thread to public health, often referred to as the \"silâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460964469291589637"}]},{"entities":{"urls":[{"start":184,"end":207,"url":"https://t.co/Mw5Acgo0yQ","expanded_url":"https://www.ema.europa.eu/en/news/ema-receives-application-conditional-marketing-authorisation-novavaxs-covid-19-vaccine-nuvaxovid","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":208,"end":231,"url":"https://t.co/ZkHugMOk47","expanded_url":"https://twitter.com/EMA_News/status/1460983590070718471/photo/1","display_url":"pic.twitter.com/ZkHugMOk47"}],"hashtags":[{"start":87,"end":95,"tag":"COVID19"},{"start":117,"end":125,"tag":"Novavax"},{"start":169,"end":181,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":118,"reply_count":33,"like_count":282,"quote_count":41},"attachments":{"media_keys":["3_1460983480842604549"],"poll_ids":{}},"conversation_id":"1460983590070718471","possibly_sensitive":false,"created_at":"2021-11-17T14:50:06.000Z","id":"1460983590070718471","text":"ğŸ“¢ EMA starts evaluating an application for conditional marketing authorisation for the #COVID19 vaccine developed by #Novavax. An outcome could be reached within weeks. #HealthUnion \nğŸ‘‰https://t.co/Mw5Acgo0yQ https://t.co/ZkHugMOk47","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":22,"tag":"EAAD2021"},{"start":120,"end":125,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460967570467610632","possibly_sensitive":false,"created_at":"2021-11-17T13:46:26.000Z","id":"1460967570467610632","text":"RT @EAAD_EU: #EAAD2021 is just around the corner!\nAnd we have prepared a lot this year:\nâ–ª video-messages\nâ–ª a high level #EAAD event at #ESCâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460947260028633094"}]},{"entities":{"urls":{},"hashtags":[{"start":52,"end":67,"tag":"CervicalCancer"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460882781593026561","possibly_sensitive":false,"created_at":"2021-11-17T08:09:31.000Z","id":"1460882781593026561","text":"RT @EU_Health: The human papillomavirus can lead to #CervicalCancer\n\nYet vaccines can prevent infection. It's our goal with the #EUCancerPlâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460855857420378115"}]},{"entities":{"urls":[{"start":189,"end":212,"url":"https://t.co/4PWpRKa2hE","expanded_url":"https://twitter.com/EMA_News/status/1460564780142448654/video/1","display_url":"pic.twitter.com/4PWpRKa2hE"}],"hashtags":[{"start":0,"end":11,"tag":"DidYouKnow"},{"start":146,"end":158,"tag":"antibiotics"},{"start":172,"end":177,"tag":"EAAD"},{"start":178,"end":183,"tag":"WAAW"},{"start":184,"end":188,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":14,"reply_count":5,"like_count":82,"quote_count":3},"attachments":{"media_keys":["13_1460235131222994949"],"poll_ids":{}},"conversation_id":"1460564780142448654","possibly_sensitive":false,"created_at":"2021-11-16T11:05:54.000Z","id":"1460564780142448654","text":"#DidYouKnow? Some people are more vulnerable to infections: pregnant women, babies, older people, cancer patients.\nYou will protect them by using #antibiotics responsibly! #EAAD #WAAW #AMR https://t.co/4PWpRKa2hE","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":33,"end":45,"tag":"ESCAIDE2021"},{"start":48,"end":57,"tag":"MediPIET"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460538012400599044","possibly_sensitive":false,"created_at":"2021-11-16T09:19:32.000Z","id":"1460538012400599044","text":"RT @ECDC_EU: Don't miss today at #ESCAIDE2021!\n\n#MediPIET in focus: The past and the future of a regional field epidemiology programme in tâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460516957548163073"}]},{"entities":{"urls":{},"hashtags":[{"start":20,"end":32,"tag":"Antibiotics"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460535999159799812","possibly_sensitive":false,"created_at":"2021-11-16T09:11:32.000Z","id":"1460535999159799812","text":"RT @EU_Health: Will #Antibiotics stop working?ğŸ’Š\nIs there an EU Action Plan?ğŸ’ª\nWhat does it mean?ğŸ”¬\nAnd the animals?ğŸ®\nWhat can I do?ğŸ¤”\n\nIf youâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460507427216904194"}]},{"entities":{"urls":[{"start":153,"end":176,"url":"https://t.co/CAtsqewdnX","expanded_url":"https://twitter.com/EMA_News/status/1460530586704039936/video/1","display_url":"pic.twitter.com/CAtsqewdnX"}],"hashtags":[{"start":59,"end":83,"tag":"AntimicrobialResistance"},{"start":141,"end":146,"tag":"EAAD"},{"start":147,"end":152,"tag":"WAAW"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":3,"reply_count":5,"like_count":65,"quote_count":2},"attachments":{"media_keys":["13_1460234677416042499"],"poll_ids":{}},"conversation_id":"1460530586704039936","possibly_sensitive":false,"created_at":"2021-11-16T08:50:01.000Z","id":"1460530586704039936","text":"Companies, we need to act now against the silent pandemic, #AntimicrobialResistance!\nEMA can support your innovative solutions to fight AMR. #EAAD #WAAW https://t.co/CAtsqewdnX","referenced_tweets":{}},{"entities":{"urls":[{"start":149,"end":172,"url":"https://t.co/uE1Wprp5gw","expanded_url":"https://twitter.com/EMA_News/status/1460530425525325826/video/1","display_url":"pic.twitter.com/uE1Wprp5gw"}],"hashtags":[{"start":54,"end":78,"tag":"AntimicrobialResistance"},{"start":132,"end":137,"tag":"EAAD"},{"start":138,"end":143,"tag":"WAAW"},{"start":144,"end":148,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":28,"reply_count":11,"like_count":176,"quote_count":2},"attachments":{"media_keys":["13_1460234816532660224"],"poll_ids":{}},"conversation_id":"1460530425525325826","possibly_sensitive":false,"created_at":"2021-11-16T08:49:23.000Z","id":"1460530425525325826","text":"Veterinarians, letâ€™s act against the silent pandemic, #AntimicrobialResistance!\nFollow good practices when prescribing antibiotics. #EAAD #WAAW #AMR https://t.co/uE1Wprp5gw","referenced_tweets":{}},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/snmvYnF3xf","expanded_url":"https://twitter.com/EMA_News/status/1460530307619299328/video/1","display_url":"pic.twitter.com/snmvYnF3xf"}],"hashtags":[{"start":49,"end":73,"tag":"AntimicrobialResistance"},{"start":155,"end":160,"tag":"EAAD"},{"start":161,"end":166,"tag":"WAAW"},{"start":167,"end":171,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["13_1460235131222994949"],"poll_ids":{}},"conversation_id":"1460530307619299328","possibly_sensitive":false,"created_at":"2021-11-16T08:48:55.000Z","id":"1460530307619299328","text":"Patients, letâ€™s act against the silent pandemic, #AntimicrobialResistance!\nWe can only overcome it if each of us acts responsibly to preserve antibiotics. #EAAD #WAAW #AMR https://t.co/snmvYnF3xf","referenced_tweets":{}},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/7yjWXlI8jI","expanded_url":"https://twitter.com/EMA_News/status/1460530177503551488/video/1","display_url":"pic.twitter.com/7yjWXlI8jI"}],"hashtags":[{"start":49,"end":73,"tag":"AntimicrobialResistance"},{"start":155,"end":160,"tag":"EAAD"},{"start":161,"end":166,"tag":"WAAW"},{"start":167,"end":171,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":10,"quote_count":0},"attachments":{"media_keys":["13_1460234950867881986"],"poll_ids":{}},"conversation_id":"1460530177503551488","possibly_sensitive":false,"created_at":"2021-11-16T08:48:24.000Z","id":"1460530177503551488","text":"Patients, letâ€™s act against the silent pandemic, #AntimicrobialResistance!\nWe can only overcome it if each of us acts responsibly to preserve antibiotics. #EAAD #WAAW #AMR https://t.co/7yjWXlI8jI","referenced_tweets":{}},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/y5eMtPCt2s","expanded_url":"https://twitter.com/EMA_News/status/1460528298388332549/video/1","display_url":"pic.twitter.com/y5eMtPCt2s"}],"hashtags":[{"start":49,"end":73,"tag":"AntimicrobialResistance"},{"start":155,"end":160,"tag":"EAAD"},{"start":161,"end":166,"tag":"WAAW"},{"start":167,"end":171,"tag":"AMR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Ads","public_metrics":{"retweet_count":50,"reply_count":10,"like_count":180,"quote_count":4},"attachments":{"media_keys":["13_1460235061358436354"],"poll_ids":{}},"conversation_id":"1460528298388332549","possibly_sensitive":false,"created_at":"2021-11-16T08:40:56.000Z","id":"1460528298388332549","text":"Patients, letâ€™s act against the silent pandemic, #AntimicrobialResistance!\nWe can only overcome it if each of us acts responsibly to preserve antibiotics. #EAAD #WAAW #AMR https://t.co/y5eMtPCt2s","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":59,"end":83,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460273019549593602","possibly_sensitive":false,"created_at":"2021-11-15T15:46:33.000Z","id":"1460273019549593602","text":"RT @EU_Health: What happens if Antibiotics stop working? \n\n#AntimicrobialResistance already presents a serious social &amp; economic burden inâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460250355124559877"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":82,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460235749555589129","possibly_sensitive":false,"created_at":"2021-11-15T13:18:27.000Z","id":"1460235749555589129","text":"RT @EU_Health: As COVID-19 case numbers are rising again across the EU, full vaccination is vital\n\nAnd to get the best protection, combineâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460200876086370305"}]},{"entities":{"urls":[{"start":186,"end":209,"url":"https://t.co/sGSa3iuLXL","expanded_url":"https://twitter.com/EUnetHTA/status/1457723606205673475","display_url":"twitter.com/EUnetHTA/statuâ€¦"}],"hashtags":[{"start":110,"end":121,"tag":"EUnetHTA21"}],"mentions":[{"start":1,"end":10,"username":"EUnetHTA","id":"56493220"}],"annotations":[{"start":15,"end":17,"probability":0.4091,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":10,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460210957100142595","possibly_sensitive":false,"created_at":"2021-11-15T11:39:56.000Z","id":"1460210957100142595","text":".@EUnetHTA and EMA have re-launched their parallel scientific consultations. Applicants should respond to the #EUnetHTA21 open call for joint scientific consultation by 7 December 2021. https://t.co/sGSa3iuLXL","referenced_tweets":[{"type":"quoted","id":"1457723606205673475"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1460181556899762188","possibly_sensitive":false,"created_at":"2021-11-15T09:43:06.000Z","id":"1460181556899762188","text":"RT @EU_Health: ğŸ“£ Calling research organisations, clinical trial networks, investors, manufacturers...â¤µ \n\nAlongside vaccines, safe &amp; effectiâ€¦","referenced_tweets":[{"type":"retweeted","id":"1460156115908505602"}]},{"entities":{"urls":[{"start":181,"end":204,"url":"https://t.co/dkIUHClvEN","expanded_url":"https://europa.eu/!MGjPwg","display_url":"europa.eu/!MGjPwg"}],"hashtags":[{"start":90,"end":99,"tag":"medicine"},{"start":175,"end":180,"tag":"CHMP"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4954,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":2,"like_count":21,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1459171913071214592","possibly_sensitive":false,"created_at":"2021-11-12T14:51:08.000Z","id":"1459171913071214592","text":"EMA recommends granting a marketing authorisation in the ğŸ‡ªğŸ‡º for Tavneos, a first-in-class #medicine to treat a rare blood vessel inflammation caused by an autoimmune disease. #CHMP https://t.co/dkIUHClvEN","referenced_tweets":{}},{"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/TWyYCCRxJz","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-8-11-november-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":143,"end":166,"url":"https://t.co/vfh49LorJc","expanded_url":"https://twitter.com/EMA_News/status/1459167232509030401/photo/1","display_url":"pic.twitter.com/vfh49LorJc"}],"hashtags":[{"start":39,"end":44,"tag":"CHMP"},{"start":64,"end":74,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":4,"like_count":35,"quote_count":5},"attachments":{"media_keys":["3_1459167181804130304"],"poll_ids":{}},"conversation_id":"1459167232509030401","possibly_sensitive":false,"created_at":"2021-11-12T14:32:32.000Z","id":"1459167232509030401","text":"ğŸ“¢ EMAâ€™s human medicines committee, the #CHMP, recommends 11 new #medicines for approval at its November 2021 meeting: \nhttps://t.co/TWyYCCRxJz https://t.co/vfh49LorJc","referenced_tweets":{}},{"entities":{"urls":[{"start":183,"end":206,"url":"https://t.co/7LIklkaB1h","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-ema-recommends-authorisation-two-monoclonal-antibody-medicines","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":241,"end":264,"url":"https://t.co/mGJ3LtkUcj","expanded_url":"https://twitter.com/EMA_News/status/1458821854597160960/photo/1","display_url":"pic.twitter.com/mGJ3LtkUcj"}],"hashtags":[{"start":37,"end":55,"tag":"COVID19treatments"},{"start":170,"end":178,"tag":"COVID19"},{"start":208,"end":217,"tag":"Pandemic"},{"start":218,"end":240,"tag":"PublicHealthEmergency"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":146,"reply_count":36,"like_count":236,"quote_count":45},"attachments":{"media_keys":["3_1458821641262227460"],"poll_ids":{}},"conversation_id":"1458821854597160960","possibly_sensitive":false,"created_at":"2021-11-11T15:40:08.000Z","id":"1458821854597160960","text":"â€¼ï¸ EMA recommends authorising 2âƒ£ new #COVID19treatments. \n\nRonapreve and Regkirona are the first monoclonal antibody medicines to receive a positive opinion from EMA for #COVID19. \n\nğŸ‘‰https://t.co/7LIklkaB1h\n\n#Pandemic #PublicHealthEmergency https://t.co/mGJ3LtkUcj","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":32,"end":47,"tag":"VaccineTracker"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1458772102123773954","possibly_sensitive":false,"created_at":"2021-11-11T12:22:26.000Z","id":"1458772102123773954","text":"RT @ECDC_EU: New version of our #VaccineTracker is up and running now!\n\nWhat is new?\n- downloadable summary tables with key figures\n- dataâ€¦","referenced_tweets":[{"type":"retweeted","id":"1458741532480229376"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":154,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1458772055961350149","possibly_sensitive":false,"created_at":"2021-11-11T12:22:15.000Z","id":"1458772055961350149","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1458758761397559304"}]},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/VDp12htR3T","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-11-november-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":156,"end":179,"url":"https://t.co/t3ZPsHnspr","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-covid-19-vaccine-janssen-11-november-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":192,"end":215,"url":"https://t.co/2a69mjpWHb","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-spikevax-previously-covid-19-vaccine-moderna-11-november-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":229,"end":252,"url":"https://t.co/0gm3bwZ2wr","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-11-november-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-11-november-2021_en.pdf"},{"start":272,"end":295,"url":"https://t.co/M5oI6PoSmE","expanded_url":"https://twitter.com/EMA_News/status/1458741505938665472/photo/1","display_url":"pic.twitter.com/M5oI6PoSmE"}],"hashtags":[{"start":50,"end":66,"tag":"COVID19vaccines"},{"start":254,"end":271,"tag":"SafetyOfVaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":65,"reply_count":33,"like_count":87,"quote_count":7},"attachments":{"media_keys":["3_1458741364200513536"],"poll_ids":{}},"conversation_id":"1458741505938665472","possibly_sensitive":false,"created_at":"2021-11-11T10:20:51.000Z","id":"1458741505938665472","text":"Check out our latest updates on the safety of all #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º: \n\nâœ”ï¸Comirnaty: https://t.co/VDp12htR3T\nâœ”ï¸COVID-19 Vaccine Janssen: https://t.co/t3ZPsHnspr\nâœ”ï¸Spikevax: https://t.co/2a69mjpWHb\nâœ”ï¸Vaxzevria: https://t.co/0gm3bwZ2wr\n\n#SafetyOfVaccines https://t.co/M5oI6PoSmE","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1458712518642348041","possibly_sensitive":false,"created_at":"2021-11-11T08:25:40.000Z","id":"1458712518642348041","text":"RT @ECDC_EU: Confidence\nConstraints\nComplacency\nCalculation\nCollective responsibility\n\nThese \"five C's\" have a major influence on one's decâ€¦","referenced_tweets":[{"type":"retweeted","id":"1458367589026045957"}]},{"entities":{"urls":{},"hashtags":[{"start":13,"end":34,"tag":"AntibioticResistance"},{"start":93,"end":113,"tag":"EnvironmentalHealth"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1458434020535115786","possibly_sensitive":false,"created_at":"2021-11-10T13:59:01.000Z","id":"1458434020535115786","text":"RT @EFSA_EU: #AntibioticResistance is a complex problem affecting human, animal, plant &amp; #EnvironmentalHealth. On 19 November, join live ouâ€¦","referenced_tweets":[{"type":"retweeted","id":"1458362392014884865"}]},{"entities":{"urls":{},"hashtags":[{"start":131,"end":139,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1458433879732334594","possibly_sensitive":false,"created_at":"2021-11-10T13:58:27.000Z","id":"1458433879732334594","text":"RT @ECDC_EU: We have recently published a report helping out Member States to overcome the barriers, having a strong impact on the #COVID19â€¦","referenced_tweets":[{"type":"retweeted","id":"1458367590946988037"}]},{"entities":{"urls":[{"start":155,"end":178,"url":"https://t.co/QWfQDOTtht","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-covid-19-vaccine-spikevax-children-aged-6-11","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":222,"end":245,"url":"https://t.co/VnFLd59SGW","expanded_url":"https://twitter.com/EMA_News/status/1458371607207026688/photo/1","display_url":"pic.twitter.com/VnFLd59SGW"}],"hashtags":[{"start":71,"end":86,"tag":"COVID19vaccine"},{"start":180,"end":188,"tag":"COVID19"},{"start":189,"end":198,"tag":"Pandemic"},{"start":199,"end":221,"tag":"PublicHealthEmergency"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":107,"reply_count":25,"like_count":185,"quote_count":30},"attachments":{"media_keys":["3_1458370983010652169"],"poll_ids":{}},"conversation_id":"1458371607207026688","possibly_sensitive":false,"created_at":"2021-11-10T09:51:01.000Z","id":"1458371607207026688","text":"â€¼ï¸ EMA starts evaluating an application to extend the use of Modernaâ€™s #COVID19vaccine, Spikevax, to children aged 6 to 11.\n\nRead the full press release: ğŸ‘‡https://t.co/QWfQDOTtht\n\n#COVID19 #Pandemic #PublicHealthEmergency https://t.co/VnFLd59SGW","referenced_tweets":{}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/DnSsTVMCu2","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-ema-heads-medicines-agencies-update-molnupiravir","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":187,"end":210,"url":"https://t.co/Fky4Kjl8bA","expanded_url":"https://twitter.com/EMA_News/status/1457988754677932034/photo/1","display_url":"pic.twitter.com/Fky4Kjl8bA"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":96,"reply_count":27,"like_count":201,"quote_count":20},"attachments":{"media_keys":["3_1457988665922183172"],"poll_ids":{}},"conversation_id":"1457988754677932034","possibly_sensitive":false,"created_at":"2021-11-09T08:29:41.000Z","id":"1457988754677932034","text":"â€¼ï¸ EMA will make recommendations as soon as possible on early use of oral antiviral molnupiravir, ahead of authorisation, to support decisions by ğŸ‡ªğŸ‡º countries. \n\nğŸ‘‰https://t.co/DnSsTVMCu2 https://t.co/Fky4Kjl8bA","referenced_tweets":{}},{"entities":{"urls":[{"start":249,"end":272,"url":"https://t.co/VL9C28JdIm","expanded_url":"https://twitter.com/i/spaces/1vAxRkoQDXkKl?s=20","display_url":"twitter.com/i/spaces/1vAxRâ€¦"}],"hashtags":[{"start":18,"end":22,"tag":"AMR"},{"start":84,"end":96,"tag":"antibiotics"},{"start":185,"end":189,"tag":"AMR"},{"start":232,"end":237,"tag":"EAAD"},{"start":238,"end":243,"tag":"WAAW"},{"start":244,"end":248,"tag":"AMR"}],"mentions":[{"start":195,"end":205,"username":"EU_Health","id":"606325697"},{"start":207,"end":215,"username":"ECDC_EU","id":"204752573"},{"start":220,"end":228,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":2,"like_count":62,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1457731498497413132","possibly_sensitive":false,"created_at":"2021-11-08T15:27:27.000Z","id":"1457731498497413132","text":"Save the date â€¼ï¸\n\n#AMR is a high priority for EMA. We cannot get to the point where #antibiotics no longer work to treat or prevent infections. \n\nOn 19 Nov, we are organising a chat on #AMR with @EU_Health, @ECDC_EU and @EFSA_EU. \n\n#EAAD #WAAW #AMR\nhttps://t.co/VL9C28JdIm","referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/Z5AI847h1I","expanded_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-8-11-november-2021-meeting_en.pdf","display_url":"ema.europa.eu/en/documents/aâ€¦"}],"hashtags":[{"start":85,"end":90,"tag":"CHMP"}],"mentions":{},"annotations":[{"start":48,"end":50,"probability":0.3759,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":15,"like_count":42,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1457702900227088384","possibly_sensitive":false,"created_at":"2021-11-08T13:33:48.000Z","id":"1457702900227088384","text":"What's on the agenda of the November meeting of EMA's human medicines committee, the #CHMPâ“\n\nSee here: ğŸ‘‡\nhttps://t.co/Z5AI847h1I","referenced_tweets":{}},{"entities":{"urls":[{"start":227,"end":250,"url":"https://t.co/yv2eKOZEL9","expanded_url":"https://twitter.com/EMA_News/status/1456625199739199490/video/1","display_url":"pic.twitter.com/yv2eKOZEL9"}],"hashtags":[{"start":195,"end":209,"tag":"MedSafetyWeek"}],"mentions":[{"start":210,"end":226,"username":"UMCGlobalSafety","id":"3173443348"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":34,"reply_count":27,"like_count":68,"quote_count":3},"attachments":{"media_keys":["7_1456624980536578052"],"poll_ids":{}},"conversation_id":"1456625199739199490","possibly_sensitive":false,"created_at":"2021-11-05T14:11:25.000Z","id":"1456625199739199490","text":"Vaccines are the best way to protect individuals against infectious diseases. Like with all medicines, side effects can happen. By reporting these, you help us to monitor the safety of vaccines. #MedSafetyWeek @UMCGlobalSafety https://t.co/yv2eKOZEL9","referenced_tweets":{}},{"entities":{"urls":[{"start":130,"end":153,"url":"https://t.co/VaXqG4sdJt","expanded_url":"https://twitter.com/i/events/1456581151980756992","display_url":"twitter.com/i/events/14565â€¦"}],"hashtags":[{"start":96,"end":104,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":6,"like_count":32,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456582035586392065","possibly_sensitive":false,"created_at":"2021-11-05T11:19:53.000Z","id":"1456582035586392065","text":"You can see all live tweets from EMA's press briefing that took place yesterday, 4 November, on #COVID19 vaccines and treatments. https://t.co/VaXqG4sdJt","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":61,"end":69,"tag":"COVID19"}],"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456556108231892994","possibly_sensitive":false,"created_at":"2021-11-05T09:36:52.000Z","id":"1456556108231892994","text":"RT @ECDC_Outbreaks: What is the current level of concern for #COVID19 situation in the EU/EEA?\n\nWhat is the 14 day forecast in terms of casâ€¦","referenced_tweets":[{"type":"retweeted","id":"1456526757247557632"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456556066133655555","possibly_sensitive":false,"created_at":"2021-11-05T09:36:42.000Z","id":"1456556066133655555","text":"RT @EU_Health: Having the right treatments for COVID-19 patients is crucial to reduce hospitalisations &amp; save lives\n\nToday we are bringingâ€¦","referenced_tweets":[{"type":"retweeted","id":"1456524182657900547"}]},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"molnupiravir"},{"start":186,"end":197,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":59,"reply_count":10,"like_count":127,"quote_count":20},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:11:18.000Z","id":"1456247683778240520","text":"Oral antiviral #molnupiravir: We are ready to give advice to ğŸ‡ªğŸ‡º Member States so that they could make this new treatment available for emergency use, ahead of a marketing authorisation. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456247571949686785"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"molnupiravir"},{"start":41,"end":55,"tag":"RollingReview"},{"start":83,"end":100,"tag":"COVID19treatment"},{"start":215,"end":223,"tag":"COVID19"},{"start":234,"end":245,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":30,"reply_count":3,"like_count":58,"quote_count":13},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:10:51.000Z","id":"1456247571949686785","text":"Oral antiviral #molnupiravir under EMAâ€™s #RollingReview: Studies suggest that this #COVID19treatment may reduce the ability of the coronavirus to multiply in the body, thereby preventing hospitalisation or death in #COVID19 patients. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456247228884996103"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":24,"end":32,"tag":"COVID19"},{"start":162,"end":173,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":65,"end":70,"probability":0.9972,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":9,"like_count":27,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:09:29.000Z","id":"1456247228884996103","text":"â€¼ï¸ We see the number of #COVID19 infections on the rise again in Europe. It is important that people get vaccinated or complete their initial vaccination course. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456246917529231366"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":8,"tag":"Novavax"},{"start":162,"end":173,"tag":"EMAPresser"},{"start":174,"end":190,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":20,"like_count":65,"quote_count":14},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:08:15.000Z","id":"1456246917529231366","text":"#Novavax has submitted data on manufacturing. This will allow us to progress in the review of this vaccine. A possible approval is expected in the coming months. #EMAPresser #COVID19vaccines","referenced_tweets":[{"type":"replied_to","id":"1456246692269989891"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":10,"tag":"Comirnaty"},{"start":242,"end":253,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":192,"end":206,"probability":0.2271,"type":"Organization","normalized_text":"BioNTech/Pfizer"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":61,"reply_count":18,"like_count":96,"quote_count":25},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:07:21.000Z","id":"1456246692269989891","text":"#Comirnaty for children aged 5 to 11: conclusion expected in December. This is a shortened timetable compared to similar reviews. We will also consider further data collected and submitted by BioNTech/Pfizer from an ongoing paediatric trial. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456246463206502401"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":15,"tag":"COVID19vaccine"},{"start":43,"end":55,"tag":"boosterdose"},{"start":253,"end":264,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":16,"end":22,"probability":0.7599,"type":"Person","normalized_text":"Janssen"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":18,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:06:27.000Z","id":"1456246463206502401","text":"#COVID19vaccine Janssen: We expect data on #boosterdose administered 6 months after the 1st dose. In parallel we will consider data from a clinical trial that investigated if a schedule of 2 doses increases protection compared to the one dose schedule. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456246134884732930"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":41,"end":54,"tag":"boosterdoses"},{"start":81,"end":93,"tag":"coronavirus"},{"start":193,"end":204,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":29,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:05:08.000Z","id":"1456246134884732930","text":"Most Member States started administering #boosterdoses to people more at risk of #coronavirus infection and transmission. Expansion of booster doses to general population may be the next step. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456245854424244230"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":32,"end":41,"tag":"Spikevax"},{"start":123,"end":131,"tag":"COVID19"},{"start":132,"end":145,"tag":"deltavariant"},{"start":171,"end":182,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":3,"like_count":35,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:04:02.000Z","id":"1456245854424244230","text":"The antibodies generated by the #Spikevax booster dose are showing an 18-fold increase in cross-neutralisation against the #COVID19 #deltavariant compared to pre-booster. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1456245304022405122"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":170,"end":193,"url":"https://t.co/8eX4FOfX45","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-7","display_url":"ema.europa.eu/en/events/ema-â€¦"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":13,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T13:01:50.000Z","id":"1456245304022405122","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser.  https://t.co/8eX4FOfX45","referenced_tweets":[{"type":"replied_to","id":"1456239536074285057"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":151,"end":174,"url":"https://t.co/8eX4FOfX45","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-7","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":175,"end":198,"url":"https://t.co/HhOzXYe0BU","expanded_url":"https://twitter.com/EMA_News/status/1456239536074285057/photo/1","display_url":"pic.twitter.com/HhOzXYe0BU"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":137,"end":148,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":25,"reply_count":13,"like_count":61,"quote_count":6},"attachments":{"media_keys":["3_1456239288753000448"],"poll_ids":{}},"conversation_id":"1456239536074285057","possibly_sensitive":false,"created_at":"2021-11-04T12:38:55.000Z","id":"1456239536074285057","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 4 November, from 14:00 to 14:30 CET. #EMAPresser\n\nğŸ‘‰https://t.co/8eX4FOfX45 https://t.co/HhOzXYe0BU","referenced_tweets":{}},{"entities":{"urls":[{"start":131,"end":154,"url":"https://t.co/6FJwSlYhON","expanded_url":"https://clinicaldata.ema.europa.eu","display_url":"clinicaldata.ema.europa.eu"},{"start":280,"end":303,"url":"https://t.co/7OfPNf2DPX","expanded_url":"https://twitter.com/EMA_News/status/1455930199829327883/photo/1","display_url":"pic.twitter.com/7OfPNf2DPX"}],"hashtags":[{"start":4,"end":17,"tag":"ClinicalData"},{"start":72,"end":82,"tag":"Comirnaty"},{"start":259,"end":267,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":33,"reply_count":8,"like_count":67,"quote_count":7},"attachments":{"media_keys":["3_1455929872988114949"],"poll_ids":{}},"conversation_id":"1455930199829327883","possibly_sensitive":false,"created_at":"2021-11-03T16:09:44.000Z","id":"1455930199829327883","text":"The #ClinicalData supporting the extension of indication for the use of #Comirnaty in children from 12 to 15, have been published: https://t.co/6FJwSlYhON \n\nThis is in line with the exceptional measures EMA has implemented to maximise the transparency on its #COVID19 activities. https://t.co/7OfPNf2DPX","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":90,"end":102,"tag":"HealthUnion"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":49,"end":63,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1455863361854484483","possibly_sensitive":false,"created_at":"2021-11-03T11:44:08.000Z","id":"1455863361854484483","text":"RT @EU_Health: ğŸ”´LIVE at 13:00 CET:\n\nCommissioner @SKyriakidesEU will discuss the European #HealthUnion and its implications with Minister Mâ€¦","referenced_tweets":[{"type":"retweeted","id":"1455863140315508739"}]},{"entities":{"urls":[{"start":189,"end":212,"url":"https://t.co/fMW3GTDcJV","expanded_url":"https://www.ema.europa.eu/en/news/ema-ends-rolling-review-antibodies-bamlanivimab-etesevimab-covid-19-following-withdrawal-lilly","display_url":"ema.europa.eu/en/news/ema-enâ€¦"},{"start":242,"end":265,"url":"https://t.co/LhHj7KLzJe","expanded_url":"https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-end-rolling-review-antibodies-bamlanivimab-etesevimab-covid-19_.pdf","display_url":"ema.europa.eu/en/documents/mâ€¦"},{"start":266,"end":289,"url":"https://t.co/rv48idXs83","expanded_url":"https://twitter.com/EMA_News/status/1455829384175267840/photo/1","display_url":"pic.twitter.com/rv48idXs83"}],"hashtags":[{"start":16,"end":30,"tag":"RollingReview"},{"start":42,"end":59,"tag":"COVID19treatment"}],"mentions":{},"annotations":[{"start":34,"end":38,"probability":0.6124,"type":"Person","normalized_text":"Lilly"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":9,"like_count":49,"quote_count":6},"attachments":{"media_keys":["3_1455828434639261697"],"poll_ids":{}},"conversation_id":"1455829384175267840","possibly_sensitive":false,"created_at":"2021-11-03T09:29:07.000Z","id":"1455829384175267840","text":"â€¼ï¸ EMA ends the #RollingReview of Lillyâ€™s #COVID19treatment bamlanivimab and etesevimab, after the company informed us that it was withdrawing from the process.\n\nğŸ‘‰ Read the press release: \nhttps://t.co/fMW3GTDcJV\n\nğŸ‘‰ Read a Q&amp;A document: \nhttps://t.co/LhHj7KLzJe https://t.co/rv48idXs83","referenced_tweets":{}},{"entities":{"urls":[{"start":256,"end":279,"url":"https://t.co/7UsPOe1NrJ","expanded_url":"https://twitter.com/EMA_News/status/1455120838542430208/video/1","display_url":"pic.twitter.com/7UsPOe1NrJ"}],"hashtags":[{"start":62,"end":73,"tag":"sideeffect"},{"start":224,"end":238,"tag":"MedSafetyWeek"}],"mentions":[{"start":239,"end":255,"username":"UMCGlobalSafety","id":"3173443348"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":16,"like_count":59,"quote_count":7},"attachments":{"media_keys":["7_1455120041385545733"],"poll_ids":{}},"conversation_id":"1455120838542430208","possibly_sensitive":false,"created_at":"2021-11-01T10:33:37.000Z","id":"1455120838542430208","text":"Have you been vaccinated but not feeling well? \nIt might be a #sideeffect. Make sure to report it to your healthcare professional, national authority or vaccine developer. \nTogether we can make vaccines better for everyone. #MedSafetyWeek @UMCGlobalSafety https://t.co/7UsPOe1NrJ","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":24,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1454063935339089930","possibly_sensitive":false,"created_at":"2021-10-29T12:33:52.000Z","id":"1454063935339089930","text":"RT @EU_Health: .@ECDC_EU's weekly surveillance report on the COVID-19 situation: \n\nThe level of concern is currently moderate, there are inâ€¦","referenced_tweets":[{"type":"retweeted","id":"1454063860558729220"}]},{"entities":{"urls":[{"start":186,"end":209,"url":"https://t.co/Q5FaAMrvGS","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-october-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦","images":[{"url":"https://pbs.twimg.com/news_img/1482094162640089088/IDKiKuqL?format=png&name=orig","width":842,"height":1102},{"url":"https://pbs.twimg.com/news_img/1482094162640089088/IDKiKuqL?format=png&name=150x150","width":150,"height":150}],"status":200,"title":"Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 - European Medicines Agency","description":"Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021","unwound_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-october-2021"},{"start":249,"end":272,"url":"https://t.co/dTOCdOpac7","expanded_url":"https://twitter.com/EMA_News/status/1454053171098161155/photo/1","display_url":"pic.twitter.com/dTOCdOpac7","images":{}}],"hashtags":[{"start":91,"end":96,"tag":"PRAC"},{"start":134,"end":150,"tag":"COVID19vaccines"},{"start":157,"end":166,"tag":"medicine"},{"start":211,"end":229,"tag":"pharmacovigilance"},{"start":230,"end":248,"tag":"SafetyOfMedicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":5,"like_count":24,"quote_count":5},"attachments":{"media_keys":["3_1454052555579969545"],"poll_ids":{}},"conversation_id":"1454053171098161155","possibly_sensitive":false,"created_at":"2021-10-29T11:51:05.000Z","id":"1454053171098161155","text":"We have just published the highlights of the November meeting of our safety committee, the #PRAC. \n\nRead the updates on the safety of #COVID19vaccines and a #medicine for blood cancers: https://t.co/Q5FaAMrvGS\n\n#pharmacovigilance #SafetyOfMedicines https://t.co/dTOCdOpac7","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"SKeersmaecker","id":"1129822272234106881"}],"annotations":[{"start":91,"end":104,"probability":0.9285,"type":"Organization","normalized_text":"The Commission"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453997960782618628","possibly_sensitive":false,"created_at":"2021-10-29T08:11:42.000Z","id":"1453997960782618628","text":"RT @SKeersmaecker: A stronger mandate for EMA to be better prepared for future pandemics - The Commission welcomes today's agreement betweeâ€¦","referenced_tweets":[{"type":"retweeted","id":"1453748484553781248"}]},{"entities":{"urls":{},"hashtags":[{"start":67,"end":84,"tag":"EUPharmaStrategy"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453997776564588547","possibly_sensitive":false,"created_at":"2021-10-29T08:10:58.000Z","id":"1453997776564588547","text":"RT @EU_Health: What if you can't get the medicines you need? \n\nThe #EUPharmaStrategy aims to ensure that the EU can develop, manufacture &amp;â€¦","referenced_tweets":[{"type":"retweeted","id":"1453972366912933892"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":[{"start":77,"end":101,"probability":0.8804,"type":"Organization","normalized_text":"European Medicines Agency"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453746837857439752","possibly_sensitive":false,"created_at":"2021-10-28T15:33:50.000Z","id":"1453746837857439752","text":"RT @SKyriakidesEU: Todayâ€™s political agreement on a stronger mandate for the European Medicines Agency puts in place the first pillar of aâ€¦","referenced_tweets":[{"type":"retweeted","id":"1453728266016079888"}]},{"entities":{"urls":[{"start":206,"end":229,"url":"https://t.co/f17pbFY3Pc","expanded_url":"https://www.ema.europa.eu/en/news/repurposing-authorised-medicines-pilot-support-not-profit-organisations-academia","display_url":"ema.europa.eu/en/news/repurpâ€¦","status":200,"title":"Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia - European Medicines Agency","description":"Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia","unwound_url":"https://www.ema.europa.eu/en/news/repurposing-authorised-medicines-pilot-support-not-profit-organisations-academia"},{"start":230,"end":253,"url":"https://t.co/vl5OHShj7C","expanded_url":"https://twitter.com/EMA_News/status/1453690165734563847/photo/1","display_url":"pic.twitter.com/vl5OHShj7C"}],"hashtags":[{"start":67,"end":76,"tag":"patients"},{"start":145,"end":155,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":3,"like_count":39,"quote_count":6},"attachments":{"media_keys":["3_1453690101607944193"],"poll_ids":{}},"conversation_id":"1453690165734563847","possibly_sensitive":false,"created_at":"2021-10-28T11:48:38.000Z","id":"1453690165734563847","text":"â€¼ï¸ We continue our work towards making new treatments available to #patients.\nEMA is launching a pilot to support the repurposing of established #medicines for use in new indications by NGOs and academia.\nğŸ‘‰https://t.co/f17pbFY3Pc https://t.co/vl5OHShj7C","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":22,"end":30,"tag":"COVID19"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453655785175764994","possibly_sensitive":false,"created_at":"2021-10-28T09:32:01.000Z","id":"1453655785175764994","text":"RT @SKyriakidesEU: â¡ï¸ #COVID19 cases are rising again across Member States.\n\nğŸ”¹The message to citizens everywhere is the same: trust the sciâ€¦","referenced_tweets":[{"type":"retweeted","id":"1453402256305446915"}]},{"entities":{"urls":[{"start":258,"end":281,"url":"https://t.co/YSrnKrtLHP","expanded_url":"https://ec.europa.eu/health/documents/public_call/call_index_en#fragment2","display_url":"ec.europa.eu/health/documenâ€¦"},{"start":282,"end":305,"url":"https://t.co/7dpLc9dYTn","expanded_url":"https://twitter.com/EMA_News/status/1453646678850945030/photo/1","display_url":"pic.twitter.com/7dpLc9dYTn"}],"hashtags":[{"start":116,"end":125,"tag":"patients"},{"start":127,"end":151,"tag":"HealthcareProfessionals"},{"start":158,"end":172,"tag":"veterinarians"}],"mentions":{},"annotations":[{"start":23,"end":44,"probability":0.219,"type":"Organization","normalized_text":"EMA's Management Board"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":16,"quote_count":2},"attachments":{"media_keys":["3_1453646133264273411"],"poll_ids":{}},"conversation_id":"1453646678850945030","possibly_sensitive":false,"created_at":"2021-10-28T08:55:50.000Z","id":"1453646678850945030","text":"Would you like to join EMA's Management Boardâ“\n\nYou can contribute to EMAâ€™s work by ensuring the views and needs of #patients, #HealthcareProfessionals &amp; #veterinarians are considered in the discussions and decisions taken by the Board\n\nğŸ“©Apply by 5 Nov: https://t.co/YSrnKrtLHP https://t.co/7dpLc9dYTn","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"COVID19"},{"start":52,"end":66,"tag":"RealWorldData"},{"start":170,"end":188,"tag":"RealWorldEvidence"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9849,"type":"Person","normalized_text":"Emer Cooke"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":14,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453331495884664837","possibly_sensitive":false,"created_at":"2021-10-27T12:21:58.000Z","id":"1453336168213385223","text":"Emer Cooke: \"#COVID19 accentuates the importance of #RealWorldData in monitoring vaccinesâ€™ effectiveness &amp; safety. I think we need to be much more proactive in using #RealWorldEvidence.\"","referenced_tweets":[{"type":"replied_to","id":"1453334946051936259"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":57,"end":73,"tag":"COVID19Pandemic"},{"start":123,"end":136,"tag":"PublicHealth"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9855,"type":"Person","normalized_text":"Emer Cooke"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2,"reply_count":3,"like_count":5,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453331495884664837","possibly_sensitive":false,"created_at":"2021-10-27T12:17:07.000Z","id":"1453334946051936259","text":"Emer Cooke: \"We are considering which learnings from the #COVID19Pandemic can lead to better processes for wider use in EU #PublicHealth and beyond.\"","referenced_tweets":[{"type":"replied_to","id":"1453331495884664837"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":162,"end":185,"url":"https://t.co/jy8g3O3uZx","expanded_url":"https://twitter.com/LivePOLITICO/status/1453329421277057024","display_url":"twitter.com/LivePOLITICO/sâ€¦"}],"hashtags":[{"start":141,"end":160,"tag":"PoliticoHealthCare"}],"mentions":[{"start":88,"end":103,"username":"POLITICOEurope","id":"2969760609"}],"annotations":[{"start":24,"end":33,"probability":0.9902,"type":"Person","normalized_text":"Emer Cooke"},{"start":104,"end":121,"probability":0.5323,"type":"Other","normalized_text":"Health Care Summit"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":21,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1453331495884664837","possibly_sensitive":false,"created_at":"2021-10-27T12:03:24.000Z","id":"1453331495884664837","text":"Our Executive Director, Emer Cooke, is the headline speaker during the first day of the @POLITICOEurope Health Care Summit on October 27-28. #PoliticoHealthCare. https://t.co/jy8g3O3uZx","referenced_tweets":[{"type":"quoted","id":"1453329421277057024"}]},{"entities":{"urls":[{"start":239,"end":262,"url":"https://t.co/4pVRV9uTcq","expanded_url":"https://www.ema.europa.eu/en/events/public-stakeholder-meeting-covid-19-vaccines-therapeutics-eu","display_url":"ema.europa.eu/en/events/publâ€¦"},{"start":284,"end":307,"url":"https://t.co/XawzM2xR6i","expanded_url":"https://twitter.com/EMA_News/status/1452996026726592528/photo/1","display_url":"pic.twitter.com/XawzM2xR6i"}],"hashtags":[{"start":134,"end":150,"tag":"COVID19vaccines"},{"start":265,"end":283,"tag":"EMAPublicMeeting4"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":30,"reply_count":6,"like_count":54,"quote_count":10},"attachments":{"media_keys":["3_1452995389070663692"],"poll_ids":{}},"conversation_id":"1452996026726592528","possibly_sensitive":false,"created_at":"2021-10-26T13:50:22.000Z","id":"1452996026726592528","text":"ğŸ“…Save the date! \n\nEMA is organising its 4th public meeting on 25 November to update citizens on the approval and safety monitoring of #COVID19vaccines &amp; therapeutics in the ğŸ‡ªğŸ‡º. \n\nRegister to join virtual room or watch live on the day: https://t.co/4pVRV9uTcq \n\n#EMAPublicMeeting4 https://t.co/XawzM2xR6i","referenced_tweets":{}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/N0DeQcnIPd","expanded_url":"https://www.ema.europa.eu/en/news/spikevax-ema-recommendation-booster","display_url":"ema.europa.eu/en/news/spikevâ€¦"},{"start":187,"end":210,"url":"https://t.co/zkd0OLroue","expanded_url":"https://twitter.com/EMA_News/status/1452687670749057026/photo/1","display_url":"pic.twitter.com/zkd0OLroue"}],"hashtags":[{"start":23,"end":35,"tag":"BoosterDose"},{"start":43,"end":58,"tag":"COVID19vaccine"},{"start":59,"end":68,"tag":"Spikevax"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":120,"reply_count":14,"like_count":223,"quote_count":42},"attachments":{"media_keys":["3_1452687518252609545"],"poll_ids":{}},"conversation_id":"1452687670749057026","possibly_sensitive":false,"created_at":"2021-10-25T17:25:04.000Z","id":"1452687670749057026","text":"ğŸ“¢ EMA concludes that a #BoosterDose of the #COVID19vaccine #Spikevax (from Moderna) may be considered in people aged 18 years and above.\nFull announcement here: \nğŸ‘‰https://t.co/N0DeQcnIPd https://t.co/zkd0OLroue","referenced_tweets":{}},{"entities":{"urls":[{"start":147,"end":170,"url":"https://t.co/M33axkADKC","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-ema-starts-rolling-review-molnupiravir","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":171,"end":194,"url":"https://t.co/pi0i5HBNhV","expanded_url":"https://twitter.com/EMA_News/status/1452584230744174595/photo/1","display_url":"pic.twitter.com/pi0i5HBNhV"}],"hashtags":[{"start":16,"end":30,"tag":"RollingReview"},{"start":34,"end":47,"tag":"molnupiravir"},{"start":97,"end":105,"tag":"COVID19"},{"start":117,"end":134,"tag":"COVID19treatment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":89,"reply_count":11,"like_count":174,"quote_count":20},"attachments":{"media_keys":["3_1452583917337329671"],"poll_ids":{}},"conversation_id":"1452584230744174595","possibly_sensitive":false,"created_at":"2021-10-25T10:34:02.000Z","id":"1452584230744174595","text":"ğŸ“¢ğŸ’Š EMA starts a #RollingReview of #molnupiravir, an oral antiviral medicine for the treatment of #COVID19 in adults. #COVID19treatment\n\nRead more: https://t.co/M33axkADKC https://t.co/pi0i5HBNhV","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":123,"end":136,"tag":"FluAwareness"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1452583165437128704","possibly_sensitive":false,"created_at":"2021-10-25T10:29:48.000Z","id":"1452583165437128704","text":"RT @EU_Health: Let's make sure our health systems do not become overburdened this flu season.\n\nWhy?\n\nListen in tomorrow â¬‡\n\n#FluAwareness #Vâ€¦","referenced_tweets":[{"type":"retweeted","id":"1452580159010353152"}]},{"entities":{"urls":{},"hashtags":[{"start":26,"end":34,"tag":"COVID19"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":[{"start":98,"end":99,"probability":0.484,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451566704383963137","possibly_sensitive":false,"created_at":"2021-10-22T15:10:45.000Z","id":"1451566704383963137","text":"RT @SKyriakidesEU: The ğŸ‡ªğŸ‡º #COVID19 Therapeutics Strategy is moving forward â¡ï¸ today we announce EU portfolio of ğŸ”Ÿ promising therapeutics.â€¦","referenced_tweets":[{"type":"retweeted","id":"1451550619702005765"}]},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/7W6Xv8L2Vl","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/research-development/prime-priority-medicines","display_url":"ema.europa.eu/en/human-regulâ€¦"},{"start":237,"end":260,"url":"https://t.co/b37Prn98gc","expanded_url":"https://twitter.com/EMA_News/status/1451456833198174209/photo/1","display_url":"pic.twitter.com/b37Prn98gc"}],"hashtags":[{"start":56,"end":70,"tag":"PRIMEschemeEU"},{"start":159,"end":169,"tag":"medicines"},{"start":205,"end":218,"tag":"PublicHealth"},{"start":219,"end":236,"tag":"healthinnovation"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":13,"quote_count":1},"attachments":{"media_keys":["3_1451456599252508675"],"poll_ids":{}},"conversation_id":"1451456833198174209","possibly_sensitive":false,"created_at":"2021-10-22T07:54:10.000Z","id":"1451456833198174209","text":"ğŸ“¢ In October 2021, 1âƒ£ medicinal product was accepted to #PRIMEschemeEU: https://t.co/7W6Xv8L2Vl\n\nPRIME is an EMA scheme launched to support the development of #medicines targeting an unmet medical need. \n\n#PublicHealth #healthinnovation https://t.co/b37Prn98gc","referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/vcLWOqu97e","expanded_url":"https://twitter.com/i/events/1451180829426683917","display_url":"twitter.com/i/events/14511â€¦","images":[{"url":"https://pbs.twimg.com/news_img/1451182375870763011/dYD0x8Bd?format=jpg&name=orig","width":1200,"height":675},{"url":"https://pbs.twimg.com/news_img/1451182375870763011/dYD0x8Bd?format=jpg&name=150x150","width":150,"height":150}],"status":200,"title":"EMA's Press Briefing 21 October 2021","description":"See the live tweets posted during EMA's technical press briefing held on 21 October 2021. #EMAPresser","unwound_url":"https://twitter.com/i/events/1451180829426683917"}],"hashtags":[{"start":90,"end":101,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":34,"end":36,"probability":0.5374,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":6,"like_count":13,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451182374016864258","possibly_sensitive":false,"created_at":"2021-10-21T13:43:34.000Z","id":"1451182374016864258","text":"See the live tweets posted during EMA's technical press briefing held on 21 October 2021. #EMAPresser\nhttps://t.co/vcLWOqu97e","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":244,"end":260,"tag":"COVID19vaccines"},{"start":262,"end":273,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":19,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:41:50.000Z","id":"1451151741114781699","text":"The Flu Awareness Week 2021 takes place on ğŸ—“ï¸18 - 22 Oct. \nWe encourage everybody who is offered a flu vaccine to get the shot to protect themselves, their family, friends and colleagues. Data show that flu vaccines can be co-administered with #COVID19vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451151545609957385"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":75,"end":88,"tag":"Molnupiravir"},{"start":121,"end":135,"tag":"RollingReview"},{"start":145,"end":162,"tag":"COVID19treatment"},{"start":174,"end":185,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3497,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":2,"like_count":31,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:41:04.000Z","id":"1451151545609957385","text":"EMA has been in constant dialogue with the developer of the oral antiviral #Molnupiravir. We expect the start of the EMA #RollingReview for this #COVID19treatment next week. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451151071720742912"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":153,"end":164,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":39,"reply_count":8,"like_count":61,"quote_count":13},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:39:11.000Z","id":"1451151071720742912","text":"â€¼ï¸ With a death toll of nearly 5âƒ£ million people worldwide, the human cost of natural immunity, when the virus is allowed to run wild, is not tolerable. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451150949104459788"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":62,"end":70,"tag":"COVID19"},{"start":195,"end":206,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":4,"like_count":24,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:38:42.000Z","id":"1451150949104459788","text":"Studies showed that receiving a vaccine after recovering from #COVID19:\nâ¡ï¸increased people's ability to fight future infections â¡ï¸better protected people from any new infection with coronavirus. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451150801787891719"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":44,"end":54,"tag":"Comirnaty"},{"start":131,"end":142,"tag":"EMAPresser"}],"mentions":[{"start":85,"end":99,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":16,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:38:06.000Z","id":"1451150801787891719","text":"The conditional marketing authorisation for #Comirnaty was renewed for 1 year by the @EU_Commission based on EMAâ€™s recommendation. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451150745928146945"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":106,"end":122,"tag":"COVID19vaccines"},{"start":237,"end":248,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":59,"end":60,"probability":0.739,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":21,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:37:53.000Z","id":"1451150745928146945","text":"Increasing the capacity of manufacturing sites enabled the EU to deliver more than 7âƒ£0âƒ£0âƒ£million doses of #COVID19vaccines to the European people, and export over 1âƒ£ billion doses to the rest of the world, to more than 1âƒ£5âƒ£0âƒ£ countries. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451150388015554568"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":56,"end":72,"tag":"COVID19vaccines"},{"start":116,"end":132,"tag":"COVID19pandemic"},{"start":154,"end":164,"tag":"pandemics"},{"start":166,"end":177,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":9,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:36:28.000Z","id":"1451150388015554568","text":"Having a range of different technological platforms for #COVID19vaccines remains important in the fight against the #COVID19pandemic and to tackle future #pandemics. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451150119823462406"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":92,"end":107,"tag":"COVID19vaccine"},{"start":263,"end":274,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":3,"like_count":35,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:35:24.000Z","id":"1451150119823462406","text":"We are seeing promising results from studies confirming a stronger immune response when the #COVID19vaccine given as a 2nd or 3rd dose is different to the vaccine that was initially received. We continue to collect and look into data on heterologous vaccination. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451149864356745218"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":51,"end":59,"tag":"Janssen"},{"start":103,"end":114,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":17,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:34:23.000Z","id":"1451149864356745218","text":"Over the coming weeks, we will receive data on the #Janssen booster given 6 months after the 1st dose. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451149754126245890"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":39,"end":48,"tag":"Spikevax"},{"start":173,"end":184,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":29,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:33:57.000Z","id":"1451149754126245890","text":"An EMA conclusion on a booster dose of #Spikevax in people over 12 years of age, 6 months after the second dose, is expected on 25 October. We will communicate the outcome. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451149654884818944"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":33,"end":42,"tag":"Spikevax"},{"start":48,"end":63,"tag":"COVID19vaccine"},{"start":228,"end":239,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":17,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:33:33.000Z","id":"1451149654884818944","text":"We are seeing data on the use of #Spikevax, the #COVID19vaccine developed by Moderna, in young children. We are discussing timelines of application with the developer to extend the use of this vaccine to children in the future. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1451149032324222980"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":160,"end":171,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Advertisers.","public_metrics":{"retweet_count":28,"reply_count":7,"like_count":42,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1451149032324222980","possibly_sensitive":false,"created_at":"2021-10-21T11:31:05.000Z","id":"1451149032324222980","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow the #EMAPresser hashtag.","referenced_tweets":{}},{"entities":{"urls":[{"start":152,"end":175,"url":"https://t.co/gZx4gt0vv2","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-6","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":176,"end":199,"url":"https://t.co/mkDYNo3KZT","expanded_url":"https://twitter.com/EMA_News/status/1451106422016589825/photo/1","display_url":"pic.twitter.com/mkDYNo3KZT"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":138,"end":149,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":9,"like_count":50,"quote_count":5},"attachments":{"media_keys":["3_1451106292878254084"],"poll_ids":{}},"conversation_id":"1451106422016589825","possibly_sensitive":false,"created_at":"2021-10-21T08:41:45.000Z","id":"1451106422016589825","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 21 October, from 13:30 to 14:00 CEST. #EMAPresser\n\nğŸ‘‰https://t.co/gZx4gt0vv2 https://t.co/mkDYNo3KZT","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1450759963127779329","possibly_sensitive":false,"created_at":"2021-10-20T09:45:03.000Z","id":"1450759963127779329","text":"RT @EU_Health: This influenza season we need to ensure our health systems do not become overburdened.\n\nEven without the pandemic, up to 40,â€¦","referenced_tweets":[{"type":"retweeted","id":"1450739626696663043"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1450471783488966668","possibly_sensitive":false,"created_at":"2021-10-19T14:39:56.000Z","id":"1450471783488966668","text":"RT @EU_Health: Vaccinate, vaccinate, vaccinate!\nDespite good progress, we are not out of the pandemic yet.\n\nâ¡ï¸Vaccination offers the best wâ€¦","referenced_tweets":[{"type":"retweeted","id":"1447857192883863552"}]},{"entities":{"urls":[{"start":200,"end":223,"url":"https://t.co/MnQPKi625n","expanded_url":"https://www.ema.europa.eu/en/news/new-manufacturing-sites-new-formulation-approved-covid-19-vaccine-biontech-pfizer","display_url":"ema.europa.eu/en/news/new-maâ€¦"},{"start":224,"end":247,"url":"https://t.co/RHhlXWcqRw","expanded_url":"https://twitter.com/EMA_News/status/1450116482919288841/photo/1","display_url":"pic.twitter.com/RHhlXWcqRw"}],"hashtags":[{"start":67,"end":82,"tag":"COVID19vaccine"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8482,"type":"Organization","normalized_text":"EMA"},{"start":96,"end":103,"probability":0.5162,"type":"Organization","normalized_text":"BioNTech"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":38,"reply_count":7,"like_count":101,"quote_count":16},"attachments":{"media_keys":["3_1450116449675227139"],"poll_ids":{}},"conversation_id":"1450116482919288841","possibly_sensitive":false,"created_at":"2021-10-18T15:08:06.000Z","id":"1450116482919288841","text":"EMA approves two additional manufacturing sites for Comirnaty, the #COVID19vaccine developed by BioNTech / Pfizer, as well as a ready-to-use formulation of this vaccine.\nRead the full announcement: \nğŸ‘‰https://t.co/MnQPKi625n https://t.co/RHhlXWcqRw","referenced_tweets":{}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/j07hskkjRO","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-covid-19-vaccine-comirnaty-children-aged-5-11","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":204,"end":227,"url":"https://t.co/EENKB10NcV","expanded_url":"https://twitter.com/EMA_News/status/1450104521695375362/photo/1","display_url":"pic.twitter.com/EENKB10NcV"}],"hashtags":[{"start":94,"end":104,"tag":"Comirnaty"},{"start":187,"end":203,"tag":"COVID19vaccines"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4573,"type":"Organization","normalized_text":"EMA"},{"start":58,"end":65,"probability":0.539,"type":"Organization","normalized_text":"BioNTech"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":205,"reply_count":65,"like_count":380,"quote_count":90},"attachments":{"media_keys":["3_1450103609446834181"],"poll_ids":{}},"conversation_id":"1450104521695375362","possibly_sensitive":false,"created_at":"2021-10-18T14:20:34.000Z","id":"1450104521695375362","text":"EMA starts evaluating an application to extend the use of BioNTech/Pfizerâ€™s COVID-19 vaccine, #Comirnaty, to children aged 5 to 11.\nRead the full press release: \nğŸ‘‰https://t.co/j07hskkjRO\n#COVID19vaccines https://t.co/EENKB10NcV","referenced_tweets":{}},{"entities":{"urls":[{"start":147,"end":170,"url":"https://t.co/8aHkHJDW0m","expanded_url":"https://www.ema.europa.eu/en/news/first-class-medicine-treat-aggressive-form-breast-cancer","display_url":"ema.europa.eu/en/news/first-â€¦"}],"hashtags":[{"start":91,"end":100,"tag":"medicine"},{"start":132,"end":145,"tag":"breastcancer"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5746,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":31,"reply_count":3,"like_count":60,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1448969715074932769","possibly_sensitive":false,"created_at":"2021-10-15T11:11:15.000Z","id":"1448969715074932769","text":"EMA recommends granting a marketing authorisation in the ğŸ‡ªğŸ‡º for Trodelvy, a first-in-class #medicine to treat an aggressive form of #breastcancer: https://t.co/8aHkHJDW0m","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":39,"end":44,"tag":"CHMP"},{"start":59,"end":69,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":31,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1448968719783403521","possibly_sensitive":false,"created_at":"2021-10-15T11:07:17.000Z","id":"1448968719783403521","text":"ğŸ“¢ EMAâ€™s human medicines committee, the #CHMP, recommends 6 #medicines for approval at its October 2021 meeting.","referenced_tweets":{}},{"entities":{"urls":[{"start":182,"end":205,"url":"https://t.co/VSXcGDukAA","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-rolling-review-evusheld-tixagevimab-cilgavimab","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":206,"end":229,"url":"https://t.co/hv0xql4SlI","expanded_url":"https://twitter.com/EMA_News/status/1448622617515208709/photo/1","display_url":"pic.twitter.com/hv0xql4SlI"}],"hashtags":[{"start":15,"end":29,"tag":"RollingReview"},{"start":37,"end":45,"tag":"COVID19"},{"start":56,"end":65,"tag":"Evusheld"}],"mentions":{},"annotations":[{"start":124,"end":134,"probability":0.5442,"type":"Organization","normalized_text":"AstraZeneca"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":39,"reply_count":2,"like_count":80,"quote_count":7},"attachments":{"media_keys":["3_1448622502566039564"],"poll_ids":{}},"conversation_id":"1448622617515208709","possibly_sensitive":false,"created_at":"2021-10-14T12:12:00.000Z","id":"1448622617515208709","text":"ğŸ“¢ EMA starts a #RollingReview of the #COVID19 treatment #Evusheld, a combination of two monoclonal antibodies developed by AstraZeneca AB for the prevention of COVID-19 in adults. \nğŸ‘‰https://t.co/VSXcGDukAA https://t.co/hv0xql4SlI","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":10,"end":18,"tag":"Patient"},{"start":20,"end":43,"tag":"HealthcareProfessional"},{"start":69,"end":80,"tag":"veterinary"},{"start":146,"end":159,"tag":"PublicHealth"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Advertisers.","public_metrics":{"retweet_count":16,"reply_count":1,"like_count":16,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1448308559675019272","possibly_sensitive":false,"created_at":"2021-10-13T15:24:03.000Z","id":"1448308559675019272","text":"Are you a #Patient, #HealthcareProfessional or a representative of a #veterinary organisation? You can now contribute to EMA's mission to protect #PublicHealth. \nApply now!","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Advertisers","public_metrics":{"retweet_count":44,"reply_count":36,"like_count":94,"quote_count":7},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1448200186413596672","possibly_sensitive":false,"created_at":"2021-10-13T08:13:25.000Z","id":"1448200186413596672","text":"Reminder about:\n\nâœ”ï¸Vero Cell, developed by Sinovac Life Sciences\n\nâœ”ï¸NVX-CoV2373, developed by Novavax\n\nâœ”ï¸Sputnik V, developed by Gamaleya National Centre of Epidemiology and Microbiology\n\nâœ”ï¸Vidprevtyn, developed by Sanofi Pasteur","referenced_tweets":{}},{"entities":{"urls":[{"start":229,"end":252,"url":"https://t.co/ENg3hcY6oV","expanded_url":"https://www.ema.europa.eu/en/news/global-approach-regulatory-flexibility-increase-manufacturing-capacity-during-covid-19","display_url":"ema.europa.eu/en/news/globalâ€¦"},{"start":253,"end":276,"url":"https://t.co/b956XmlvuH","expanded_url":"https://twitter.com/EMA_News/status/1447953482896531465/photo/1","display_url":"pic.twitter.com/b956XmlvuH"}],"hashtags":[{"start":185,"end":193,"tag":"COVID19"},{"start":211,"end":217,"tag":"ICMRA"}],"mentions":{},"annotations":[{"start":4,"end":50,"probability":0.3035,"type":"Organization","normalized_text":"International Coalition of Medicines Regulatory"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":18,"quote_count":0},"attachments":{"media_keys":["3_1447953431201726467"],"poll_ids":{}},"conversation_id":"1447953482896531465","possibly_sensitive":false,"created_at":"2021-10-12T15:53:06.000Z","id":"1447953482896531465","text":"The International Coalition of Medicines Regulatory Authorities (ICMRA) presents pre-requisites for regulatory flexibility that can be applied to increase manufacturing capacity during #COVID19.  \n\nSee the full #ICMRA statement: https://t.co/ENg3hcY6oV https://t.co/b956XmlvuH","referenced_tweets":{}},{"entities":{"urls":[{"start":162,"end":185,"url":"https://t.co/Po1vzAV1am","expanded_url":"https://www.ema.europa.eu/en/news/ema-ends-rolling-review-cvncov-covid-19-vaccine-following-withdrawal-curevac-ag","display_url":"ema.europa.eu/en/news/ema-enâ€¦"},{"start":186,"end":209,"url":"https://t.co/wkcMV2ltqC","expanded_url":"https://twitter.com/EMA_News/status/1447916983576633352/photo/1","display_url":"pic.twitter.com/wkcMV2ltqC"}],"hashtags":[{"start":16,"end":30,"tag":"RollingReview"},{"start":47,"end":62,"tag":"COVID19vaccine"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":61,"reply_count":11,"like_count":65,"quote_count":21},"attachments":{"media_keys":["3_1447916874407231496"],"poll_ids":{}},"conversation_id":"1447916983576633352","possibly_sensitive":false,"created_at":"2021-10-12T13:28:04.000Z","id":"1447916983576633352","text":"â€¼ï¸ EMA ends the #RollingReview of CureVac AGâ€˜s #COVID19vaccine, after the company informed us that it was withdrawing from the process.\nRead the press release: \nğŸ‘‰https://t.co/Po1vzAV1am https://t.co/wkcMV2ltqC","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":64,"end":80,"tag":"COVID19pandemic"},{"start":105,"end":113,"tag":"COVID19"},{"start":159,"end":171,"tag":"HealthUnion"}],"mentions":[{"start":194,"end":210,"username":"LancetRH_Europe","id":"1309494598268575745"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for Advertisers.","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":22,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1447584278179627010","possibly_sensitive":false,"created_at":"2021-10-11T15:26:01.000Z","id":"1447584278179627010","text":"Find out more about:\nâœ”ï¸ how EMA &amp; ğŸ‡ªğŸ‡º countries responded to #COVID19pandemic\nâœ”ï¸lessons learnt during #COVID19\nâœ”ï¸how to prepare for future crisis in the EU #HealthUnion\n\nRead this article in @LancetRH_Europe","referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/zk2QyI8cve","expanded_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-11-14-october-2021-meeting_en.pdf","display_url":"ema.europa.eu/en/documents/aâ€¦"}],"hashtags":[{"start":84,"end":89,"tag":"CHMP"}],"mentions":{},"annotations":[{"start":47,"end":49,"probability":0.3888,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":3,"like_count":13,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1447573328907079686","possibly_sensitive":false,"created_at":"2021-10-11T14:42:30.000Z","id":"1447573328907079686","text":"What's on the agenda of the October meeting of EMA's human medicines committee, the #CHMP? See here: \nhttps://t.co/zk2QyI8cve","referenced_tweets":{}},{"entities":{"urls":[{"start":193,"end":216,"url":"https://t.co/bnqJ0Iphzx","expanded_url":"https://www.ema.europa.eu/en/news/ema-receives-application-marketing-authorisation-ronapreve-casirivimab-imdevimab-treatment","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":217,"end":240,"url":"https://t.co/QOj8YaP8hx","expanded_url":"https://twitter.com/EMA_News/status/1447545286319030274/photo/1","display_url":"pic.twitter.com/QOj8YaP8hx"}],"hashtags":[{"start":111,"end":119,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":47,"reply_count":3,"like_count":90,"quote_count":5},"attachments":{"media_keys":["3_1447545201900273673"],"poll_ids":{}},"conversation_id":"1447545286319030274","possibly_sensitive":false,"created_at":"2021-10-11T12:51:05.000Z","id":"1447545286319030274","text":"ğŸ“¢ EMA starts evaluating an application for marketing authorisation for the Ronapreve (casirivimab / imdevimab) #COVID19 treatment. Opinion expected in 2 months.\n\nRead the full press release: \nğŸ‘‰https://t.co/bnqJ0Iphzx https://t.co/QOj8YaP8hx","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"MentalHealth"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":115,"end":129,"username":"SKyriakidesEU","id":"2476130260"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1447467229906415617","possibly_sensitive":false,"created_at":"2021-10-11T07:40:54.000Z","id":"1447467229906415617","text":"RT @EU_Health: #MentalHealth: Breaking the Silence\nFriday 15th October 2021, 10:00 â€“ 11:00 CET\n\nğŸ”´Join Commissioner @SKyriakidesEU for the lâ€¦","referenced_tweets":[{"type":"retweeted","id":"1447462125874593798"}]},{"entities":{"urls":[{"start":254,"end":277,"url":"https://t.co/1TUOrGA0fN","expanded_url":"https://www.ema.europa.eu/en/news/highlights-management-board-october-2021-meeting","display_url":"ema.europa.eu/en/news/highliâ€¦"},{"start":278,"end":301,"url":"https://t.co/cHdXQ0N3Ak","expanded_url":"https://twitter.com/EMA_News/status/1446464721096515586/photo/1","display_url":"pic.twitter.com/cHdXQ0N3Ak"}],"hashtags":[{"start":114,"end":122,"tag":"COVID19"},{"start":206,"end":220,"tag":"clinicaltrial"},{"start":240,"end":248,"tag":"CTIS4EU"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":5,"like_count":23,"quote_count":0},"attachments":{"media_keys":["3_1446464665748377633"],"poll_ids":{}},"conversation_id":"1446464721096515586","possibly_sensitive":false,"created_at":"2021-10-08T13:17:18.000Z","id":"1446464721096515586","text":"ğŸ“¢ The highlights of the Management Board meeting are now available.\n\nRead more about EMA's recent response to the #COVID19 pandemic, the Agencyâ€™s activities in the first half of 2021, and progress with the #clinicaltrial information system #CTIS4EU   \n\nğŸ‘‰https://t.co/1TUOrGA0fN https://t.co/cHdXQ0N3Ak","referenced_tweets":{}},{"entities":{"urls":[{"start":165,"end":188,"url":"https://t.co/Q9ZeQLOBzR","expanded_url":"https://www.ema.europa.eu/en/news/additional-manufacturing-site-covid-19-vaccine-janssen-0","display_url":"ema.europa.eu/en/news/additiâ€¦"},{"start":220,"end":243,"url":"https://t.co/fVSxOEunNr","expanded_url":"https://twitter.com/EMA_News/status/1446120533892890631/photo/1","display_url":"pic.twitter.com/fVSxOEunNr"}],"hashtags":[{"start":189,"end":202,"tag":"PublicHealth"},{"start":203,"end":219,"tag":"COVID19vaccines"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.7469,"type":"Organization","normalized_text":"EMA"},{"start":91,"end":94,"probability":0.7141,"type":"Place","normalized_text":"West"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":28,"reply_count":3,"like_count":50,"quote_count":2},"attachments":{"media_keys":["3_1446120430557794319"],"poll_ids":{}},"conversation_id":"1446120533892890631","possibly_sensitive":false,"created_at":"2021-10-07T14:29:37.000Z","id":"1446120533892890631","text":"EMA has approved an additional manufacturing site for COVID-19 Vaccine Janssen, located in West Point ğŸ‡ºğŸ‡¸. This will increase the supply of the vaccine in the ğŸ‡ªğŸ‡º.  \nğŸ‘‰https://t.co/Q9ZeQLOBzR\n#PublicHealth #COVID19vaccines https://t.co/fVSxOEunNr","referenced_tweets":{}},{"entities":{"urls":[{"start":278,"end":301,"url":"https://t.co/KeFIocK7SI","expanded_url":"https://twitter.com/EMA_News/status/1446038955443593216/photo/1","display_url":"pic.twitter.com/KeFIocK7SI"}],"hashtags":[{"start":66,"end":81,"tag":"MalariaVaccine"},{"start":168,"end":181,"tag":"publichealth"},{"start":269,"end":277,"tag":"EUM4All"}],"mentions":[{"start":39,"end":43,"username":"WHO","id":"14499829"}],"annotations":[{"start":0,"end":2,"probability":0.4682,"type":"Organization","normalized_text":"EMA"},{"start":98,"end":115,"probability":0.4718,"type":"Place","normalized_text":"sub-Saharan Africa"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":37,"reply_count":1,"like_count":95,"quote_count":4},"attachments":{"media_keys":["3_1446038126162595843"],"poll_ids":{}},"conversation_id":"1446038955443593216","possibly_sensitive":false,"created_at":"2021-10-07T09:05:27.000Z","id":"1446038955443593216","text":"EMA welcomes the recommendation by the @WHO to broadly deploy the #MalariaVaccine for children in sub-Saharan Africa.ğŸ‘\n\nEMA is also committed to contributing to global #publichealth by improving access to safe and effective medicines for patients living outside the ğŸ‡ªğŸ‡º #EUM4All https://t.co/KeFIocK7SI","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":27,"end":35,"tag":"malaria"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2756,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1446025934360952832","possibly_sensitive":false,"created_at":"2021-10-07T08:13:43.000Z","id":"1446025934360952832","text":"RT @WHO: A child dies from #malaria every two minutes.\nOne death is one too many.\n\nğŸš¨ Today, WHO recommends RTS,S, a groundbreaking malariaâ€¦","referenced_tweets":[{"type":"retweeted","id":"1445783298756595721"}]},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/e4AHG1Q4ZV","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-6-october-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":156,"end":179,"url":"https://t.co/TNUlJDq5Y1","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-covid-19-vaccine-janssen-6-october-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":192,"end":215,"url":"https://t.co/714BXq4lIl","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-spikevax-previously-covid-19-vaccine-moderna-6-october-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":229,"end":252,"url":"https://t.co/4lRTJOLwS5","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-6-october-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":272,"end":295,"url":"https://t.co/YZYBKHjRwV","expanded_url":"https://twitter.com/EMA_News/status/1445774798320144384/photo/1","display_url":"pic.twitter.com/YZYBKHjRwV"}],"hashtags":[{"start":50,"end":66,"tag":"COVID19vaccines"},{"start":254,"end":271,"tag":"SafetyOfVaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":62,"reply_count":10,"like_count":76,"quote_count":12},"attachments":{"media_keys":["3_1445772921318739971"],"poll_ids":{}},"conversation_id":"1445774798320144384","possibly_sensitive":false,"created_at":"2021-10-06T15:35:47.000Z","id":"1445774798320144384","text":"Check out our latest updates on the safety of all #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º: \n\nâœ”ï¸Comirnaty: https://t.co/e4AHG1Q4ZV\nâœ”ï¸COVID-19 Vaccine Janssen: https://t.co/TNUlJDq5Y1\nâœ”ï¸Spikevax: https://t.co/714BXq4lIl\nâœ”ï¸Vaxzevria: https://t.co/4lRTJOLwS5\n\n#SafetyOfVaccines https://t.co/YZYBKHjRwV","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":128,"end":136,"tag":"COVID19"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":147,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445670787160047622","possibly_sensitive":false,"created_at":"2021-10-06T08:42:29.000Z","id":"1445670787160047622","text":"RT @EU_Commission: Every hour and every dose matters.\n\nMore than 75% of the EU adult population is now fully vaccinated against #COVID19.â€¦","referenced_tweets":[{"type":"retweeted","id":"1445629897276329984"}]},{"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/qefPg2kMMO","expanded_url":"https://lnkd.in/dCRamZ5Q","display_url":"lnkd.in/dCRamZ5Q"},{"start":198,"end":221,"url":"https://t.co/HeyOACbWXm","expanded_url":"https://twitter.com/EMA_News/status/1445394776925294602/photo/1","display_url":"pic.twitter.com/HeyOACbWXm"}],"hashtags":[{"start":50,"end":60,"tag":"Comirnaty"},{"start":65,"end":74,"tag":"Spikevax"},{"start":181,"end":193,"tag":"boosterdose"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":84,"reply_count":20,"like_count":159,"quote_count":24},"attachments":{"media_keys":["3_1445394464382623748"],"poll_ids":{}},"conversation_id":"1445394776925294602","possibly_sensitive":false,"created_at":"2021-10-05T14:25:43.000Z","id":"1445394776925294602","text":"EMA recommended additional doses and boosters for #Comirnaty and #Spikevax. https://t.co/qefPg2kMMO\n\nIn this context, see below what the difference between an additional dose and a #boosterdose is. https://t.co/HeyOACbWXm","referenced_tweets":{}},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/hjXuZPY06x","expanded_url":"https://twitter.com/i/events/1445374699723231233","display_url":"twitter.com/i/events/14453â€¦"}],"hashtags":{},"mentions":{},"annotations":[{"start":37,"end":39,"probability":0.4345,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":20,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445376598484701196","possibly_sensitive":false,"created_at":"2021-10-05T13:13:29.000Z","id":"1445376598484701196","text":"See our live tweets published during EMA's Press Briefing on 5 October 2021. https://t.co/hjXuZPY06x","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":41,"end":56,"tag":"RollingReviews"},{"start":192,"end":200,"tag":"COVID19"},{"start":236,"end":247,"tag":"EMAPresser"}],"mentions":[{"start":120,"end":134,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":6,"like_count":24,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:12:34.000Z","id":"1445361267808612352","text":"In the meantime, we continue our work on #RollingReviews for 4 antiviral monoclonal antibody products, in line with the @EU_Commission Therapeutics Strategy. Its objective is to authorise new #COVID19 treatments by the end of the year. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445361129962807297"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":241,"end":264,"url":"https://t.co/YCnDdXvLkE","expanded_url":"https://www.ema.europa.eu/en/news/ema-receives-application-marketing-authorisation-regkirona-regdanvimab-treating-patients-covid-19","display_url":"ema.europa.eu/en/news/ema-reâ€¦"}],"hashtags":[{"start":110,"end":118,"tag":"COVID19"},{"start":229,"end":240,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":65,"end":73,"probability":0.396,"type":"Organization","normalized_text":"Regkirona"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":9,"reply_count":2,"like_count":21,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:12:01.000Z","id":"1445361129962807297","text":"EMA started evaluating a marketing authorisation application for Regkirona (regdanvimab) to treat adults with #COVID19 who do not require additional oxygen therapy and who are at increased risk of progressing to severe COVID-19. #EMAPresser https://t.co/YCnDdXvLkE","referenced_tweets":[{"type":"replied_to","id":"1445360929982590981"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":89,"end":101,"tag":"SideEffects"},{"start":107,"end":123,"tag":"COVID19vaccines"},{"start":125,"end":136,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2,"reply_count":3,"like_count":12,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:11:13.000Z","id":"1445360929982590981","text":"We remind everyone that EMA is closely monitoring and assessing any reports of suspected #SideEffects with #COVID19vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445360762315329536"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":46,"end":62,"tag":"COVID19vaccines"},{"start":177,"end":188,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":10,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:10:33.000Z","id":"1445360762315329536","text":"Marketing authorisation holders for the other #COVID19vaccines approved in the ğŸ‡ªğŸ‡º have also submitted their annual renewal application. These assessments are currently ongoing. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445360354805026820"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":108,"end":124,"tag":"COVID19vaccines"},{"start":170,"end":179,"tag":"Spikevax"},{"start":259,"end":270,"tag":"EMAPresser"}],"mentions":[{"start":213,"end":227,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":14,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:08:56.000Z","id":"1445360354805026820","text":"The annual renewal of conditional marketing authorisations is a standard process and it is on track for all #COVID19vaccines. The conditional marketing authorisation for #Spikevax has been renewed for one year by @EU_Commission based on EMAâ€™s recommendation. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445360186689048577"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":89,"end":97,"tag":"COVID19"},{"start":243,"end":254,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":127,"end":130,"probability":0.476,"type":"Place","normalized_text":"ğŸ‡ªğŸ‡º"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":19,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:08:16.000Z","id":"1445360186689048577","text":"Some EU countries have already started administering booster doses. â€¼ï¸ Implementation of #COVID19 vaccination campaigns in the ğŸ‡ªğŸ‡º remains the prerogative of the public health authorities guiding the vaccination campaigns in each Member State. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445360012876992512"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":52,"end":68,"tag":"COVID19vaccines"},{"start":116,"end":124,"tag":"COVID19"},{"start":229,"end":240,"tag":"EMAPresser"}],"mentions":[{"start":171,"end":179,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":21,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:07:35.000Z","id":"1445360012876992512","text":"What we know for now: When administered in 2 doses, #COVID19vaccines protect against hospitalisation and death from #COVID19. We monitor this very carefully together with @ECDC_EU, so that we can spot trends and update guidance. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359867548557314"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":65,"end":77,"tag":"boosterdose"},{"start":81,"end":90,"tag":"Spikevax"},{"start":227,"end":238,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3468,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":3,"like_count":13,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:07:00.000Z","id":"1445359867548557314","text":"EMA is also currently evaluating an application for the use of a #boosterdose of #Spikevax to be given at least 6 months after the 2nd dose in people aged 12 years and older. EMA will communicate the outcome of the assessment. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359696706248707"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":0,"end":12,"tag":"Myocarditis"},{"start":255,"end":266,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":8,"like_count":25,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:06:19.000Z","id":"1445359696706248707","text":"#Myocarditis is the main safety concern emerging with mRNA vaccines, especially after the 2nd dose. \nâ€¼ï¸ Most of the myocarditis cases reported are mild and self-limiting. \nWe cannot yet characterise this risk after a 3rd dose because it occurs so rarely. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359583141236740"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":16,"end":26,"tag":"Comirnaty"},{"start":27,"end":39,"tag":"boosterdose"},{"start":273,"end":284,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":7,"like_count":53,"quote_count":12},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:05:52.000Z","id":"1445359583141236740","text":"EMA conclusion: #Comirnaty #boosterdose is safe &amp; effective, as data show a rise in antibody levels when giving a booster approx. 6 months after the 2nd dose in people aged 18 to 55. \nCurrently we cannot firmly recommend when &amp; for whom to implement booster doses. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359334280638465"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":105,"end":118,"tag":"boosterdoses"},{"start":147,"end":158,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":2,"like_count":26,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:04:53.000Z","id":"1445359334280638465","text":"â€¼ï¸ It is important to distinguish between 3rd doses for people with severely weakened immune systems and #boosterdoses for the general population. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359195981860866"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":245,"end":256,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":2,"like_count":26,"quote_count":9},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:04:20.000Z","id":"1445359195981860866","text":"Based on limited data available, the use of a 3rd dose is restricted to severely immunocompromised patients. There is no clear evidence that less immunocompromised patients would benefit from a 3d dose as part of the primary vaccination series. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445359105015681025"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":176,"end":187,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":13,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:03:58.000Z","id":"1445359105015681025","text":"The EMA conclusion for both vaccines is based on studies in patients with severely weakened immune systems because of use of immunosuppressive drugs after an organ transplant. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445358958307422211"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":32,"end":42,"tag":"Comirnaty"},{"start":47,"end":56,"tag":"Spikevax"},{"start":178,"end":189,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":3,"like_count":27,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:03:23.000Z","id":"1445358958307422211","text":"EMA concluded that 3rd doses of #Comirnaty and #Spikevax may be given to people with severely weakened immune systems aged 12 or older, at least 28 days after their second dose. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1445358461999591428"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/3nyFOMsafp","expanded_url":"https://www.ema.europa.eu/en/events/ema-press-briefing-inform-chmp-discussion-booster-doses","display_url":"ema.europa.eu/en/events/ema-â€¦"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":179,"end":190,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":12,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T12:01:25.000Z","id":"1445358461999591428","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. https://t.co/3nyFOMsafp\n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser.","referenced_tweets":[{"type":"replied_to","id":"1445355356314558469"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":150,"end":173,"url":"https://t.co/3nyFOMsafp","expanded_url":"https://www.ema.europa.eu/en/events/ema-press-briefing-inform-chmp-discussion-booster-doses","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":174,"end":197,"url":"https://t.co/FTtlbwF0SB","expanded_url":"https://twitter.com/EMA_News/status/1445355356314558469/photo/1","display_url":"pic.twitter.com/FTtlbwF0SB"}],"hashtags":[{"start":35,"end":51,"tag":"COVID19vaccines"},{"start":136,"end":147,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":43,"reply_count":10,"like_count":69,"quote_count":5},"attachments":{"media_keys":["3_1445355128316383235"],"poll_ids":{}},"conversation_id":"1445355356314558469","possibly_sensitive":false,"created_at":"2021-10-05T11:49:05.000Z","id":"1445355356314558469","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19vaccines and treatments will be broadcast live ğŸ”´ today, 5 October, from 14:00 to 14:30 CEST. #EMAPresser\n\nğŸ‘‰https://t.co/3nyFOMsafp https://t.co/FTtlbwF0SB","referenced_tweets":{}},{"entities":{"urls":[{"start":199,"end":222,"url":"https://t.co/v0jiuKbum2","expanded_url":"https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters","display_url":"ema.europa.eu/en/news/comirnâ€¦","status":200,"title":"Comirnaty and Spikevax: EMA recommendations on extra doses boosters - European Medicines Agency","description":"Comirnaty and Spikevax: EMA recommendations on extra doses boosters","unwound_url":"https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters"}],"hashtags":[{"start":223,"end":239,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":141,"reply_count":14,"like_count":186,"quote_count":62},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1445028339169861640","possibly_sensitive":false,"created_at":"2021-10-04T14:09:38.000Z","id":"1445028341426364419","text":"Comirnaty booster doses may be considered for people aged 18 years and older, at least 6 months after the 2nd dose. Decisions for boosters will be taken by public health bodies at national level. \n\nğŸ‘‰https://t.co/v0jiuKbum2 #COVID19vaccines","referenced_tweets":[{"type":"replied_to","id":"1445028339169861640"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":178,"end":201,"url":"https://t.co/v0jiuKbum2","expanded_url":"https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters","display_url":"ema.europa.eu/en/news/comirnâ€¦","status":200,"title":"Comirnaty and Spikevax: EMA recommendations on extra doses boosters - European Medicines Agency","description":"Comirnaty and Spikevax: EMA recommendations on extra doses boosters","unwound_url":"https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters"},{"start":202,"end":225,"url":"https://t.co/mUHRhru35r","expanded_url":"https://twitter.com/EMA_News/status/1445028339169861640/photo/1","display_url":"pic.twitter.com/mUHRhru35r"}],"hashtags":[{"start":32,"end":48,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":240,"reply_count":24,"like_count":294,"quote_count":77},"attachments":{"media_keys":["3_1445027443354517508"],"poll_ids":{}},"conversation_id":"1445028339169861640","possibly_sensitive":false,"created_at":"2021-10-04T14:09:38.000Z","id":"1445028339169861640","text":"â€¼ï¸ EMA conclusion: 3rd doses of #COVID19vaccines Comirnaty &amp; Spikevax may be given to people with severely weakened immune systems, at least 28 days after their 2nd dose. \n\nğŸ‘‰https://t.co/v0jiuKbum2 https://t.co/mUHRhru35r","referenced_tweets":{}},{"entities":{"urls":[{"start":237,"end":260,"url":"https://t.co/YCnDdXvLkE","expanded_url":"https://www.ema.europa.eu/en/news/ema-receives-application-marketing-authorisation-regkirona-regdanvimab-treating-patients-covid-19","display_url":"ema.europa.eu/en/news/ema-reâ€¦"},{"start":280,"end":303,"url":"https://t.co/HZWvmsrlcB","expanded_url":"https://twitter.com/EMA_News/status/1445004000772956160/photo/1","display_url":"pic.twitter.com/HZWvmsrlcB"}],"hashtags":[{"start":116,"end":124,"tag":"COVID19"},{"start":261,"end":279,"tag":"COVID19treatments"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":61,"reply_count":5,"like_count":95,"quote_count":4},"attachments":{"media_keys":["3_1445003162792964101"],"poll_ids":{}},"conversation_id":"1445004000772956160","possibly_sensitive":false,"created_at":"2021-10-04T12:32:55.000Z","id":"1445004000772956160","text":"â€¼ï¸ EMA starts evaluating an application to authorise the monoclonal antibody Regkirona (regdanvimab) to treat adult #COVID19 patients at increased risk of progressing to severe disease but who do not require supplemental oxygen therapy\nğŸ‘‰https://t.co/YCnDdXvLkE #COVID19treatments https://t.co/HZWvmsrlcB","referenced_tweets":{}},{"entities":{"urls":[{"start":209,"end":232,"url":"https://t.co/aakIepb0xA","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-27-30-september-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":253,"end":276,"url":"https://t.co/cEJKT7Ftir","expanded_url":"https://twitter.com/EMA_News/status/1443898876008833026/photo/1","display_url":"pic.twitter.com/cEJKT7Ftir"}],"hashtags":[{"start":90,"end":95,"tag":"PRAC"},{"start":133,"end":149,"tag":"COVID19vaccines"},{"start":234,"end":252,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":10,"like_count":26,"quote_count":2},"attachments":{"media_keys":["3_1443898810263015427"],"poll_ids":{}},"conversation_id":"1443898876008833026","possibly_sensitive":false,"created_at":"2021-10-01T11:21:33.000Z","id":"1443898876008833026","text":"We have just published the highlights of the October meeting of our safety committee, the #PRAC. \n\nRead the updates on the safety of #COVID19vaccines and nomegestrol- and chlormadinone-containing medicines. \nğŸ‘‰https://t.co/aakIepb0xA\n\n#pharmacovigilance https://t.co/cEJKT7Ftir","referenced_tweets":{}},{"entities":{"urls":[{"start":196,"end":219,"url":"https://t.co/J08gsH63Ko","expanded_url":"https://www.ema.europa.eu/en/news/transatlantic-taskforce-continues-international-fight-against-antimicrobial-resistance","display_url":"ema.europa.eu/en/news/transaâ€¦"},{"start":225,"end":248,"url":"https://t.co/xxAnwaysTM","expanded_url":"https://twitter.com/EMA_News/status/1443534819196084224/photo/1","display_url":"pic.twitter.com/xxAnwaysTM"}],"hashtags":[{"start":124,"end":148,"tag":"AntimicrobialResistance"},{"start":159,"end":166,"tag":"TATFAR"},{"start":220,"end":224,"tag":"AMR"}],"mentions":{},"annotations":[{"start":17,"end":39,"probability":0.4823,"type":"Organization","normalized_text":"Transatlantic Taskforce"},{"start":44,"end":67,"probability":0.3567,"type":"Other","normalized_text":"Antimicrobial Resistance"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":3,"like_count":29,"quote_count":3},"attachments":{"media_keys":["3_1443534686156906500"],"poll_ids":{}},"conversation_id":"1443534819196084224","possibly_sensitive":false,"created_at":"2021-09-30T11:14:55.000Z","id":"1443534819196084224","text":"As member of the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR), EMA supports the international fight against #AntimicrobialResistance. Read the #TATFAR 2016-2020 Progress Report: \nğŸ‘‰https://t.co/J08gsH63Ko #AMR https://t.co/xxAnwaysTM","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":44,"end":54,"tag":"ECDCOnAir"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":100,"end":111,"probability":0.8862,"type":"Person","normalized_text":"Andrea Ammon"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1443491027285954562","possibly_sensitive":false,"created_at":"2021-09-30T08:20:54.000Z","id":"1443491027285954562","text":"RT @ECDC_EU: For this week's episode of the #ECDCOnAir podcast, we sat down again with our Director Andrea Ammon to talk about community enâ€¦","referenced_tweets":[{"type":"retweeted","id":"1443487516108144641"}]},{"entities":{"urls":{},"hashtags":[{"start":80,"end":93,"tag":"EUCancerPlan"},{"start":102,"end":116,"tag":"MissionCancer"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1443490991588184067","possibly_sensitive":false,"created_at":"2021-09-30T08:20:45.000Z","id":"1443490991588184067","text":"RT @EU_Health: Cancer is one of the greatest challenges we face today\n\nWith the #EUCancerPlan and the #MissionCancer there are 2 major EU iâ€¦","referenced_tweets":[{"type":"retweeted","id":"1443198811418107910"}]},{"entities":{"urls":[{"start":184,"end":207,"url":"https://t.co/OEykacXGb4","expanded_url":"https://www.ema.europa.eu/en/news/ema-implements-new-measures-minimise-animal-testing-during-medicines-development","display_url":"ema.europa.eu/en/news/ema-imâ€¦"},{"start":208,"end":231,"url":"https://t.co/dVGKYEj5d4","expanded_url":"https://twitter.com/EMA_News/status/1443244148279156746/photo/1","display_url":"pic.twitter.com/dVGKYEj5d4"}],"hashtags":[{"start":119,"end":123,"tag":"3Rs"},{"start":160,"end":169,"tag":"medicine"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4372,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":34,"quote_count":2},"attachments":{"media_keys":["3_1443241537882705932"],"poll_ids":{}},"conversation_id":"1443244148279156746","possibly_sensitive":false,"created_at":"2021-09-29T15:59:53.000Z","id":"1443244148279156746","text":"EMA takes further steps in supporting developers of ğŸ’Š (or pharmaceutical organisations) to replace, reduce and refine (#3Rs) animal use in human and veterinary #medicine. \n\nRead more: https://t.co/OEykacXGb4 https://t.co/dVGKYEj5d4","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":24,"end":38,"tag":"WorldHeartDay"},{"start":112,"end":116,"tag":"CVD"},{"start":121,"end":130,"tag":"UseHeart"}],"mentions":[{"start":3,"end":17,"username":"worldheartfed","id":"83809282"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1443216378719346700","possibly_sensitive":false,"created_at":"2021-09-29T14:09:33.000Z","id":"1443216378719346700","text":"RT @worldheartfed: This #WorldHeartDay, start with simple steps to reverse the trend of cardiovascular disease (#CVD ğŸ’”)\n\n#UseHeart to conneâ€¦","referenced_tweets":[{"type":"retweeted","id":"1443214418637172736"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":36,"end":37,"probability":0.7095,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1443163538030276613","possibly_sensitive":false,"created_at":"2021-09-29T10:39:34.000Z","id":"1443163538030276613","text":"RT @EU_Health: We are reviewing the EUâ€™s pharmaceutical legislation\n\nHelp us shape a future-proof, crisis-resistant medicines regulatory syâ€¦","referenced_tweets":[{"type":"retweeted","id":"1442805456087535620"}]},{"entities":{"urls":[{"start":236,"end":259,"url":"https://t.co/y7Q8uEEqVh","expanded_url":"https://www.ema.europa.eu/en/news/ema-evaluating-data-booster-dose-covid-19-vaccine-spikevax","display_url":"ema.europa.eu/en/news/ema-evâ€¦","status":200,"title":"EMA evaluating data on booster dose of COVID-19 vaccine Spikevax - European Medicines Agency","description":"EMA evaluating data on booster dose of COVID-19 vaccine Spikevax","unwound_url":"https://www.ema.europa.eu/en/news/ema-evaluating-data-booster-dose-covid-19-vaccine-spikevax"},{"start":260,"end":283,"url":"https://t.co/Hut63TH1fe","expanded_url":"https://twitter.com/EMA_News/status/1442498933478105094/photo/1","display_url":"pic.twitter.com/Hut63TH1fe"}],"hashtags":[{"start":90,"end":105,"tag":"COVID19vaccine"},{"start":193,"end":206,"tag":"VaccinesWork"},{"start":207,"end":220,"tag":"publichealth"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":76,"reply_count":12,"like_count":108,"quote_count":16},"attachments":{"media_keys":["3_1442497897350635523"],"poll_ids":{}},"conversation_id":"1442498933478105094","possibly_sensitive":false,"created_at":"2021-09-27T14:38:40.000Z","id":"1442498933478105094","text":"EMA starts evaluating an application for the use of a booster dose of Spikevax, Modernaâ€™s #COVID19vaccine, to be given at least 6 months after the 2nd dose in people aged 12 years and older. \n\n#VaccinesWork #publichealth \n\nRead more:\nğŸ‘‰ https://t.co/y7Q8uEEqVh https://t.co/Hut63TH1fe","referenced_tweets":{}},{"entities":{"urls":[{"start":223,"end":246,"url":"https://t.co/VFnIESvGE8","expanded_url":"https://www.ema.europa.eu/en/news/call-expressions-interest-civil-society-representatives-participate-work-committee-advanced","display_url":"ema.europa.eu/en/news/call-eâ€¦"},{"start":247,"end":270,"url":"https://t.co/gEuVKkGQro","expanded_url":"https://twitter.com/EMA_News/status/1442414874168938500/photo/1","display_url":"pic.twitter.com/gEuVKkGQro"}],"hashtags":[{"start":65,"end":69,"tag":"CAT"}],"mentions":[{"start":188,"end":202,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":27,"end":62,"probability":0.32,"type":"Organization","normalized_text":"EMA Committee for Advanced Therapies"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":3,"like_count":27,"quote_count":2},"attachments":{"media_keys":["3_1442414462758232064"],"poll_ids":{}},"conversation_id":"1442414874168938500","possibly_sensitive":false,"created_at":"2021-09-27T09:04:39.000Z","id":"1442414874168938500","text":"Would you like to join the EMA Committee for Advanced Therapies (#CAT) to represent patient or healthcare professional organisationsâ“\n\nğŸ“© Expressions of interest should be submitted to the @EU_Commission by 29 October 2021: https://t.co/VFnIESvGE8 https://t.co/gEuVKkGQro","referenced_tweets":{}},{"entities":{"urls":[{"start":268,"end":291,"url":"https://t.co/lq0I2mjZX8","expanded_url":"https://twitter.com/EMA_News/status/1441700491726049282/photo/1","display_url":"pic.twitter.com/lq0I2mjZX8"}],"hashtags":[{"start":9,"end":29,"tag":"WorldPharmacistsDay"},{"start":74,"end":86,"tag":"pharmacists"},{"start":249,"end":258,"tag":"Pharmacy"},{"start":259,"end":267,"tag":"WPD2021"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":69,"reply_count":4,"like_count":182,"quote_count":11},"attachments":{"media_keys":["3_1441699528147673088"],"poll_ids":{}},"conversation_id":"1441700491726049282","possibly_sensitive":false,"created_at":"2021-09-25T09:45:57.000Z","id":"1441700491726049282","text":"Today is #WorldPharmacistsDay 2021!\n\nA great opportunity for EMA to thank #pharmacists for their extra efforts during the COVID-19 pandemic and to highlight that the engagement of pharmacists is essential at all stages of medicines development.ğŸ‘ğŸ’ŠğŸ¥¼\n\n#Pharmacy #WPD2021 https://t.co/lq0I2mjZX8","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":108,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441412795732533249","possibly_sensitive":false,"created_at":"2021-09-24T14:42:45.000Z","id":"1441412795732533249","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1440976938647048194"}]},{"entities":{"urls":{},"hashtags":[{"start":61,"end":69,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441412359549902851","possibly_sensitive":false,"created_at":"2021-09-24T14:41:01.000Z","id":"1441412359549902851","text":"RT @ECDC_EU: How many Europeans have been vaccinated against #COVID19 so far? How does it look in the specific age groups? \n\nFind all the iâ€¦","referenced_tweets":[{"type":"retweeted","id":"1441320662744780802"}]},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/IUj318tOuz","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-4","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":145,"end":168,"url":"https://t.co/f8Ilz7FxlU","expanded_url":"https://twitter.com/i/events/1441045192602161157","display_url":"twitter.com/i/events/14410â€¦"}],"hashtags":[{"start":171,"end":182,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":4,"like_count":15,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441054491005132808","possibly_sensitive":false,"created_at":"2021-09-23T14:58:58.000Z","id":"1441054491005132808","text":"â–¶ï¸The recording of the press briefing is available on EMA's website: https://t.co/IUj318tOuz\n\nâ–¶ï¸Our tweets during the briefing can be seen here: https://t.co/f8Ilz7FxlU \n\n#EMAPresser","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":52,"end":62,"tag":"ECDCOnAir"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":81,"end":94,"probability":0.7578,"type":"Person","normalized_text":"Tarik Derrough"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441051372128964610","possibly_sensitive":false,"created_at":"2021-09-23T14:46:35.000Z","id":"1441051372128964610","text":"RT @ECDC_EU: For this week's episode of our podcast #ECDCOnAir, we sat down with Tarik Derrough, expert on vaccine-preventable diseases.\n\nTâ€¦","referenced_tweets":[{"type":"retweeted","id":"1440679859622015001"}]},{"entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"JustPublished"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441051285382483973","possibly_sensitive":false,"created_at":"2021-09-23T14:46:14.000Z","id":"1441051285382483973","text":"RT @ECDC_EU: #JustPublished:\n\nOverview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA\n\nRead thâ€¦","referenced_tweets":[{"type":"retweeted","id":"1441037922917048322"}]},{"entities":{"urls":{},"hashtags":[{"start":150,"end":158,"tag":"COVID19"},{"start":267,"end":278,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":6,"like_count":19,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:11:00.000Z","id":"1441042419076763651","text":"ğŸ’ŠğŸ’‰EMA is actively supporting vaccine and treatment developers to expand the portfolio of options available for the prevention and treatment of severe #COVID19. There is an active pipeline of treatments, including antiviral pills that could be used by people at home. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441042148602744833"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":261,"end":284,"url":"https://t.co/YZCZKopT2q","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-treatments","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":56,"end":64,"tag":"COVID19"},{"start":249,"end":260,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":18,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:09:56.000Z","id":"1441042148602744833","text":"While vaccination is the cornerstone of our response to #COVID19, the urgent need for treatments remains at the forefront of EMA's activities: 4âƒ£ antiviral monoclonal antibody products &amp; 3âƒ£ immunomodulatory agents are currently under evaluation #EMAPresser\nhttps://t.co/YZCZKopT2q","referenced_tweets":[{"type":"replied_to","id":"1441041738374713348"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":60,"end":75,"tag":"COVID19vaccine"},{"start":269,"end":280,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":147,"end":152,"probability":0.6845,"type":"Organization","normalized_text":"Pfizer"},{"start":228,"end":234,"probability":0.3921,"type":"Place","normalized_text":"Moderna"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":4,"like_count":23,"quote_count":8},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:08:18.000Z","id":"1441041738374713348","text":"To date no application for an extension of indication for a #COVID19vaccine in children under 12 years of age has been received. \n\nğŸ—“ï¸ EMA expects Pfizer to submit data in children aged 5-11 years in early October and data from Moderna to be received in early November. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441041016627269632"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":84,"end":99,"tag":"COVID19vaccine"},{"start":219,"end":230,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4957,"type":"Organization","normalized_text":"EMA"},{"start":66,"end":73,"probability":0.7458,"type":"Organization","normalized_text":"BioNTech"},{"start":75,"end":80,"probability":0.5543,"type":"Organization","normalized_text":"Pfizer"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":17,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:05:26.000Z","id":"1441041016627269632","text":"EMA is evaluating an application for the use of a booster dose of BioNTech/Pfizerâ€™s #COVID19vaccine to be given at least 6 months after the 2nd dose in people over 16. \n\nğŸ—“ï¸ Outcome expected at the beginning of October. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441040670513377282"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":144,"end":160,"tag":"COVID19vaccines"},{"start":231,"end":242,"tag":"EMAPresser"}],"mentions":[{"start":19,"end":27,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":11,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:04:03.000Z","id":"1441040670513377282","text":"EMA, together with @ECDC_EU, is constantly reviewing evidence from vaccination campaigns to assess if the levels of protection offered by the 4 #COVID19vaccines authorised for use in the ğŸ‡ªğŸ‡º need to be enhanced with a booster dose. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441040452732456963"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":185,"end":196,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":2,"like_count":12,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:03:11.000Z","id":"1441040452732456963","text":"Studies in immunocompromised people show that an additional dose of mRNA vaccines can increase the level of protection. Data for both Comirnaty and Spikevax are currently under review. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441040174998343681"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":23,"end":39,"tag":"COVID19vaccines"},{"start":105,"end":113,"tag":"COVID19"},{"start":206,"end":219,"tag":"PublicHealth"},{"start":220,"end":231,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":4,"like_count":25,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T14:02:05.000Z","id":"1441040174998343681","text":"All currently approved #COVID19vaccines provide strong protection against hospitalisation and death from #COVID19. The priority remains on making sure that as many people as possible are fully vaccinated. \n#PublicHealth #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1441039514227691520"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":174,"end":197,"url":"https://t.co/IUj318tOuz","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-4","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":198,"end":221,"url":"https://t.co/iDgBV95d9g","expanded_url":"https://twitter.com/EMA_News/status/1441039514227691520/photo/1","display_url":"pic.twitter.com/iDgBV95d9g"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":23,"reply_count":3,"like_count":25,"quote_count":1},"attachments":{"media_keys":["3_1441036889239265281"],"poll_ids":{}},"conversation_id":"1441039514227691520","possibly_sensitive":false,"created_at":"2021-09-23T13:59:28.000Z","id":"1441039514227691520","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser. \n\nâ–¶ï¸ https://t.co/IUj318tOuz https://t.co/iDgBV95d9g","referenced_tweets":{}},{"entities":{"urls":[{"start":153,"end":176,"url":"https://t.co/IUj318tOuz","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-4","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":177,"end":200,"url":"https://t.co/W1X5FaJdgm","expanded_url":"https://twitter.com/EMA_News/status/1441012839813160960/photo/1","display_url":"pic.twitter.com/W1X5FaJdgm"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":140,"end":151,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":5,"like_count":32,"quote_count":1},"attachments":{"media_keys":["3_1441012602868576256"],"poll_ids":{}},"conversation_id":"1441012839813160960","possibly_sensitive":false,"created_at":"2021-09-23T12:13:28.000Z","id":"1441012839813160960","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 23 September, from 16:00 to 16:30 CEST. #EMAPresser\nğŸ‘‰https://t.co/IUj318tOuz https://t.co/W1X5FaJdgm","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1440993672548528132","possibly_sensitive":false,"created_at":"2021-09-23T10:57:18.000Z","id":"1440993672548528132","text":"RT @EU_Health: Make your voice heard when it comes to health in the EU!\n\nWe want to hear from you! Visit the online platform, organise &amp; atâ€¦","referenced_tweets":[{"type":"retweeted","id":"1440926404573470721"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":[{"start":61,"end":62,"probability":0.9281,"type":"Place","normalized_text":"US"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":323,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1440993287842713605","possibly_sensitive":false,"created_at":"2021-09-23T10:55:46.000Z","id":"1440993287842713605","text":"RT @vonderleyen: Glad to announce a new partnership with the US to help vaccinate the world. \n\nWe aim for a 70% global vaccination rate byâ€¦","referenced_tweets":[{"type":"retweeted","id":"1440700570227011603"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1440993079004123137","possibly_sensitive":false,"created_at":"2021-09-23T10:54:57.000Z","id":"1440993079004123137","text":"RT @EU_Health: In 2020 we promised:\n\nâ–¶ A better-prepared &amp; more resilient EU\nâ–¶ Improved quality of life for cancer patients, survivors &amp; caâ€¦","referenced_tweets":[{"type":"retweeted","id":"1440681024707383306"}]},{"entities":{"urls":[{"start":255,"end":278,"url":"https://t.co/9xn7iWKlXS","expanded_url":"https://www.ema.europa.eu/en/news/call-expressions-interest-civil-society-representatives-participate-work-ema","display_url":"ema.europa.eu/en/news/call-eâ€¦"},{"start":279,"end":302,"url":"https://t.co/Q5mPiSk39s","expanded_url":"https://twitter.com/EMA_News/status/1440697830151102477/photo/1","display_url":"pic.twitter.com/Q5mPiSk39s"}],"hashtags":[{"start":47,"end":52,"tag":"PRAC"}],"mentions":[{"start":205,"end":219,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":23,"end":25,"probability":0.4947,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":20,"quote_count":1},"attachments":{"media_keys":["3_1440697718779760657"],"poll_ids":{}},"conversation_id":"1440697830151102477","possibly_sensitive":false,"created_at":"2021-09-22T15:21:44.000Z","id":"1440697830151102477","text":"Would you like to join EMAâ€™s safety committee (#PRAC) or the Management Board to represent patient, healthcare professional and veterinary organisationsâ“\n\nğŸ“© Expressions of interest can be submitted to the @EU_Commission by 18 and 20 October respectively: https://t.co/9xn7iWKlXS https://t.co/Q5mPiSk39s","referenced_tweets":{}},{"entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/kTU0SNOx0Q","expanded_url":"https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-13-16-september-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":204,"end":227,"url":"https://t.co/vclXFd7UBm","expanded_url":"https://twitter.com/EMA_News/status/1440623894658912256/photo/1","display_url":"pic.twitter.com/vclXFd7UBm"}],"hashtags":[{"start":58,"end":72,"tag":"PRIMEschemeEU"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":18,"quote_count":0},"attachments":{"media_keys":["3_1440623797929795590"],"poll_ids":{}},"conversation_id":"1440623894658912256","possibly_sensitive":false,"created_at":"2021-09-22T10:27:56.000Z","id":"1440623894658912256","text":"ğŸ“¢In September 2021, one medicinal product was accepted to #PRIMEschemeEU: https://t.co/kTU0SNOx0Q\n\nPRIME is an EMA scheme launched to support the development of medicines targeting an unmet medical need. https://t.co/vclXFd7UBm","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":241,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1440339977104097287","possibly_sensitive":false,"created_at":"2021-09-21T15:39:45.000Z","id":"1440339977104097287","text":"RT @EU_Commission: We did it the European way. And it worked! \n\nMore than 70% of the ğŸ‡ªğŸ‡º EU adult population is fully vaccinated. And the EUâ€¦","referenced_tweets":[{"type":"retweeted","id":"1439839240804872197"}]},{"entities":{"urls":{},"hashtags":[{"start":27,"end":48,"tag":"EpidemicSurveillance"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1439943958440906756","possibly_sensitive":false,"created_at":"2021-09-20T13:26:07.000Z","id":"1439943958440906756","text":"RT @ECDC_EU: Interested in #EpidemicSurveillance?\nWant to know more what it is and how it is done?\nAlready working on EI but want to hone yâ€¦","referenced_tweets":[{"type":"retweeted","id":"1439273021085298688"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":33,"end":36,"probability":0.5301,"type":"Person","normalized_text":"HERA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":165,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1439943610741497859","possibly_sensitive":false,"created_at":"2021-09-20T13:24:44.000Z","id":"1439943610741497859","text":"RT @EU_Health: Do you know about HERA?\n\nIt's the new European ğ—›ealth ğ—˜mergency preparedness and ğ—¥esponse ğ—”uthority.\n\nIt will help prevent,â€¦","referenced_tweets":[{"type":"retweeted","id":"1439850872071237635"}]},{"entities":{"urls":[{"start":260,"end":283,"url":"https://t.co/oX12wu0TkT","expanded_url":"https://www.who.int/news-room/events/detail/2021/09/17/default-calendar/world-patient-safety-day-2021","display_url":"who.int/news-room/evenâ€¦"},{"start":284,"end":307,"url":"https://t.co/RKldWhETvx","expanded_url":"https://twitter.com/EMA_News/status/1438857865201061897/photo/1","display_url":"pic.twitter.com/RKldWhETvx"}],"hashtags":[{"start":18,"end":40,"tag":"WorldPatientSafetyDay"},{"start":244,"end":258,"tag":"PatientSafety"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":21,"quote_count":0},"attachments":{"media_keys":["3_1438856044130848772"],"poll_ids":{}},"conversation_id":"1438857865201061897","possibly_sensitive":false,"created_at":"2021-09-17T13:30:22.000Z","id":"1438857865201061897","text":"The 2021 theme of #WorldPatientSafetyDay is safe maternal and newborn care. ğŸ¤°\nEMA is committed to increasing the number of effective treatments &amp; reducing the harm caused to pregnant women and newborns when they receive inappropriate care. #PatientSafety \nhttps://t.co/oX12wu0TkT https://t.co/RKldWhETvx","referenced_tweets":{}},{"entities":{"urls":[{"start":192,"end":215,"url":"https://t.co/DrOzRSDRFG","expanded_url":"https://www.ema.europa.eu/en/news/new-add-treatment-rare-autoimmune-inflammatory-disorder","display_url":"ema.europa.eu/en/news/new-adâ€¦"}],"hashtags":[{"start":32,"end":37,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":20,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438819570215702528","possibly_sensitive":false,"created_at":"2021-09-17T10:58:12.000Z","id":"1438819570215702528","text":"EMA's human medicines committee #CHMP has recommended an extension of indication for a new add-on treatment for patients aged 6 years and older with a rare autoimmune inflammatory disorder.\n\nğŸ‘‰https://t.co/DrOzRSDRFG","referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/IaugEbM0qK","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-september-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦","images":[{"url":"https://pbs.twimg.com/news_img/1442589041992552462/lygKFwSH?format=png&name=orig","width":800,"height":920},{"url":"https://pbs.twimg.com/news_img/1442589041992552462/lygKFwSH?format=png&name=150x150","width":150,"height":150}],"status":200,"title":"Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 13-16 September 2021 - European Medicines Agency","description":"Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 13-16 September 2021","unwound_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-september-2021"},{"start":138,"end":161,"url":"https://t.co/BMHdhlH5Po","expanded_url":"https://twitter.com/EMA_News/status/1438817812554846210/photo/1","display_url":"pic.twitter.com/BMHdhlH5Po","images":{}}],"hashtags":[{"start":39,"end":44,"tag":"CHMP"},{"start":59,"end":69,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":29,"quote_count":0},"attachments":{"media_keys":["3_1438817093315665925"],"poll_ids":{}},"conversation_id":"1438817812554846210","possibly_sensitive":false,"created_at":"2021-09-17T10:51:13.000Z","id":"1438817812554846210","text":"ğŸ“¢ EMAâ€™s human medicines committee, the #CHMP, recommends 9 #medicines for approval at its September 2021 meeting: https://t.co/IaugEbM0qK https://t.co/BMHdhlH5Po","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":37,"end":42,"tag":"HERA"},{"start":66,"end":78,"tag":"HealthUnion"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438431494549168128","possibly_sensitive":false,"created_at":"2021-09-16T09:16:07.000Z","id":"1438431494549168128","text":"RT @EU_Health: Today we will present #HERA as a key pillar of the #HealthUnion\n\nThe European Health Emergency Preparedness and Response Autâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438382138429038592"}]},{"entities":{"urls":{},"hashtags":[{"start":51,"end":55,"tag":"AMR"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":30,"end":42,"username":"Europarl_EN","id":"36329597"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438430205710848002","possibly_sensitive":false,"created_at":"2021-09-16T09:11:00.000Z","id":"1438430205710848002","text":"RT @SKyriakidesEU: âœ…I welcome @Europarl_EN vote on #AMR today.\n\nâ–ªï¸Crucial antimicrobials can now be selected and reserved for human medicinâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438406675816501250"}]},{"entities":{"urls":{},"hashtags":[{"start":36,"end":42,"tag":"SOTEU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438417063555604480","possibly_sensitive":false,"created_at":"2021-09-16T08:18:47.000Z","id":"1438417063555604480","text":"RT @EU_Health: A clear message from #SOTEU: Vaccination protects you and those around you.\n\nComplete your vaccination to get the best possiâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438148095934492676"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":198,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438131730154729474","possibly_sensitive":false,"created_at":"2021-09-15T13:24:58.000Z","id":"1438131730154729474","text":"RT @vonderleyen: Information is a public good.\n\nWe must protect those who create transparency â€“ the journalists.\n\nToday we have put forwardâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438050576932220933"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":76,"end":81,"probability":0.9511,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438128692677517314","possibly_sensitive":false,"created_at":"2021-09-15T13:12:54.000Z","id":"1438128692677517314","text":"RT @EU_Health: Throughout the pandemic, we worked on procuring vaccines for Europe &amp; the world\n\nA broad portfolio was created, today more tâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438111606190137355"}]},{"entities":{"urls":{},"hashtags":[{"start":15,"end":21,"tag":"SOTEU"},{"start":38,"end":45,"tag":"Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438088540253003776","possibly_sensitive":false,"created_at":"2021-09-15T10:33:21.000Z","id":"1438088540253003776","text":"RT @EU_Health: #SOTEU made clear that #Health remains THE top priority, including: \n\nğŸ”¸Speed up EU &amp; global vaccination\nğŸ”¸Increase preparedneâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438083910148165638"}]},{"entities":{"urls":{},"hashtags":[{"start":61,"end":73,"tag":"HealthUnion"},{"start":104,"end":110,"tag":"SOTEU"},{"start":112,"end":117,"tag":"HERA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438064493276405761","possibly_sensitive":false,"created_at":"2021-09-15T08:57:47.000Z","id":"1438064493276405761","text":"RT @EU_Health: \" Last year we said it was time to build a EU #HealthUnion. Today we are delivering. \" â€“ #SOTEU\n\n#HERA â€“ our Health Emergencâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438046188880764932"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":131,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438064444354048001","possibly_sensitive":false,"created_at":"2021-09-15T08:57:36.000Z","id":"1438064444354048001","text":"RT @vonderleyen: Our most urgent priority is to speed up global vaccination.\n\nWe have already committed to share 250 million doses.\n\nWe wilâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438038788010385410"}]},{"entities":{"urls":{},"hashtags":[{"start":32,"end":38,"tag":"SOTEU"},{"start":121,"end":126,"tag":"HERA"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":50,"end":62,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438040416029483008","possibly_sensitive":false,"created_at":"2021-09-15T07:22:07.000Z","id":"1438040416029483008","text":"RT @SKyriakidesEU: With todayâ€™s #SOTEU, President @vonderleyen sets a new course for ğŸ‡ªğŸ‡º. \n\nTogether, we will build a new #HERA that ensuresâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438039469056303105"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438038500146880515","possibly_sensitive":false,"created_at":"2021-09-15T07:14:30.000Z","id":"1438038500146880515","text":"RT @EU_Commission: Our most urgent priority is to speed up global vaccination.\n\nWe have already committed to share 250 million doses.\n\nWe wâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438038168658382853"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":19,"end":24,"probability":0.9895,"type":"Place","normalized_text":"Europe"},{"start":95,"end":100,"probability":0.9325,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":325,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438037842203189251","possibly_sensitive":false,"created_at":"2021-09-15T07:11:53.000Z","id":"1438037842203189251","text":"RT @EU_Commission: Europe needs a soul, an ideal, and the political will to serve this ideal.\n\nEurope has brought those words to life in thâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438036615440502786"}]},{"entities":{"urls":{},"hashtags":[{"start":77,"end":83,"tag":"SOTEU"},{"start":92,"end":105,"tag":"DemocracyDay"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":19,"end":24,"probability":0.9819,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":188,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1438037761504727040","possibly_sensitive":false,"created_at":"2021-09-15T07:11:34.000Z","id":"1438037761504727040","text":"RT @EU_Commission: Europe and its future go hand in hand with democracy.\n\nOn #SOTEU day and #DemocracyDay we renew our commitment to buildâ€¦","referenced_tweets":[{"type":"retweeted","id":"1438012200933683205"}]},{"entities":{"urls":{},"hashtags":[{"start":31,"end":37,"tag":"SOTEU"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":127,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437762243404382212","possibly_sensitive":false,"created_at":"2021-09-14T12:56:45.000Z","id":"1437762243404382212","text":"RT @EU_Commission: Tomorrow is #SOTEU day!\n\nEvery year in September, the President of the European Commission delivers the SOTEU address beâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437668687071252481"}]},{"entities":{"urls":{},"hashtags":[{"start":19,"end":25,"tag":"SOTEU"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":73,"end":85,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":["1437757627627458565"]},"conversation_id":"1437762188832296963","possibly_sensitive":false,"created_at":"2021-09-14T12:56:32.000Z","id":"1437762188832296963","text":"RT @EU_Commission: #SOTEU will take place tomorrow morning. \n \nPresident @vonderleyen will take stock of the past year and present prioritiâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437757628302647301"}]},{"entities":{"urls":{},"hashtags":[{"start":108,"end":113,"tag":"HERA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":57,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437762119135604736","possibly_sensitive":false,"created_at":"2021-09-14T12:56:16.000Z","id":"1437762119135604736","text":"RT @EU_Health: This week we will present the European ğ—›ealth ğ—˜mergency preparedness and ğ—¥esponse ğ—”uthority\n\n#HERA will detect and rapidly râ€¦","referenced_tweets":[{"type":"retweeted","id":"1437759376358531073"}]},{"entities":{"urls":{},"hashtags":[{"start":50,"end":55,"tag":"EASO"},{"start":103,"end":111,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437411211193327622","possibly_sensitive":false,"created_at":"2021-09-13T13:41:53.000Z","id":"1437411211193327622","text":"RT @EASO: ğŸ“ To help inform policies and analyses, #EASO has just published a new Situational Update on #COVID19  measures in asylum proceduâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437395958996819972"}]},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/puXYdAdueu","expanded_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-13-16-september-2021-meeting_en.pdf","display_url":"ema.europa.eu/en/documents/aâ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-13-16-september-2021-meeting_en.pdf"}],"hashtags":[{"start":84,"end":89,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":14,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437380457226715149","possibly_sensitive":false,"created_at":"2021-09-13T11:39:40.000Z","id":"1437380457226715149","text":"ğŸ“‹ğŸ”What's on the agenda of the September meeting of EMA's human medicines committee (#CHMP): https://t.co/puXYdAdueu","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":62,"end":69,"tag":"sepsis"}],"mentions":[{"start":3,"end":18,"username":"WorldSepsisDay","id":"594492867"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":120,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437363558468177924","possibly_sensitive":false,"created_at":"2021-09-13T10:32:31.000Z","id":"1437363558468177924","text":"RT @WorldSepsisDay: 1 in 5 deaths globally is associated with #sepsis. Do you know the symptoms, sources, and risk groups of sepsis? This #â€¦","referenced_tweets":[{"type":"retweeted","id":"1437349498989301762"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":112,"end":127,"probability":0.9558,"type":"Person","normalized_text":"Dr. Marko Pokorn"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437333910468366340","possibly_sensitive":false,"created_at":"2021-09-13T08:34:43.000Z","id":"1437333910468366340","text":"RT @EU_Health: Vaccination can help end the COVID-19 pandemic so we can get back to enjoying life \n\nğŸ“º Watch as Dr. Marko Pokorn shares hisâ€¦","referenced_tweets":[{"type":"retweeted","id":"1436947686767226880"}]},{"entities":{"urls":{},"hashtags":[{"start":29,"end":35,"tag":"SOTEU"}],"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":201,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437325683018113030","possibly_sensitive":false,"created_at":"2021-09-13T08:02:01.000Z","id":"1437325683018113030","text":"RT @vonderleyen: Join me for #SOTEU on 15 September to look back on what we achieved together in this momentous year &amp; talk about the futurâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437084438945488901"}]},{"entities":{"urls":{},"hashtags":[{"start":37,"end":41,"tag":"AMR"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":59,"end":71,"username":"Europarl_EN","id":"36329597"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437318877541814273","possibly_sensitive":false,"created_at":"2021-09-13T07:34:59.000Z","id":"1437318877541814273","text":"RT @SKyriakidesEU: Important vote on #AMR next week in the @Europarl_EN. \n\nI urge all MEPs to support our efforts â–¶ï¸ensure that the most imâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437104770033070080"}]},{"entities":{"urls":{},"hashtags":[{"start":42,"end":54,"tag":"HealthUnion"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":97,"end":106,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1437318667927232514","possibly_sensitive":false,"created_at":"2021-09-13T07:34:09.000Z","id":"1437318667927232514","text":"RT @EU_Health: We are building a stronger #HealthUnion including 3 key proposals: \n\nâ–¶ Strengthen @EMA_News \nâ–¶ Reinforce the mandate of @ECDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1437302526001418242"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1436324058287808514","possibly_sensitive":false,"created_at":"2021-09-10T13:41:55.000Z","id":"1436324058287808514","text":"RT @EU_Commission: For more than a year, our priority has been to lead the way out of the global health crisis. \n\nFind out more in our newâ€¦","referenced_tweets":[{"type":"retweeted","id":"1436275763246944272"}]},{"entities":{"urls":{},"hashtags":[{"start":61,"end":69,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1436285807858438170","possibly_sensitive":false,"created_at":"2021-09-10T11:09:56.000Z","id":"1436285807858438170","text":"RT @ECDC_EU: How many Europeans have been vaccinated against #COVID19 so far? How does it look in the specific age groups? \n\nFind all the iâ€¦","referenced_tweets":[{"type":"retweeted","id":"1436284772767121410"}]},{"entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/pbXDKmGZMZ","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines","display_url":"ema.europa.eu/en/human-regulâ€¦"},{"start":278,"end":301,"url":"https://t.co/9wdqDGP9oe","expanded_url":"https://twitter.com/EMA_News/status/1436245486168690691/photo/1","display_url":"pic.twitter.com/9wdqDGP9oe"}],"hashtags":[{"start":31,"end":47,"tag":"COVID19vaccines"},{"start":233,"end":250,"tag":"SafetyOfVaccines"},{"start":251,"end":264,"tag":"VaccinesWork"},{"start":265,"end":277,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":46,"reply_count":17,"like_count":56,"quote_count":5},"attachments":{"media_keys":["3_1436245381231390746"],"poll_ids":{}},"conversation_id":"1436245486168690691","possibly_sensitive":false,"created_at":"2021-09-10T08:29:42.000Z","id":"1436245486168690691","text":"How does EMA monitor safety of #COVID19vaccines? Find out on our new webpage: \nğŸ‘‰https://t.co/pbXDKmGZMZ\n\nIt also presents updated information, including correct numbers, on the safety of each COVID-19 vaccine authorised in the ğŸ‡ªğŸ‡º. \n\n#SafetyOfVaccines #VaccinesWork #HealthUnion https://t.co/9wdqDGP9oe","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1436234001308585987","possibly_sensitive":false,"created_at":"2021-09-10T07:44:04.000Z","id":"1436234001308585987","text":"RT @EU_Health: ğŸ“ŒToday at 10:00 am â¬‡","referenced_tweets":[{"type":"retweeted","id":"1436208062633816070"}]},{"entities":{"urls":[{"start":233,"end":256,"url":"https://t.co/plP6rglnE7","expanded_url":"https://www.ema.europa.eu/en/news/increase-manufacturing-capacity-covid-19-vaccine-biontechpfizer","display_url":"ema.europa.eu/en/news/increaâ€¦"},{"start":257,"end":280,"url":"https://t.co/viikyoADGJ","expanded_url":"https://twitter.com/EMA_News/status/1435993283826749442/photo/1","display_url":"pic.twitter.com/viikyoADGJ"}],"hashtags":[{"start":90,"end":105,"tag":"COVID19vaccine"},{"start":204,"end":217,"tag":"PublicHealth"},{"start":218,"end":230,"tag":"HealthUnion"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8032,"type":"Organization","normalized_text":"EMA"},{"start":136,"end":142,"probability":0.9995,"type":"Place","normalized_text":"Germany"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":48,"reply_count":6,"like_count":117,"quote_count":10},"attachments":{"media_keys":["3_1435992524519247885"],"poll_ids":{}},"conversation_id":"1435993283826749442","possibly_sensitive":false,"created_at":"2021-09-09T15:47:32.000Z","id":"1435993283826749442","text":"EMA has approved additional manufacturing sites for the production of the BioNTech/Pfizer #COVID19vaccine. \n\nThese two sites located in Germany will provide up to 50 million additional doses in 2021 ğŸ’‰ğŸ’‰ğŸ’‰\n\n#PublicHealth #HealthUnion\n\nğŸ‘‰https://t.co/plP6rglnE7 https://t.co/viikyoADGJ","referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/2F2FmAMuyE","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-3","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":140,"end":163,"url":"https://t.co/PutxkewG0g","expanded_url":"https://twitter.com/i/events/1435934513654337539","display_url":"twitter.com/i/events/14359â€¦"}],"hashtags":[{"start":165,"end":176,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":4,"like_count":22,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435936001583689729","possibly_sensitive":false,"created_at":"2021-09-09T11:59:55.000Z","id":"1435936001583689729","text":"The recording of the press briefing is available on EMA's website: https://t.co/2F2FmAMuyE\nOur tweets during the briefing can be seen here: https://t.co/PutxkewG0g \n#EMAPresser","referenced_tweets":{}},{"entities":{"urls":[{"start":191,"end":214,"url":"https://t.co/f6wxWlHdEh","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/treatments-covid-19/covid-19-treatments-under-evaluation#covid-19-treatments-under-rolling-review-section","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":106,"end":114,"tag":"COVID19"},{"start":215,"end":226,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":50,"reply_count":5,"like_count":76,"quote_count":10},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:10:38.000Z","id":"1435923598561136646","text":"4 antiviral monoclonal antibodies products are currently under EMAâ€™s rolling review for treatment of mild #COVID19 to avoid disease progression, and in some cases for prevention of COVID-19: https://t.co/f6wxWlHdEh #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435923491979776009"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":205,"end":228,"url":"https://t.co/c3OiWLn9uv","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/treatments-covid-19/covid-19-treatments-under-evaluation#covid-19-treatments-under-marketing-authorisation-evaluation-section","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":73,"end":81,"tag":"COVID19"},{"start":229,"end":240,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":22,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:10:13.000Z","id":"1435923491979776009","text":"Besides vaccines, therapeutics are needed for patients that get ill with #COVID19. EMA is reviewing extension of indication for 3 immunomodulatory agents to be used in hospitalised patients with COVID-19: https://t.co/c3OiWLn9uv #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435923382390906881"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":202,"end":225,"url":"https://t.co/pbXDKmGZMZ","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines","display_url":"ema.europa.eu/en/human-regulâ€¦"}],"hashtags":[{"start":71,"end":83,"tag":"SideEffects"},{"start":184,"end":200,"tag":"COVID19vaccines"},{"start":227,"end":238,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":13,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:09:47.000Z","id":"1435923382390906881","text":"EMA and the ğŸ‡ªğŸ‡º Member States continuously analyse reports of suspected #SideEffects to detect any potential new safety concern. EMA publishes regular safety updates for all authorised #COVID19vaccines: https://t.co/pbXDKmGZMZ\n #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435923209178828804"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":48,"end":64,"tag":"COVID19vaccines"},{"start":114,"end":125,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":5,"like_count":20,"quote_count":5},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:09:05.000Z","id":"1435923209178828804","text":"Worldwide safety data show that the benefits of #COVID19vaccines are much greater than any possible side effects. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435922925438263297"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":64,"end":80,"tag":"COVID19vaccines"},{"start":144,"end":157,"tag":"PublicHealth"},{"start":158,"end":169,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":10,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:07:58.000Z","id":"1435922925438263297","text":"EMA granted authorisations to additional manufacturing sites of #COVID19vaccines, to increase the supply for the ongoing vaccination campaigns. #PublicHealth #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435922746131759111"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":230,"end":241,"tag":"EMAPresser"}],"mentions":[{"start":174,"end":182,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":64,"end":70,"probability":0.408,"type":"Organization","normalized_text":"Moderna"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":15,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:07:15.000Z","id":"1435922746131759111","text":"Other manufacturers may soon submit data on a 3rd booster dose. Moderna has started submitting data from their clinical trial with booster doses.\nEMA is closely working with @ECDC_EU to collect &amp; review data on booster doses. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435922631631515653"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":77,"end":92,"tag":"COVID19vaccine"},{"start":251,"end":262,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4943,"type":"Organization","normalized_text":"EMA"},{"start":66,"end":74,"probability":0.3828,"type":"Organization","normalized_text":"Comirnaty"},{"start":106,"end":113,"probability":0.7619,"type":"Organization","normalized_text":"BionTech"},{"start":115,"end":120,"probability":0.3875,"type":"Organization","normalized_text":"Pfizer"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":2,"like_count":23,"quote_count":11},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:06:48.000Z","id":"1435922631631515653","text":"EMA is evaluating an application for the use of a booster dose of Comirnaty (#COVID19vaccine developed by BionTech/Pfizer) to be given at least 6 months after the 2nd dose in people aged 16 years and older. Outcome expected within the next few weeks. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435922106412412934"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":119,"end":127,"tag":"COVID19"},{"start":219,"end":230,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":2,"like_count":27,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:04:42.000Z","id":"1435922106412412934","text":"The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435921992755130370"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":19,"end":35,"tag":"COVID19vaccines"},{"start":175,"end":186,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":22,"reply_count":2,"like_count":19,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:04:15.000Z","id":"1435921992755130370","text":"Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1435921336099033093"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":170,"end":193,"url":"https://t.co/2F2FmAMuyE","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-3","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":194,"end":217,"url":"https://t.co/gTAMLhSLgm","expanded_url":"https://twitter.com/EMA_News/status/1435921336099033093/photo/1","display_url":"pic.twitter.com/gTAMLhSLgm"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":47,"reply_count":7,"like_count":63,"quote_count":6},"attachments":{"media_keys":["3_1435916540822556672"],"poll_ids":{}},"conversation_id":"1435921336099033093","possibly_sensitive":false,"created_at":"2021-09-09T11:01:39.000Z","id":"1435921336099033093","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser.\nğŸ‘‰https://t.co/2F2FmAMuyE https://t.co/gTAMLhSLgm","referenced_tweets":{}},{"entities":{"urls":[{"start":142,"end":165,"url":"https://t.co/2F2FmAMuyE","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-3","display_url":"ema.europa.eu/en/events/ema-â€¦"}],"hashtags":[{"start":35,"end":43,"tag":"COVID19"},{"start":130,"end":141,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":4,"like_count":32,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435914024433160192","possibly_sensitive":false,"created_at":"2021-09-09T10:32:36.000Z","id":"1435914024433160192","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19 vaccines and treatments will be broadcast live ğŸ”´ today, 9 September, from 13:00 CEST. #EMAPresser\nhttps://t.co/2F2FmAMuyE","referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/vd7JYNuG9G","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-8-september-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-comirnaty-8-september-2021_en.pdf"},{"start":155,"end":178,"url":"https://t.co/8r257LMkwD","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-covid-19-vaccine-janssen-8-september-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":191,"end":214,"url":"https://t.co/qYhd19tG9Y","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-spikevax-previously-covid-19-vaccine-moderna-8-september-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-spikevax-previously-covid-19-vaccine-moderna-8-september-2021_en.pdf"},{"start":228,"end":251,"url":"https://t.co/iu5loX9nmH","expanded_url":"https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-8-september-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦"},{"start":271,"end":294,"url":"https://t.co/ixAh3vbQd2","expanded_url":"https://twitter.com/EMA_News/status/1435619862429282312/photo/1","display_url":"pic.twitter.com/ixAh3vbQd2"}],"hashtags":[{"start":50,"end":66,"tag":"COVID19vaccines"},{"start":253,"end":270,"tag":"SafetyOfVaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":63,"reply_count":19,"like_count":97,"quote_count":13},"attachments":{"media_keys":["3_1435619567422824448"],"poll_ids":{}},"conversation_id":"1435619862429282312","possibly_sensitive":false,"created_at":"2021-09-08T15:03:42.000Z","id":"1435619862429282312","text":"Check out our latest updates on the safety of all #COVID19vaccines authorised in the ğŸ‡ªğŸ‡º: \nâœ”ï¸Comirnaty: https://t.co/vd7JYNuG9G\nâœ”ï¸COVID-19 Vaccine Janssen: https://t.co/8r257LMkwD\nâœ”ï¸Spikevax: https://t.co/qYhd19tG9Y\nâœ”ï¸Vaxzevria: https://t.co/iu5loX9nmH\n\n#SafetyOfVaccines https://t.co/ixAh3vbQd2","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":46,"end":58,"tag":"Antibiotics"},{"start":86,"end":99,"tag":"veterinarian"}],"mentions":[{"start":3,"end":18,"username":"animalhealthEU","id":"1017044760"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435595418575024130","possibly_sensitive":false,"created_at":"2021-09-08T13:26:34.000Z","id":"1435595418575024130","text":"RT @animalhealthEU: âœ… New EU rules say animal #Antibiotics need to be prescribed by a #veterinarian\nâ¡ï¸ This is already the case in most memâ€¦","referenced_tweets":[{"type":"retweeted","id":"1435573645368336389"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":81,"end":86,"probability":0.9745,"type":"Place","normalized_text":"Europe"},{"start":126,"end":141,"probability":0.4781,"type":"Person","normalized_text":"President Ursula"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1435561176340090885","possibly_sensitive":false,"created_at":"2021-09-08T11:10:30.000Z","id":"1435561176340090885","text":"RT @EU_Health: Green, digital, resilient and ğ—›ğ—˜ğ—”ğ—Ÿğ—§ğ—›ğ—¬. This is how we want Europeâ€™s future to be. \n\nğŸ“… On 15 September, President Ursula vonâ€¦","referenced_tweets":[{"type":"retweeted","id":"1435528342539755522"}]},{"entities":{"urls":[{"start":256,"end":279,"url":"https://t.co/icmEY3T8E0","expanded_url":"https://www.ema.europa.eu/en/news/ema-evaluating-data-booster-dose-covid-19-vaccine-comirnaty","display_url":"ema.europa.eu/en/news/ema-evâ€¦"},{"start":280,"end":303,"url":"https://t.co/jpmlQhIpUD","expanded_url":"https://twitter.com/EMA_News/status/1434872408477999108/photo/1","display_url":"pic.twitter.com/jpmlQhIpUD"}],"hashtags":[{"start":70,"end":85,"tag":"COVID19vaccine"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":153,"reply_count":22,"like_count":273,"quote_count":30},"attachments":{"media_keys":["3_1434872133281325061"],"poll_ids":{}},"conversation_id":"1434872408477999108","possibly_sensitive":false,"created_at":"2021-09-06T13:33:35.000Z","id":"1434872408477999108","text":"EMA starts evaluating an application for the use of a booster dose of #COVID19vaccine Comirnaty to be given 6 months after the 2nd dose in 16+; Data on the use of a 3rd dose of an mRNA vaccine in severely immunocompromised people are also being assessed.\nğŸ‘‰https://t.co/icmEY3T8E0 https://t.co/jpmlQhIpUD","referenced_tweets":{}},{"entities":{"urls":[{"start":125,"end":148,"url":"https://t.co/F80VQQstpr","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-30-august-2-september-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":149,"end":172,"url":"https://t.co/n1AdNaCC2N","expanded_url":"https://twitter.com/EMA_News/status/1433762001248038914/photo/1","display_url":"pic.twitter.com/n1AdNaCC2N"}],"hashtags":[{"start":24,"end":29,"tag":"PRAC"},{"start":56,"end":72,"tag":"COVID19vaccines"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3722,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":8,"like_count":30,"quote_count":1},"attachments":{"media_keys":["3_1433761780845666321"],"poll_ids":{}},"conversation_id":"1433762001248038914","possibly_sensitive":false,"created_at":"2021-09-03T12:01:13.000Z","id":"1433762001248038914","text":"EMAâ€™s safety committee (#PRAC) updates on the safety of #COVID19vaccines and blood-cancer treatment Imbruvica. \n\nğŸ‘‰Read more: https://t.co/F80VQQstpr https://t.co/n1AdNaCC2N","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":154,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1433720054353367040","possibly_sensitive":false,"created_at":"2021-09-03T09:14:32.000Z","id":"1433720054353367040","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1433395782892331015"}]},{"entities":{"urls":{},"hashtags":[{"start":49,"end":57,"tag":"COVID19"}],"mentions":[{"start":3,"end":17,"username":"SKyriakidesEU","id":"2476130260"},{"start":37,"end":45,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1433344794168811520","possibly_sensitive":false,"created_at":"2021-09-02T08:23:23.000Z","id":"1433344794168811520","text":"RT @SKyriakidesEU: New guidance from @ECDC_EU on #COVID19 vaccination recommends additional doses for the most vulnerable of our citizens.â€¦","referenced_tweets":[{"type":"retweeted","id":"1433119212264886283"}]},{"entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"JustPublished"},{"start":98,"end":106,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1433344502215892992","possibly_sensitive":false,"created_at":"2021-09-02T08:22:14.000Z","id":"1433344502215892992","text":"RT @ECDC_EU: #JustPublished!\nInterim public health considerations for the provision of additional #COVID19 vaccine doses.\n\nRead full reportâ€¦","referenced_tweets":[{"type":"retweeted","id":"1433114658878201857"}]},{"entities":{"urls":[{"start":263,"end":286,"url":"https://t.co/OXQkNMRJan","expanded_url":"https://www.ema.europa.eu/en/news/ecdc-ema-highlight-considerations-additional-booster-doses-covid-19-vaccines","display_url":"ema.europa.eu/en/news/ecdc-eâ€¦"},{"start":287,"end":310,"url":"https://t.co/QaYbZMbHEV","expanded_url":"https://twitter.com/EMA_News/status/1433341089495371778/photo/1","display_url":"pic.twitter.com/QaYbZMbHEV"}],"hashtags":[{"start":104,"end":120,"tag":"COVID19vaccines"}],"mentions":[{"start":13,"end":21,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":223,"reply_count":13,"like_count":262,"quote_count":58},"attachments":{"media_keys":["3_1433340276181975041"],"poll_ids":{}},"conversation_id":"1433341089495371778","possibly_sensitive":false,"created_at":"2021-09-02T08:08:40.000Z","id":"1433341089495371778","text":"â€¼ï¸ EMA &amp; @ECDC_EU highlight that there is no urgent need for the administration of booster doses of #COVID19vaccines to fully vaccinated individuals in the general population.\nRead the 3rd joint statementğŸ“on considerations for additional &amp; booster doses\nğŸ‘‰https://t.co/OXQkNMRJan https://t.co/QaYbZMbHEV","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":302,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1432651178840662020","possibly_sensitive":false,"created_at":"2021-08-31T10:27:13.000Z","id":"1432651178840662020","text":"RT @EU_Commission: 70% of all adults in the EU are now fully vaccinated.\n\nThis is a great achievement but we need more â€“ the pandemic is noâ€¦","referenced_tweets":[{"type":"retweeted","id":"1432646393752137732"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":[{"start":34,"end":35,"probability":0.7358,"type":"Place","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":1515,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1432640136714534915","possibly_sensitive":false,"created_at":"2021-08-31T09:43:20.000Z","id":"1432640136714534915","text":"RT @vonderleyen: 70% of adults in EU are fully vaccinated.\n\nI want to thank the many people making this great achievement possible.\n\nBut weâ€¦","referenced_tweets":[{"type":"retweeted","id":"1432638914142089220"}]},{"entities":{"urls":[{"start":205,"end":228,"url":"https://t.co/CccKVAKjfJ","expanded_url":"https://politicos-eu-confidential.simplecast.com/episodes/eu-migration-wrangle-economist-joseph-stiglitz-ema-chief-emer-cooke?t=24m20s","display_url":"â€¦iticos-eu-confidential.simplecast.com/episodes/eu-miâ€¦"}],"hashtags":[{"start":148,"end":164,"tag":"COVID19vaccines"}],"mentions":[{"start":59,"end":74,"username":"POLITICOEurope","id":"2969760609"}],"annotations":[{"start":0,"end":9,"probability":0.9926,"type":"Person","normalized_text":"Emer Cooke"},{"start":119,"end":124,"probability":0.9159,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":2,"like_count":41,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1432312714634874883","possibly_sensitive":false,"created_at":"2021-08-30T12:02:16.000Z","id":"1432312714634874883","text":"Emer Cooke, our Executive Director, was a special guest on @POLITICOEurope's EU Confidential podcast.\n\nShe talks about Europeâ€™s coronavirus battle, #COVID19vaccines and her own background.\n\nListen here: ğŸ‘‡ https://t.co/CccKVAKjfJ","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":17,"end":25,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":58,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1432263512944959489","possibly_sensitive":false,"created_at":"2021-08-30T08:46:46.000Z","id":"1432263512944959489","text":"RT @ECDC_EU: The #COVID19 storm is not yet over!\nGet vaccinated!\n\nHad one out of two vaccine doses so far? Then don't forget the 2nd one!\nMâ€¦","referenced_tweets":[{"type":"retweeted","id":"1431246710022492163"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1432256503235350528","possibly_sensitive":false,"created_at":"2021-08-30T08:18:55.000Z","id":"1432256503235350528","text":"RT @EU_Commission: Full vaccination offers the best protection against the coronavirus and its variants, including the delta variant, and iâ€¦","referenced_tweets":[{"type":"retweeted","id":"1431564717999407108"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1431247764051136513","possibly_sensitive":false,"created_at":"2021-08-27T13:30:32.000Z","id":"1431247764051136513","text":"RT @EU_Health: Online disinformation has real world effects.\n\nCheck your sources before sharing information about vaccines and vaccination,â€¦","referenced_tweets":[{"type":"retweeted","id":"1430054768228003848"}]},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/FMQdQTfvSa","expanded_url":"https://twitter.com/WHO_Europe/status/1430839192691613698/photo/1","display_url":"pic.twitter.com/FMQdQTfvSa"},{"start":97,"end":120,"url":"https://t.co/FMQdQTfvSa","expanded_url":"https://twitter.com/WHO_Europe/status/1430839192691613698/photo/1","display_url":"pic.twitter.com/FMQdQTfvSa"}],"hashtags":[{"start":74,"end":82,"tag":"COVID19"},{"start":83,"end":96,"tag":"VaccinesWork"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_1430839187587149834","3_1430839190254723088"],"poll_ids":{}},"conversation_id":"1431176375373811715","possibly_sensitive":false,"created_at":"2021-08-27T08:46:52.000Z","id":"1431176375373811715","text":"RT @WHO_Europe: What is vaccine effectiveness? Find out in the images ğŸ‘‡ \n\n#COVID19 #VaccinesWork https://t.co/FMQdQTfvSa","referenced_tweets":[{"type":"retweeted","id":"1430839192691613698"}]},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/FMl3dWhwD4","expanded_url":"https://twitter.com/WHO_Europe/status/1430511546912890884/photo/1","display_url":"pic.twitter.com/FMl3dWhwD4"},{"start":102,"end":125,"url":"https://t.co/FMl3dWhwD4","expanded_url":"https://twitter.com/WHO_Europe/status/1430511546912890884/photo/1","display_url":"pic.twitter.com/FMl3dWhwD4"},{"start":102,"end":125,"url":"https://t.co/FMl3dWhwD4","expanded_url":"https://twitter.com/WHO_Europe/status/1430511546912890884/photo/1","display_url":"pic.twitter.com/FMl3dWhwD4"}],"hashtags":[{"start":79,"end":87,"tag":"COVID19"},{"start":88,"end":101,"tag":"VaccinesWork"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":["3_1430511538557837319","3_1430511541300903942","3_1430511544027262979"],"poll_ids":{}},"conversation_id":"1431176348173733890","possibly_sensitive":false,"created_at":"2021-08-27T08:46:46.000Z","id":"1431176348173733890","text":"RT @WHO_Europe: What is vaccine efficacy? Find out the answer in the images ğŸ‘‡\n\n#COVID19 #VaccinesWork https://t.co/FMl3dWhwD4","referenced_tweets":[{"type":"retweeted","id":"1430511546912890884"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":95,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1431162247439601667","possibly_sensitive":false,"created_at":"2021-08-27T07:50:44.000Z","id":"1431162247439601667","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1430886495200575499"}]},{"entities":{"urls":{},"hashtags":[{"start":15,"end":27,"tag":"SaveTheDate"},{"start":95,"end":105,"tag":"EU4Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1431161452275118085","possibly_sensitive":false,"created_at":"2021-08-27T07:47:34.000Z","id":"1431161452275118085","text":"RT @EU_Health: #SaveTheDate\n\nWhat should be the priorities &amp; needs to be addressed for the #EU4Health 2022 working programme?\n\nThis is whatâ€¦","referenced_tweets":[{"type":"retweeted","id":"1430830600508874752"}]},{"entities":{"urls":{},"hashtags":[{"start":113,"end":119,"tag":"COVID"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1430805077082656775","possibly_sensitive":false,"created_at":"2021-08-26T08:11:28.000Z","id":"1430805077082656775","text":"RT @EU_Health: Reminder! \n\nIt is necessary to complete your vaccination to get the best possible protection from #COVID-19. Depending on thâ€¦","referenced_tweets":[{"type":"retweeted","id":"1430454911381213185"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":85,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1430536082676985863","possibly_sensitive":false,"created_at":"2021-08-25T14:22:34.000Z","id":"1430536082676985863","text":"RT @EU_Commission: The more people fully protected, the stronger our response is.\n\nFull vaccination offers the best protection against theâ€¦","referenced_tweets":[{"type":"retweeted","id":"1430518676575358984"}]},{"entities":{"urls":[{"start":198,"end":221,"url":"https://t.co/ckwHqPmYuq","expanded_url":"https://www.ema.europa.eu/en/news/increase-vaccine-manufacturing-capacity-covid-19-vaccines-biontech-pfizer-moderna","display_url":"ema.europa.eu/en/news/increaâ€¦"},{"start":222,"end":245,"url":"https://t.co/9LFW7TZ4VN","expanded_url":"https://twitter.com/EMA_News/status/1430165029404413956/photo/1","display_url":"pic.twitter.com/9LFW7TZ4VN"}],"hashtags":[{"start":155,"end":171,"tag":"COVID19vaccines"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.7382,"type":"Organization","normalized_text":"EMA"},{"start":72,"end":79,"probability":0.6119,"type":"Organization","normalized_text":"BioNTech"},{"start":81,"end":96,"probability":0.2518,"type":"Organization","normalized_text":"Pfizer & Moderna"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":92,"reply_count":25,"like_count":230,"quote_count":27},"attachments":{"media_keys":["3_1430164764894941185"],"poll_ids":{}},"conversation_id":"1430165029404413956","possibly_sensitive":false,"created_at":"2021-08-24T13:48:08.000Z","id":"1430165029404413956","text":"EMA has approved increasing the manufacturing capacity of vaccines from BioNTech/Pfizer &amp; Moderna. This is expected to support the continued supply of #COVID19vaccines in the EU ğŸ‡ªğŸ‡º\n\nRead more:\nğŸ‘‰https://t.co/ckwHqPmYuq https://t.co/9LFW7TZ4VN","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1429735872606441480","possibly_sensitive":false,"created_at":"2021-08-23T09:22:49.000Z","id":"1429735872606441480","text":"RT @EU_Health: All vaccines are closely monitored after they are authorised and put on the EU market via:\n\nâœ… Constant monitoring of any sidâ€¦","referenced_tweets":[{"type":"retweeted","id":"1429703702932344835"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":45,"end":46,"probability":0.4064,"type":"Place","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":193,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1429734144129572864","possibly_sensitive":false,"created_at":"2021-08-23T09:15:57.000Z","id":"1429734144129572864","text":"RT @EU_Commission: 250 million adults in the EU are now fully vaccinated âœ…\n\nNow, we must push even further. We must continue to vaccinate.â€¦","referenced_tweets":[{"type":"retweeted","id":"1428727483944390659"}]},{"entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/6FJwSlYhON","expanded_url":"https://clinicaldata.ema.europa.eu","display_url":"clinicaldata.ema.europa.eu"},{"start":280,"end":303,"url":"https://t.co/xMJHU84kLE","expanded_url":"https://twitter.com/EMA_News/status/1427960704359936010/photo/1","display_url":"pic.twitter.com/xMJHU84kLE"}],"hashtags":[{"start":4,"end":17,"tag":"ClinicalData"},{"start":260,"end":268,"tag":"COVID19"}],"mentions":{},"annotations":[{"start":44,"end":50,"probability":0.4105,"type":"Organization","normalized_text":"Veklury"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":25,"reply_count":13,"like_count":37,"quote_count":1},"attachments":{"media_keys":["3_1427960503008104451"],"poll_ids":{}},"conversation_id":"1427960704359936010","possibly_sensitive":false,"created_at":"2021-08-18T11:48:56.000Z","id":"1427960704359936010","text":"The #ClinicalData supporting the renewal of Veklury's authorisation have been published on our Clinical Data website: https://t.co/6FJwSlYhON \n\nThis is in line with the exceptional measures EMA has implemented to maximise the transparency of its activities on #COVID19 medicines. https://t.co/xMJHU84kLE","referenced_tweets":{}},{"entities":{"urls":[{"start":124,"end":147,"url":"https://t.co/DAUhi05KFn","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-roactemra-hospitalised-adults-severe-covid-19","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":148,"end":171,"url":"https://t.co/Pq6Gb65zPN","expanded_url":"https://twitter.com/EMA_News/status/1427238472268591104/photo/1","display_url":"pic.twitter.com/Pq6Gb65zPN"}],"hashtags":[{"start":112,"end":120,"tag":"COVID19"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":80,"reply_count":23,"like_count":136,"quote_count":12},"attachments":{"media_keys":["3_1427238413355393025"],"poll_ids":{}},"conversation_id":"1427238472268591104","possibly_sensitive":false,"created_at":"2021-08-16T11:59:03.000Z","id":"1427238472268591104","text":"EMA starts evaluating the anti-inflammatory medicine RoActemra (tocilizumab) in hospitalised adults with severe #COVID19: \nğŸ‘‰https://t.co/DAUhi05KFn https://t.co/Pq6Gb65zPN","referenced_tweets":{}},{"entities":{"urls":[{"start":199,"end":222,"url":"https://t.co/OZZntGhSnd","expanded_url":"https://www.ema.europa.eu/en/news/artificial-intelligence-medicine-regulation","display_url":"ema.europa.eu/en/news/artifiâ€¦"},{"start":223,"end":246,"url":"https://t.co/YylORIocT5","expanded_url":"https://twitter.com/EMA_News/status/1427202009720147968/photo/1","display_url":"pic.twitter.com/YylORIocT5"}],"hashtags":[{"start":65,"end":71,"tag":"ICMRA"},{"start":182,"end":185,"tag":"AI"},{"start":186,"end":196,"tag":"medicines"}],"mentions":{},"annotations":[{"start":4,"end":62,"probability":0.2184,"type":"Organization","normalized_text":"International Coalition of Medicines Regulatory Authorities"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":37,"reply_count":5,"like_count":45,"quote_count":6},"attachments":{"media_keys":["3_1427201955319930883"],"poll_ids":{}},"conversation_id":"1427202009720147968","possibly_sensitive":false,"created_at":"2021-08-16T09:34:09.000Z","id":"1427202009720147968","text":"The International Coalition of Medicines Regulatory Authorities (#ICMRA) has set out recommendations for global medicine regulators to address challenges of artificial intelligence. #AI #medicines \nğŸ‘‰https://t.co/OZZntGhSnd https://t.co/YylORIocT5","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":61,"end":69,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1427176657299849217","possibly_sensitive":false,"created_at":"2021-08-16T07:53:25.000Z","id":"1427176657299849217","text":"RT @ECDC_EU: How many Europeans have been vaccinated against #COVID19 so far? How does it look in the specific age groups? \n\nFind all the iâ€¦","referenced_tweets":[{"type":"retweeted","id":"1426552682882478086"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1425836756876759053","possibly_sensitive":false,"created_at":"2021-08-12T15:09:08.000Z","id":"1425836756876759053","text":"RT @EU_Commission: All vaccines are closely monitored after they are authorised and put on the EU market.\n\nâœ… Constant monitoring of any sidâ€¦","referenced_tweets":[{"type":"retweeted","id":"1425113985070813184"}]},{"entities":{"urls":[{"start":246,"end":269,"url":"https://t.co/HatmLkjBDo","expanded_url":"https://www.ema.europa.eu/en/documents/other/clinical-trial-information-system-ctis-sponsor-handbook_en.pdf","display_url":"ema.europa.eu/en/documents/oâ€¦"},{"start":270,"end":293,"url":"https://t.co/4uKveNIMc4","expanded_url":"https://twitter.com/EMA_News/status/1425756449662291968/photo/1","display_url":"pic.twitter.com/4uKveNIMc4"}],"hashtags":[{"start":219,"end":227,"tag":"CTIS4EU"},{"start":228,"end":243,"tag":"clinicaltrials"}],"mentions":{},"annotations":[{"start":177,"end":209,"probability":0.5928,"type":"Other","normalized_text":"Clinical Trial Information System"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":5,"like_count":45,"quote_count":0},"attachments":{"media_keys":["3_1425756250944544776"],"poll_ids":{}},"conversation_id":"1425756449662291968","possibly_sensitive":false,"created_at":"2021-08-12T09:50:01.000Z","id":"1425756449662291968","text":"Clinical trial sponsors can now consult a compilation of key guidance, technical information, recommendations and references that will help them to get ready for the use of the Clinical Trial Information System (CTIS). #CTIS4EU #clinicaltrials\nâ¡ï¸https://t.co/HatmLkjBDo https://t.co/4uKveNIMc4","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":56,"end":69,"tag":"EUCancerPlan"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1425735848281116676","possibly_sensitive":false,"created_at":"2021-08-12T08:28:09.000Z","id":"1425735848281116676","text":"RT @EU_Health: Letâ€™s turn the tide against cancer.\n\nThe #EUCancerPlan sets out a new approach to cancer prevention, diagnosis, treatment &amp;â€¦","referenced_tweets":[{"type":"retweeted","id":"1425698565326704640"}]},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/FSzHE7C1RM","expanded_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#safety-updates-section","display_url":"ema.europa.eu/en/medicines/hâ€¦"},{"start":153,"end":176,"url":"https://t.co/43N57RQa9T","expanded_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen#safety-updates-section","display_url":"ema.europa.eu/en/medicines/hâ€¦"},{"start":188,"end":211,"url":"https://t.co/RChzYNKXsC","expanded_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-moderna#safety-updates-section","display_url":"ema.europa.eu/en/medicines/hâ€¦","status":200,"title":"Spikevax (previously COVID-19 Vaccine Moderna) - European Medicines Agency","description":"Spikevax (previously COVID-19 Vaccine Moderna)","unwound_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-moderna#safety-updates-section"},{"start":224,"end":247,"url":"https://t.co/wHRzrdUug6","expanded_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca#safety-updates-section","display_url":"ema.europa.eu/en/medicines/hâ€¦"},{"start":281,"end":304,"url":"https://t.co/UaUMTQvRMB","expanded_url":"https://twitter.com/EMA_News/status/1425458211595894784/photo/1","display_url":"pic.twitter.com/UaUMTQvRMB"}],"hashtags":[{"start":50,"end":66,"tag":"COVID19vaccines"},{"start":249,"end":266,"tag":"SafetyOfVaccines"},{"start":267,"end":280,"tag":"VaccinesWork"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":87,"reply_count":20,"like_count":116,"quote_count":13},"attachments":{"media_keys":["3_1425456462856327170"],"poll_ids":{}},"conversation_id":"1425458211595894784","possibly_sensitive":false,"created_at":"2021-08-11T14:04:56.000Z","id":"1425458211595894784","text":"Check out our latest updates on the safety of all #COVID19vaccines authorised in the EU\n\nâ¡ï¸Comirnaty\nhttps://t.co/FSzHE7C1RM\nâ¡ï¸ COVID-19 Vaccine Janssen https://t.co/43N57RQa9T\nâ¡ï¸Spikevax https://t.co/RChzYNKXsC\nâ¡ï¸Vaxzevria https://t.co/wHRzrdUug6\n\n#SafetyOfVaccines #VaccinesWork https://t.co/UaUMTQvRMB","referenced_tweets":{}},{"entities":{"urls":[{"start":156,"end":179,"url":"https://t.co/RwLw6674S6","expanded_url":"https://www.ema.europa.eu/en/annual-report-2020/","display_url":"ema.europa.eu/en/annual-repoâ€¦"},{"start":248,"end":271,"url":"https://t.co/rhVlcPW0ex","expanded_url":"https://ec.europa.eu/eusurvey/runner/EMA_AR_2020_feedback","display_url":"ec.europa.eu/eusurvey/runneâ€¦","status":200,"unwound_url":"https://ec.europa.eu/eusurvey/runner/EMA_AR_2020_feedback"},{"start":272,"end":295,"url":"https://t.co/jEBLohw38e","expanded_url":"https://twitter.com/EMA_News/status/1425072291122135040/photo/1","display_url":"pic.twitter.com/jEBLohw38e"}],"hashtags":[{"start":18,"end":34,"tag":"AnnualReportEMA"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":4,"like_count":21,"quote_count":2},"attachments":{"media_keys":["3_1425072243445481472"],"poll_ids":{}},"conversation_id":"1425072291122135040","possibly_sensitive":false,"created_at":"2021-08-10T12:31:25.000Z","id":"1425072291122135040","text":"Have you seen the #AnnualReportEMA 2020? \nIt includes an overview of EMAâ€™s major achievements and key figures from the last year + an interactive timeline: https://t.co/RwLw6674S6 \n\nYou can help us improve next yearâ€™s edition by taking our survey: https://t.co/rhVlcPW0ex https://t.co/jEBLohw38e","referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/9Ws7Y0zHgC","expanded_url":"https://twitter.com/ECDC_EU/status/1423736009896992770","display_url":"twitter.com/ECDC_EU/statusâ€¦"}],"hashtags":[{"start":78,"end":88,"tag":"ECDConAir"}],"mentions":[{"start":19,"end":27,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":2,"like_count":55,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1424702085308768258","possibly_sensitive":false,"created_at":"2021-08-09T12:00:21.000Z","id":"1424702085308768258","text":"Our sister agency, @ECDC_EU, has launched a podcast on European epidemiology. #ECDConAir https://t.co/9Ws7Y0zHgC","referenced_tweets":[{"type":"quoted","id":"1423736009896992770"}]},{"entities":{"urls":{},"hashtags":[{"start":75,"end":86,"tag":"gonorrhoea"},{"start":87,"end":111,"tag":"AntimicrobialResistance"},{"start":112,"end":125,"tag":"azithromycin"},{"start":126,"end":130,"tag":"AMR"}],"mentions":[{"start":3,"end":19,"username":"Eurosurveillanc","id":"455839750"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1424662025473511431","possibly_sensitive":false,"created_at":"2021-08-09T09:21:10.000Z","id":"1424662025473511431","text":"RT @Eurosurveillanc: A new ğ˜Œğ˜¶ğ˜³ğ˜°ğ˜´ğ˜¶ğ˜³ğ˜·ğ˜¦ğ˜ªğ˜­ğ˜­ğ˜¢ğ˜¯ğ˜¤ğ˜¦ issue is out \n\nTopics include:\n#gonorrhoea #AntimicrobialResistance #azithromycin #AMR #SARSCoVâ€¦","referenced_tweets":[{"type":"retweeted","id":"1423291563254325273"}]},{"entities":{"urls":{},"hashtags":[{"start":33,"end":43,"tag":"EU4Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1424660833414656001","possibly_sensitive":false,"created_at":"2021-08-09T09:16:26.000Z","id":"1424660833414656001","text":"RT @EU_Health: With â‚¬5.3 billion #EU4Health is our biggest-ever investment in public health.\n\nIts first annual work programme has been adopâ€¦","referenced_tweets":[{"type":"retweeted","id":"1424618949103210498"}]},{"entities":{"urls":{},"hashtags":[{"start":52,"end":65,"tag":"DeltaVariant"},{"start":77,"end":81,"tag":"EMA"},{"start":88,"end":93,"tag":"ECDC"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":69,"end":70,"probability":0.5894,"type":"Place","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1423644253717204992","possibly_sensitive":false,"created_at":"2021-08-06T13:56:54.000Z","id":"1423644253717204992","text":"RT @ECDC_EU: With the increasing circulation of the #DeltaVariant in EU/EEA, #EMA &amp; #ECDC strongly encourage those who are eligible for vacâ€¦","referenced_tweets":[{"type":"retweeted","id":"1423026039865946118"}]},{"entities":{"urls":{},"hashtags":[{"start":79,"end":87,"tag":"COVID19"},{"start":117,"end":130,"tag":"DeltaVariant"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1423644227603423235","possibly_sensitive":false,"created_at":"2021-08-06T13:56:48.000Z","id":"1423644227603423235","text":"RT @ECDC_EU: â€¼ï¸ IMPORTANT â€¼ï¸\n\nVaccination is key to protecting against serious #COVID19, including disease caused by #DeltaVariant.\n\nWith @â€¦","referenced_tweets":[{"type":"retweeted","id":"1423026033037651969"}]},{"entities":{"urls":[{"start":125,"end":148,"url":"https://t.co/n655W6qPKt","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-august-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":180,"end":203,"url":"https://t.co/uXVkpwpx5W","expanded_url":"https://twitter.com/EMA_News/status/1423625068769337345/photo/1","display_url":"pic.twitter.com/uXVkpwpx5W"}],"hashtags":[{"start":63,"end":68,"tag":"PRAC"},{"start":94,"end":110,"tag":"COVID19vaccines"},{"start":149,"end":166,"tag":"SafetyOfVaccines"},{"start":167,"end":179,"tag":"HealthUnion"}],"mentions":{},"annotations":[{"start":35,"end":37,"probability":0.4671,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":33,"reply_count":10,"like_count":40,"quote_count":4},"attachments":{"media_keys":["3_1423624907401973772"],"poll_ids":{}},"conversation_id":"1423625068769337345","possibly_sensitive":false,"created_at":"2021-08-06T12:40:40.000Z","id":"1423625068769337345","text":"During its August plenary meeting, EMAâ€™s safety committee, the #PRAC, discussed the safety of #COVID19vaccines. Read more: \nğŸ‘‰https://t.co/n655W6qPKt\n#SafetyOfVaccines #HealthUnion https://t.co/uXVkpwpx5W","referenced_tweets":{}},{"entities":{"urls":[{"start":261,"end":284,"url":"https://t.co/gX3OMCsF9t","expanded_url":"https://www.ema.europa.eu/en/news/interoperability-track-trace-systems-key-public-health-protection","display_url":"ema.europa.eu/en/news/interoâ€¦"},{"start":285,"end":308,"url":"https://t.co/jGW9NPCgF6","expanded_url":"https://twitter.com/EMA_News/status/1423561101862637568/photo/1","display_url":"pic.twitter.com/jGW9NPCgF6"}],"hashtags":[{"start":99,"end":105,"tag":"ICMRA"},{"start":246,"end":259,"tag":"PublicHealth"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3917,"type":"Organization","normalized_text":"EMA"},{"start":38,"end":96,"probability":0.4039,"type":"Organization","normalized_text":"International Coalition of Medicines Regulatory Authorities"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":45,"quote_count":0},"attachments":{"media_keys":["3_1423560085326995459"],"poll_ids":{}},"conversation_id":"1423561101862637568","possibly_sensitive":false,"created_at":"2021-08-06T08:26:29.000Z","id":"1423561101862637568","text":"EMA endorses a paper published by the International Coalition of Medicines Regulatory Authorities (#ICMRA) to facilitate the use of track &amp; trace systems globally. Rapid exchange of info on medicines and their supply chains is key to protect #PublicHealth \nhttps://t.co/gX3OMCsF9t https://t.co/jGW9NPCgF6","referenced_tweets":{}},{"entities":{"urls":[{"start":241,"end":264,"url":"https://t.co/CiHQOKOR7C","expanded_url":"https://www.ema.europa.eu/en/news/ecdc-ema-update-covid-19","display_url":"ema.europa.eu/en/news/ecdc-eâ€¦"},{"start":278,"end":301,"url":"https://t.co/L3jDla1Xqu","expanded_url":"https://twitter.com/EMA_News/status/1422901141705302016/photo/1","display_url":"pic.twitter.com/L3jDla1Xqu"}],"hashtags":[{"start":114,"end":127,"tag":"DeltaVariant"},{"start":221,"end":229,"tag":"COVID19"},{"start":265,"end":277,"tag":"HealthUnion"}],"mentions":[{"start":11,"end":19,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":159,"reply_count":18,"like_count":264,"quote_count":24},"attachments":{"media_keys":["3_1422900625784950784"],"poll_ids":{}},"conversation_id":"1422901141705302016","possibly_sensitive":false,"created_at":"2021-08-04T12:44:03.000Z","id":"1422901141705302016","text":"â€¼ï¸ EMA and @ECDC_EU urge ğŸ‡ªğŸ‡º citizens to get fully vaccinated to be protected against severe disease caused by the #DeltaVariant and greatly reduce the number of people hospitalised.\n\nğŸ‘‰ Read the 2nd joint statementğŸ“on the #COVID19 situation: https://t.co/CiHQOKOR7C #HealthUnion https://t.co/L3jDla1Xqu","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":112,"end":120,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1422485706346221571","possibly_sensitive":false,"created_at":"2021-08-03T09:13:15.000Z","id":"1422485706346221571","text":"RT @ECDC_EU: Visiting your close ones at a care home?\n\nWe need to keep the elderly and the frail protected from #COVID19. When paying a visâ€¦","referenced_tweets":[{"type":"retweeted","id":"1422141839805648897"}]},{"entities":{"urls":{},"hashtags":[{"start":106,"end":114,"tag":"COVID19"}],"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":483,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1422461310692962305","possibly_sensitive":false,"created_at":"2021-08-03T07:36:19.000Z","id":"1422461310692962305","text":"RT @vonderleyen: 60% of all adults in the EU are now fully vaccinated.\n\nFull vaccination protects us from #COVID19 and its variants.â€¨\n\nLet'â€¦","referenced_tweets":[{"type":"retweeted","id":"1422212899418918918"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1422145244825595904","possibly_sensitive":false,"created_at":"2021-08-02T10:40:23.000Z","id":"1422145244825595904","text":"RT @EU_Health: ğŸ†•Clinical Trials Information System, as part of the Clinical Trials Regulation to ensure:\n\nâœ…Higher safety protection for parâ€¦","referenced_tweets":[{"type":"retweeted","id":"1422142634752102400"}]},{"entities":{"urls":[{"start":139,"end":162,"url":"https://t.co/bxDkorRYrM","expanded_url":"https://www.ema.europa.eu/en/news/six-month-countdown-go-live-clinical-trials-information-system-ctis","display_url":"ema.europa.eu/en/news/six-moâ€¦"},{"start":173,"end":196,"url":"https://t.co/Jki7QdhNuO","expanded_url":"https://twitter.com/EMA_News/status/1422143398685851648/video/1","display_url":"pic.twitter.com/Jki7QdhNuO"}],"hashtags":[{"start":27,"end":42,"tag":"ClinicalTrials"},{"start":164,"end":172,"tag":"CTIS4EU"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":28,"reply_count":6,"like_count":45,"quote_count":3},"attachments":{"media_keys":["7_1422143231869992962"],"poll_ids":{}},"conversation_id":"1422143398685851648","possibly_sensitive":false,"created_at":"2021-08-02T10:33:03.000Z","id":"1422143398685851648","text":"ğŸ“¢ The go-live date for the #ClinicalTrials Information System (CTIS) is 31 January 2022. Read what this means for sponsor organisations: \nğŸ‘‰https://t.co/bxDkorRYrM \n#CTIS4EU https://t.co/Jki7QdhNuO","referenced_tweets":{}},{"entities":{"urls":[{"start":142,"end":165,"url":"https://t.co/XbIRdjcT9T","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates","display_url":"ema.europa.eu/en/human-regulâ€¦","status":200,"title":"COVID-19: latest updates - European Medicines Agency","description":"COVID-19: latest updates","unwound_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates"},{"start":187,"end":210,"url":"https://t.co/ZGZ3nrKF9W","expanded_url":"https://clinicaldata.ema.europa.eu/web/cdp/home","display_url":"clinicaldata.ema.europa.eu/web/cdp/home"}],"hashtags":[{"start":112,"end":127,"tag":"COVID19Vaccine"},{"start":167,"end":180,"tag":"ClinicalData"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.6071,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":31,"reply_count":7,"like_count":57,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1421108336074891268","possibly_sensitive":false,"created_at":"2021-07-30T14:00:04.000Z","id":"1421108336074891268","text":"EMA has published the clinical data supporting the conditional marketing authorisation of Vaxzevria, previously #COVID19Vaccine AstraZeneca. \nhttps://t.co/XbIRdjcT9T \n#ClinicalData\nVisit https://t.co/ZGZ3nrKF9W","referenced_tweets":{}},{"entities":{"urls":[{"start":198,"end":221,"url":"https://t.co/8d66LZxnOQ","expanded_url":"https://www.ema.europa.eu/en/news/increased-manufacturing-capacity-supply-spikevax","display_url":"ema.europa.eu/en/news/increaâ€¦"},{"start":222,"end":245,"url":"https://t.co/nwZlu53zAo","expanded_url":"https://twitter.com/EMA_News/status/1421103627419242498/photo/1","display_url":"pic.twitter.com/nwZlu53zAo"}],"hashtags":[{"start":87,"end":102,"tag":"COVID19Vaccine"}],"mentions":{},"annotations":[{"start":3,"end":5,"probability":0.5968,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":67,"reply_count":15,"like_count":177,"quote_count":9},"attachments":{"media_keys":["3_1421103499438395393"],"poll_ids":{}},"conversation_id":"1421103627419242498","possibly_sensitive":false,"created_at":"2021-07-30T13:41:22.000Z","id":"1421103627419242498","text":"ğŸ“¢ EMA has approved  an increase of the manufacturing capacity for Spikevax (previously #COVID19Vaccine Moderna) in the ğŸ‡ºğŸ‡¸. This will have a significant impact on the supply of Spikevax in the ğŸ‡ªğŸ‡º. \nğŸ‘‰https://t.co/8d66LZxnOQ https://t.co/nwZlu53zAo","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1421008739549814785","possibly_sensitive":false,"created_at":"2021-07-30T07:24:19.000Z","id":"1421008739549814785","text":"RT @EU_Health: Why should you get a COVID19 vaccine when offered?\n\nğŸ’ªVaccines protect you from severe illness/complications\nğŸ’ªAuthorised vaccâ€¦","referenced_tweets":[{"type":"retweeted","id":"1420682651929825282"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":75,"end":89,"username":"EU_ScienceHub","id":"2754681001"}],"annotations":[{"start":43,"end":58,"probability":0.2782,"type":"Organization","normalized_text":"Knowledge Center"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1421008570481618949","possibly_sensitive":false,"created_at":"2021-07-30T07:23:38.000Z","id":"1421008570481618949","text":"RT @EU_Health: 1 month ago we launched the Knowledge Center on Cancer with @EU_ScienceHub\n\nThis new online platform will help to coordinateâ€¦","referenced_tweets":[{"type":"retweeted","id":"1420995071101456386"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":184,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1420732412498169856","possibly_sensitive":false,"created_at":"2021-07-29T13:06:17.000Z","id":"1420732412498169856","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1420721208081977348"}]},{"entities":{"urls":[{"start":185,"end":208,"url":"https://t.co/n3FMvg6atM","expanded_url":"https://www.ema.europa.eu/en/events/clinical-trials-information-system-ctis-webinar-how-sponsor-organisations-can-prepare-ctis#registration-section","display_url":"ema.europa.eu/en/events/clinâ€¦"},{"start":209,"end":232,"url":"https://t.co/qkBGwHkSBG","expanded_url":"https://twitter.com/EMA_News/status/1420709554589941767/photo/1","display_url":"pic.twitter.com/qkBGwHkSBG"}],"hashtags":[{"start":74,"end":89,"tag":"ClinicalTrials"},{"start":117,"end":125,"tag":"CTIS4EU"},{"start":126,"end":138,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":25,"quote_count":0},"attachments":{"media_keys":["3_1420709378970296321"],"poll_ids":{}},"conversation_id":"1420709554589941767","possibly_sensitive":false,"created_at":"2021-07-29T11:35:27.000Z","id":"1420709554589941767","text":"Watch the EMA webinar for sponsor organisations on how to prepare for the #ClinicalTrials Information System (CTIS). #CTIS4EU #HealthUnion\n\nLive broadcast ğŸ”´ from 14h00 to 16h30 CEST.\n\nğŸ‘‰https://t.co/n3FMvg6atM https://t.co/qkBGwHkSBG","referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/XXFWVHPZim","expanded_url":"https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-19-22-july-2021_en.pdf","display_url":"ema.europa.eu/en/documents/câ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-19-22-july-2021_en.pdf"},{"start":237,"end":260,"url":"https://t.co/7W6Xv8L2Vl","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/research-development/prime-priority-medicines","display_url":"ema.europa.eu/en/human-regulâ€¦"},{"start":261,"end":284,"url":"https://t.co/sdXWW6GUAk","expanded_url":"https://twitter.com/EMA_News/status/1420680795086262274/photo/1","display_url":"pic.twitter.com/sdXWW6GUAk"}],"hashtags":[{"start":92,"end":106,"tag":"PRIMEschemeEU"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":16,"quote_count":0},"attachments":{"media_keys":["3_1420680019681202176"],"poll_ids":{}},"conversation_id":"1420680795086262274","possibly_sensitive":false,"created_at":"2021-07-29T09:41:11.000Z","id":"1420680795086262274","text":"ğŸ“¢ In July 2021, one medicinal product received an EMA positive recommendation for access to #PRIMEschemeEU: https://t.co/XXFWVHPZim\nPRIME is an EMA scheme launched to support the development of medicines targeting an unmet medical need. https://t.co/7W6Xv8L2Vl https://t.co/sdXWW6GUAk","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":20,"end":34,"tag":"JustPublished"},{"start":84,"end":93,"tag":"diseases"}],"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1420679754366296068","possibly_sensitive":false,"created_at":"2021-07-29T09:37:03.000Z","id":"1420679754366296068","text":"RT @ECDC_Outbreaks: #JustPublished: Rapid Risk Assessment on the risk of infectious #diseases following extreme rainfall and catastrophic #â€¦","referenced_tweets":[{"type":"retweeted","id":"1420675846755471363"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":117,"end":118,"probability":0.7635,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1420661275848237057","possibly_sensitive":false,"created_at":"2021-07-29T08:23:37.000Z","id":"1420661275848237057","text":"RT @EU_Health: 38% of Europeans \n\nThat's how many consider HEALTH as the most important issue currently faced by the EU according to a newâ€¦","referenced_tweets":[{"type":"retweeted","id":"1420632683177259010"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1420311895677022213","possibly_sensitive":false,"created_at":"2021-07-28T09:15:18.000Z","id":"1420311895677022213","text":"RT @EU_Health: Hepatitis can't wait: highly effective diagnostics &amp; therapeutics can help eliminate viral hepatitis by 2030\n\nThe #EUCancerPâ€¦","referenced_tweets":[{"type":"retweeted","id":"1420308737873547265"}]},{"entities":{"urls":{},"hashtags":[{"start":30,"end":48,"tag":"WorldHepatitisDay"}],"mentions":[{"start":3,"end":15,"username":"EuropeLiver","id":"333363576"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1420290920084279297","possibly_sensitive":false,"created_at":"2021-07-28T07:51:57.000Z","id":"1420290920084279297","text":"RT @EuropeLiver: Each year on #WorldHepatitisDay, we have an opportunity to reflect on how far we have come on the path to eliminating #Hepâ€¦","referenced_tweets":[{"type":"retweeted","id":"1419901470875521024"}]},{"entities":{"urls":{},"hashtags":[{"start":28,"end":36,"tag":"COVID19"},{"start":41,"end":51,"tag":"influenza"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":61,"end":70,"username":"ppenttin","id":"35465163"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1419935323237326874","possibly_sensitive":false,"created_at":"2021-07-27T08:18:56.000Z","id":"1419935323237326874","text":"RT @ECDC_EU: Watch now:\nOur #COVID19 and #influenza expert - @ppenttin on the key messages in today's Rapid Risk Assessment on care homes aâ€¦","referenced_tweets":[{"type":"retweeted","id":"1419684377697689606"}]},{"entities":{"urls":{},"hashtags":[{"start":83,"end":92,"tag":"ReopenEU"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":65,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1419925103731789825","possibly_sensitive":false,"created_at":"2021-07-27T07:38:20.000Z","id":"1419925103731789825","text":"RT @EU_Commission: 2âƒ£0âƒ£ million visits to the website ğŸ–±\n1âƒ£.5âƒ£ million downloads ğŸ“²\n\n#ReopenEU is our tool providing timely information on trâ€¦","referenced_tweets":[{"type":"retweeted","id":"1419591657180344322"}]},{"entities":{"urls":[{"start":130,"end":153,"url":"https://t.co/oeLfeopIVm","expanded_url":"https://clinicaldata.ema.europa.eu/web/cdp","display_url":"clinicaldata.ema.europa.eu/web/cdp","status":200,"title":"Home - Clinical Data Publication - clinicaldata.ema.europa.eu","unwound_url":"https://clinicaldata.ema.europa.eu/web/cdp"}],"hashtags":[{"start":104,"end":119,"tag":"COVID19Vaccine"},{"start":155,"end":168,"tag":"ClinicalData"}],"mentions":[{"start":8,"end":21,"username":"GovCanHealth","id":"36375825"}],"annotations":[{"start":120,"end":126,"probability":0.6471,"type":"Person","normalized_text":"Janssen"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":5,"like_count":40,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1419696031290339334","possibly_sensitive":false,"created_at":"2021-07-26T16:28:05.000Z","id":"1419696031290339334","text":"EMA and @GovCanHealth published the clinical data supporting the conditional marketing authorisation of #COVID19Vaccine Janssen. \nhttps://t.co/oeLfeopIVm \n#ClinicalData","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":22,"tag":"SARSCoV2"},{"start":23,"end":36,"tag":"DeltaVariant"},{"start":71,"end":76,"tag":"ECDC"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":81,"end":92,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":53,"end":67,"probability":0.3975,"type":"Place","normalized_text":"European Region"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":89,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1419630419528536065","possibly_sensitive":false,"created_at":"2021-07-26T12:07:22.000Z","id":"1419630419528536065","text":"RT @ECDC_EU: #SARSCoV2 #DeltaVariant now dominant in European Region.\n\n#ECDC and @WHO_Europe call for reinforcement of efforts to prevent tâ€¦","referenced_tweets":[{"type":"retweeted","id":"1419604651188670468"}]},{"entities":{"urls":{},"hashtags":[{"start":44,"end":50,"tag":"Delta"},{"start":95,"end":103,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":205,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1419580379581779972","possibly_sensitive":false,"created_at":"2021-07-26T08:48:31.000Z","id":"1419580379581779972","text":"RT @ECDC_EU: The storm is not yet over!\nThe #Delta variant is spreading fast.\n\nOne dose of the #COVID19 vaccine is not enough (apart from #â€¦","referenced_tweets":[{"type":"retweeted","id":"1418133862333534211"}]},{"entities":{"urls":[{"start":138,"end":161,"url":"https://t.co/pnxvNYXDBH","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-vaccine-spikevax-approved-children-aged-12-17-eu","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":162,"end":185,"url":"https://t.co/WZgUz7G19K","expanded_url":"https://twitter.com/EMA_News/status/1418559013810315266/photo/1","display_url":"pic.twitter.com/WZgUz7G19K"}],"hashtags":[{"start":26,"end":41,"tag":"COVID19vaccine"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3694,"type":"Person","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":603,"reply_count":79,"like_count":1224,"quote_count":198},"attachments":{"media_keys":["3_1418558951671611396"],"poll_ids":{}},"conversation_id":"1418559013810315266","possibly_sensitive":false,"created_at":"2021-07-23T13:09:59.000Z","id":"1418559013810315266","text":"EMA has just approved the #COVID19vaccine Spikevax, previously known as COVID-19 Vaccine Moderna, for children aged 12 to 17 in the ğŸ‡ªğŸ‡º. \nğŸ‘‰https://t.co/pnxvNYXDBH https://t.co/WZgUz7G19K","referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/Z0cZdmdTDC","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-july-2021","display_url":"ema.europa.eu/en/news/meetinâ€¦"},{"start":133,"end":156,"url":"https://t.co/m1mY1hAOQO","expanded_url":"https://twitter.com/EMA_News/status/1418527209019658246/photo/1","display_url":"pic.twitter.com/m1mY1hAOQO"}],"hashtags":[{"start":39,"end":44,"tag":"CHMP"},{"start":59,"end":69,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":35,"quote_count":0},"attachments":{"media_keys":["3_1418527181890854912"],"poll_ids":{}},"conversation_id":"1418527209019658246","possibly_sensitive":false,"created_at":"2021-07-23T11:03:36.000Z","id":"1418527209019658246","text":"ğŸ“¢ EMAâ€™s human medicines committee, the #CHMP, recommends 2 #medicines for approval at its July 2021 meeting: https://t.co/Z0cZdmdTDC https://t.co/m1mY1hAOQO","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418520209820893196","possibly_sensitive":false,"created_at":"2021-07-23T10:35:47.000Z","id":"1418520209820893196","text":"RT @EU_Health: &gt; propose selection criteria for a list of 10 promising COVID-19 therapeutics, as announced under the Therapeutics Strategy.â€¦","referenced_tweets":[{"type":"retweeted","id":"1418520004560052225"}]},{"entities":{"urls":{},"hashtags":[{"start":82,"end":88,"tag":"COVID"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":19,"end":33,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418520142749736963","possibly_sensitive":false,"created_at":"2021-07-23T10:35:31.000Z","id":"1418520142749736963","text":"RT @EU_Health: The @EU_Commission appointed today an expert group on variants and #COVID-19 therapeutics.\n\nThe expert group will \n&gt; supportâ€¦","referenced_tweets":[{"type":"retweeted","id":"1418520003041693696"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":23,"end":24,"probability":0.5642,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":125,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418515002202415106","possibly_sensitive":false,"created_at":"2021-07-23T10:15:05.000Z","id":"1418515002202415106","text":"RT @EU_Commission: The EU delivers.\n\nOur vaccination campaign has accelerated tremendously since the beginning of the year.\n\nBy 22 July:\n\nğŸŸ¨â€¦","referenced_tweets":[{"type":"retweeted","id":"1418260123106021379"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":[{"start":53,"end":54,"probability":0.3956,"type":"Place","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":433,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418478639100858368","possibly_sensitive":false,"created_at":"2021-07-23T07:50:36.000Z","id":"1418478639100858368","text":"RT @vonderleyen: More than 200 million adults in the EU are now fully vaccinated! Thatâ€™s almost 55% of adults in the EU. \n\nFull vaccinationâ€¦","referenced_tweets":[{"type":"retweeted","id":"1418253466535870473"}]},{"entities":{"urls":[{"start":261,"end":284,"url":"https://t.co/a1Gayik85V","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-vaccine-janssen-guillain-barre-syndrome-listed-very-rare-side-effect","display_url":"ema.europa.eu/en/news/covid-â€¦"},{"start":285,"end":308,"url":"https://t.co/ojDtfDsW0a","expanded_url":"https://twitter.com/EMA_News/status/1418230762428633089/photo/1","display_url":"pic.twitter.com/ojDtfDsW0a"}],"hashtags":[{"start":93,"end":108,"tag":"COVID19Vaccine"}],"mentions":{},"annotations":[{"start":28,"end":50,"probability":0.2036,"type":"Other","normalized_text":"Guillain BarrÃ© syndrome"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":77,"reply_count":4,"like_count":93,"quote_count":22},"attachments":{"media_keys":["3_1418230548334587910"],"poll_ids":{}},"conversation_id":"1418230762428633089","possibly_sensitive":false,"created_at":"2021-07-22T15:25:37.000Z","id":"1418230762428633089","text":"â€¼ï¸ Following an EMA review, Guillain BarrÃ© syndrome is listed as a very rare side effect for #COVID19Vaccine Janssen. Healthcare professionals &amp; vaccinated people should be alert to symptoms of this syndrome, to allow for early diagnosis &amp; treatment: \nğŸ‘‰https://t.co/a1Gayik85V https://t.co/ojDtfDsW0a","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":214,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418228607646945280","possibly_sensitive":false,"created_at":"2021-07-22T15:17:04.000Z","id":"1418228607646945280","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil recommendation on travel measures in the EU during #COVIDâ€¦","referenced_tweets":[{"type":"retweeted","id":"1418184379717799968"}]},{"entities":{"urls":{},"hashtags":[{"start":101,"end":113,"tag":"HealthUnion"},{"start":126,"end":143,"tag":"EUPharmaStrategy"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418119654124445701","possibly_sensitive":false,"created_at":"2021-07-22T08:04:07.000Z","id":"1418119654124445701","text":"RT @EU_Health: Access to medicines for all is a fundamental European value &amp; instrumental to our #HealthUnion vision\n\nThe #EUPharmaStrategyâ€¦","referenced_tweets":[{"type":"retweeted","id":"1418095968784818187"}]},{"entities":{"urls":{},"hashtags":[{"start":31,"end":40,"tag":"vaccines"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":75,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1418107246723178496","possibly_sensitive":false,"created_at":"2021-07-22T07:14:49.000Z","id":"1418107246723178496","text":"RT @ECDC_EU: Misinformation on #vaccines prevents you from making healthy decisions.\n\nGet your information from verified, trusted sources.â€¦","referenced_tweets":[{"type":"retweeted","id":"1418088417909379072"}]},{"entities":{"urls":[{"start":164,"end":187,"url":"https://t.co/Soucend28N","expanded_url":"https://twitter.com/EMA_News/status/1417863876415262725/photo/1","display_url":"pic.twitter.com/Soucend28N"}],"hashtags":[{"start":0,"end":16,"tag":"COVID19vaccines"},{"start":53,"end":67,"tag":"RollingReview"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":54,"reply_count":23,"like_count":121,"quote_count":30},"attachments":{"media_keys":["3_1417863770018402304"],"poll_ids":{}},"conversation_id":"1417863876415262725","possibly_sensitive":false,"created_at":"2021-07-21T15:07:45.000Z","id":"1417863876415262725","text":"#COVID19vaccines: Where are we now? EMA starts a new #RollingReview for Vidprevtyn (Sanofi Pasteur). No marketing authorisation application currently under review. https://t.co/Soucend28N","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":112,"end":118,"tag":"COVID"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":128,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417859527509258243","possibly_sensitive":false,"created_at":"2021-07-21T14:50:28.000Z","id":"1417859527509258243","text":"RT @EU_Health: Reminder!\n\nIt is necessary to complete your vaccination to get the best possible protection from #COVID-19. Depending on theâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417733579602157570"}]},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/n3FMvg6atM","expanded_url":"https://www.ema.europa.eu/en/events/clinical-trials-information-system-ctis-webinar-how-sponsor-organisations-can-prepare-ctis#registration-section","display_url":"ema.europa.eu/en/events/clinâ€¦"},{"start":235,"end":258,"url":"https://t.co/PHp6b4hsJ5","expanded_url":"https://twitter.com/EMA_News/status/1417825580351905795/photo/1","display_url":"pic.twitter.com/PHp6b4hsJ5"}],"hashtags":[{"start":87,"end":102,"tag":"ClinicalTrials"},{"start":226,"end":234,"tag":"CTIS4EU"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5421,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":22,"quote_count":1},"attachments":{"media_keys":["3_1417825405969608709"],"poll_ids":{}},"conversation_id":"1417825580351905795","possibly_sensitive":false,"created_at":"2021-07-21T12:35:34.000Z","id":"1417825580351905795","text":"EMA holds a webinar for sponsor organisations to inform them on how to prepare for the #ClinicalTrials Information System (CTIS). \n\nğŸ—“ï¸ 29 July, 14h00-16h30 CEST\n\nğŸ‘‰https://t.co/n3FMvg6atM\n\nThe event will be ğŸ”´ live broadcast. \n\n#CTIS4EU https://t.co/PHp6b4hsJ5","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":48,"end":60,"tag":"vaccination"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417772204356423681","possibly_sensitive":false,"created_at":"2021-07-21T09:03:29.000Z","id":"1417772204356423681","text":"RT @ECDC_EU: Want to make a healthy decision on #vaccination?\nCareful! Misinformation can lead you astray!\n\nDon't get fooled!\nGet your vaccâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417757487445446656"}]},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/31QDcPUMfY","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-rolling-review-covid-19-vaccine-vidprevtyn","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":127,"end":150,"url":"https://t.co/EILcE0y1nf","expanded_url":"https://twitter.com/EMA_News/status/1417486167017144325/photo/1","display_url":"pic.twitter.com/EILcE0y1nf"}],"hashtags":[{"start":13,"end":27,"tag":"RollingReview"},{"start":45,"end":60,"tag":"COVID19vaccine"},{"start":114,"end":126,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"und","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":97,"reply_count":12,"like_count":155,"quote_count":31},"attachments":{"media_keys":["3_1417485918223613953"],"poll_ids":{}},"conversation_id":"1417486167017144325","possibly_sensitive":false,"created_at":"2021-07-20T14:06:52.000Z","id":"1417486167017144325","text":"EMA starts a #RollingReview of Vidprevtyn, a #COVID19vaccine developed by Sanofi Pasteur: https://t.co/31QDcPUMfY #HealthUnion https://t.co/EILcE0y1nf","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":66,"end":76,"tag":"NextGenEU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417392235952357376","possibly_sensitive":false,"created_at":"2021-07-20T07:53:37.000Z","id":"1417392235952357376","text":"RT @EU_Health: Weâ€™re striving to make tomorrow healthier.  \n\nWith #NextGenEU, we are: \nğŸ‹ Promoting physical activity &amp; a healthy lifestyleâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417371191560441862"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EU_opendata","id":"115660120"},{"start":99,"end":107,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417392011737456654","possibly_sensitive":false,"created_at":"2021-07-20T07:52:44.000Z","id":"1417392011737456654","text":"RT @EU_opendata: Discover EpiPulse: the European surveillance portal for infectious diseases. This @ECDC_EU tool supports health care profeâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417106963054227457"}]},{"entities":{"urls":{},"hashtags":[{"start":34,"end":43,"tag":"vaccines"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":115,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417391954678145027","possibly_sensitive":false,"created_at":"2021-07-20T07:52:30.000Z","id":"1417391954678145027","text":"RT @ECDC_EU: Misinformation about #vaccines spreads like a disease.\n\nDon't let anyone fool you. Get your vaccination information from publiâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417378745837490180"}]},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/IAdmqlQ9vF","expanded_url":"https://www.pscp.tv/w/c8RCZnR3LTE0NDk5ODI5fDFkakdYcVBvQVF6SloPQk1aaXG7R6jPipKo9Ox7h9N64vyuXz8OQuNIiYzo5A==","display_url":"pscp.tv/w/c8RCZnR3LTE0â€¦"}],"hashtags":[{"start":25,"end":33,"tag":"COVID19"},{"start":75,"end":82,"tag":"AskWHO"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"},{"start":39,"end":50,"username":"DrMikeRyan","id":"1106160968734773248"},{"start":60,"end":73,"username":"mvankerkhove","id":"2178775035"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":180,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417147407658258432","possibly_sensitive":false,"created_at":"2021-07-19T15:40:45.000Z","id":"1417147407658258432","text":"RT @WHO: LIVE Q&amp;A on #COVID19 with @DrMikeRyan &amp; Dr @mvankerkhove. #AskWHO https://t.co/IAdmqlQ9vF","referenced_tweets":[{"type":"retweeted","id":"1417146771805859842"}]},{"entities":{"urls":{},"hashtags":[{"start":64,"end":76,"tag":"vaccination"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417126552672915463","possibly_sensitive":false,"created_at":"2021-07-19T14:17:53.000Z","id":"1417126552672915463","text":"RT @ECDC_EU: Don't know whom to trust?\nTrust science.\n\nGet your #vaccination information from public health authorities!\n\nConfused where toâ€¦","referenced_tweets":[{"type":"retweeted","id":"1417118108213448707"}]},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/LrKPKaKW7x","expanded_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-19-22-july-2021-meeting_en.pdf","display_url":"ema.europa.eu/en/documents/aâ€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-19-22-july-2021-meeting_en.pdf"}],"hashtags":[{"start":81,"end":86,"tag":"CHMP"}],"mentions":{},"annotations":[{"start":44,"end":46,"probability":0.341,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":17,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1417099836978040839","possibly_sensitive":false,"created_at":"2021-07-19T12:31:44.000Z","id":"1417099836978040839","text":"What's on the agenda of the July meeting of EMA's human medicines committee, the #CHMP? https://t.co/LrKPKaKW7x","referenced_tweets":{}},{"entities":{"urls":[{"start":257,"end":280,"url":"https://t.co/VbgtGvKjMN","expanded_url":"https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/draft-eu-common-standard-electronic-product-information-human-medicines-epi_en.pdf","display_url":"ema.europa.eu/en/documents/râ€¦"},{"start":281,"end":304,"url":"https://t.co/MKQwejrdvU","expanded_url":"https://twitter.com/EMA_News/status/1417083255468199936/photo/1","display_url":"pic.twitter.com/MKQwejrdvU"}],"hashtags":[{"start":242,"end":256,"tag":"ePI4Medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":30,"quote_count":2},"attachments":{"media_keys":["3_1417083134294859778"],"poll_ids":{}},"conversation_id":"1417083255468199936","possibly_sensitive":false,"created_at":"2021-07-19T11:25:50.000Z","id":"1417083255468199936","text":"Share your views on the draft EU common standard for electronic product information (ePI). Your feedback will help to align the standard to citizens' needs when accessing, viewing &amp; disseminating product information in electronic format. #ePI4Medicines https://t.co/VbgtGvKjMN https://t.co/MKQwejrdvU","referenced_tweets":{}},{"entities":{"urls":[{"start":122,"end":145,"url":"https://t.co/fLGkX03H82","expanded_url":"https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-kineret-adult-covid-19-patients-increased-risk-severe-respiratory-failure","display_url":"ema.europa.eu/en/news/ema-stâ€¦"},{"start":179,"end":202,"url":"https://t.co/uMLyvC7Gbf","expanded_url":"https://twitter.com/EMA_News/status/1417049551324729344/photo/1","display_url":"pic.twitter.com/uMLyvC7Gbf"}],"hashtags":[{"start":53,"end":61,"tag":"COVID19"},{"start":62,"end":71,"tag":"patients"},{"start":147,"end":165,"tag":"COVID19treatments"},{"start":166,"end":178,"tag":"HealthUnion"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":36,"reply_count":2,"like_count":79,"quote_count":7},"attachments":{"media_keys":["3_1417049410979221506"],"poll_ids":{}},"conversation_id":"1417049551324729344","possibly_sensitive":false,"created_at":"2021-07-19T09:11:55.000Z","id":"1417049551324729344","text":"â€¼ï¸ EMA starts evaluating the use of Kineret in adult #COVID19 #patients at increased risk of severe respiratory failure. \nhttps://t.co/fLGkX03H82 \n#COVID19treatments #HealthUnion https://t.co/uMLyvC7Gbf","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"COVID19"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":306,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1416047377757229057","possibly_sensitive":false,"created_at":"2021-07-16T14:49:38.000Z","id":"1416047377757229057","text":"RT @WHO: AllÂ #COVID19 vaccinesÂ approved by WHO have been through clinical trials to test their quality, safety &amp; efficacy. After approval,â€¦","referenced_tweets":[{"type":"retweeted","id":"1415809390372921344"}]},{"entities":{"urls":{},"hashtags":[{"start":61,"end":69,"tag":"COVID19"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415973692727832576","possibly_sensitive":false,"created_at":"2021-07-16T09:56:50.000Z","id":"1415973692727832576","text":"RT @ECDC_EU: How many Europeans have been vaccinated against #COVID19 so far? How does it look in the specific age groups?\n\nFind all the inâ€¦","referenced_tweets":[{"type":"retweeted","id":"1415971096243867649"}]},{"entities":{"urls":[{"start":186,"end":209,"url":"https://t.co/6XIlsIiUBa","expanded_url":"https://www.ema.europa.eu/en/news/international-regulators-work-towards-alignment-development-authorisation-second-generation-covid-19","display_url":"ema.europa.eu/en/news/internâ€¦"},{"start":210,"end":233,"url":"https://t.co/Qb0UdUkAy8","expanded_url":"https://twitter.com/EMA_News/status/1415972006940512257/photo/1","display_url":"pic.twitter.com/Qb0UdUkAy8"}],"hashtags":[{"start":0,"end":6,"tag":"ICMRA"},{"start":124,"end":140,"tag":"COVID19vaccines"},{"start":161,"end":173,"tag":"coronavirus"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":18,"reply_count":4,"like_count":30,"quote_count":1},"attachments":{"media_keys":["3_1415971970576003072"],"poll_ids":{}},"conversation_id":"1415972006940512257","possibly_sensitive":false,"created_at":"2021-07-16T09:50:08.000Z","id":"1415972006940512257","text":"#ICMRA workshop report: International regulators work towards alignment on development and authorisation of new or modified #COVID19vaccines to address emerging #coronavirus variants. \nğŸ‘‰https://t.co/6XIlsIiUBa https://t.co/Qb0UdUkAy8","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":71,"end":81,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":225,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415657195295936521","possibly_sensitive":false,"created_at":"2021-07-15T12:59:11.000Z","id":"1415657195295936521","text":"RT @ECDC_EU: Updated ğŸš¦ maps are online!\n\nThese maps aim to support the @EUCouncil  recommendation on travel measures in the EU during #COVIâ€¦","referenced_tweets":[{"type":"retweeted","id":"1415656012971917314"}]},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/SyqMFJwzck","expanded_url":"https://twitter.com/i/events/1415650661316890635","display_url":"twitter.com/i/events/14156â€¦"}],"hashtags":[{"start":54,"end":62,"tag":"COVID19"},{"start":88,"end":99,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":23,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415654186826571777","possibly_sensitive":false,"created_at":"2021-07-15T12:47:14.000Z","id":"1415654186826571777","text":"See our tweets during EMA's regular press briefing on #COVID19 vaccines and treatments. #EMAPresser https://t.co/SyqMFJwzck","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":8,"end":23,"tag":"COVID19vaccine"},{"start":190,"end":201,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":66,"end":67,"probability":0.4154,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":107,"reply_count":20,"like_count":226,"quote_count":76},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:25:20.000Z","id":"1415648675330727941","text":"For the #COVID19vaccine Covishield to be evaluated for use in the EU, the developer needs to submit a formal marketing authorisation application to EMA, which to date has not been received. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415648465409949696"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":188,"end":211,"url":"https://t.co/G9pLB4jrLW","expanded_url":"https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/travel-during-coronavirus-pandemic_en","display_url":"ec.europa.eu/info/live-workâ€¦"}],"hashtags":[{"start":126,"end":134,"tag":"COVID19"},{"start":212,"end":221,"tag":"ReopenEU"},{"start":222,"end":233,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5903,"type":"Organization","normalized_text":"EMA"},{"start":160,"end":161,"probability":0.4006,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":6,"like_count":24,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:24:30.000Z","id":"1415648465409949696","text":"EMAâ€™s remit is the evaluation of vaccines &amp; medicines in view of their use in the EU. EMA has no responsibility regarding #COVID19 vaccinations accepted in the EU for travel purposes. https://t.co/G9pLB4jrLW #ReopenEU #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644995961376769"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":169,"end":180,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4024,"type":"Organization","normalized_text":"EMA"},{"start":64,"end":71,"probability":0.3199,"type":"Organization","normalized_text":"Spikevax"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":8,"reply_count":5,"like_count":26,"quote_count":8},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:10:43.000Z","id":"1415644995961376769","text":"EMA is currently evaluating an application to extend the use of Spikevax to include young people aged 12 to 17. We expect to reach a conclusion at the end of next week. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644573259505675"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":62,"end":76,"tag":"RollingReview"},{"start":196,"end":207,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":19,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:09:02.000Z","id":"1415644573259505675","text":"Four monoclonal antibodies or antibody combinations are under #RollingReview. The rolling review will continue until there is sufficient evidence for a formal marketing authorisation application. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644508155490307"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":23,"end":31,"tag":"COVID19"},{"start":255,"end":266,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":13,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:08:46.000Z","id":"1415644508155490307","text":"We also need effective #COVID19 treatments to save the lives of those becoming ill through the infection and to bring the pandemic under control. EMA is currently evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644254177726468"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":145,"end":157,"tag":"SideEffects"},{"start":220,"end":231,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4272,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":9,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:07:46.000Z","id":"1415644254177726468","text":"EMA and ğŸ‡ªğŸ‡º Member States continuously monitor these reports to detect any new safety issues. We are committed to ensuring that any new suspected #SideEffects are rapidly investigated, and decisions are based on science. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644176948072448"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":265,"end":276,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":4,"like_count":26,"quote_count":7},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:07:27.000Z","id":"1415644176948072448","text":"ğŸ“¢ The fact that someone has had a medical issue or died after vaccination does not necessarily mean that the death was caused by the vaccine. \nOther reasons, for example underlying or emerging health problems not related to the vaccination, may have played a role. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415644043103584262"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":57,"end":73,"tag":"COVID19vaccines"},{"start":108,"end":120,"tag":"SideEffects"},{"start":167,"end":178,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":2,"reply_count":2,"like_count":9,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:06:55.000Z","id":"1415644043103584262","text":"We updated our monthly safety reports for all authorised #COVID19vaccines. These reports describe suspected #SideEffects observed after the use of a COVID-19 vaccine. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643755844100099"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":244,"end":255,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":18,"quote_count":6},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:05:47.000Z","id":"1415643755844100099","text":"Healthcare professionals and people getting vaccinated with Comirnaty &amp; Spikevax should be aware of symptoms of myocarditis &amp; pericarditis. Available data suggest that these symptoms are usually mild and improve with rest or treatment. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643646330904582"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":251,"end":262,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":98,"end":106,"probability":0.4408,"type":"Organization","normalized_text":"Comirnaty"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":17,"reply_count":1,"like_count":31,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:05:21.000Z","id":"1415643646330904582","text":"EMA concluded that there is a small risk of myocarditis &amp; pericarditis following vaccination with Comirnaty and Spikevax. The product information will be updated to include myocarditis and pericarditis as very rare side effects of these vaccines. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643365685743616"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":105,"end":116,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":12,"quote_count":2},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:04:30.000Z","id":"1415643434543718403","text":"â€¼ï¸ People should complete their vaccination course as soon as possible, within the recommended interval. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643255249768455"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":54,"end":70,"tag":"COVID19vaccines"},{"start":82,"end":92,"tag":"Comirnaty"},{"start":132,"end":140,"tag":"Moderna"},{"start":145,"end":155,"tag":"Vaxzevria"},{"start":210,"end":223,"tag":"DeltaVariant"},{"start":225,"end":238,"tag":"VaccinesWork"},{"start":239,"end":250,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":22,"quote_count":3},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:04:14.000Z","id":"1415643365685743616","text":"Preliminary data suggest a full vaccination course of #COVID19vaccines, including #Comirnaty, Spikevax (previously COVID-19 vaccine #Moderna) or #Vaxzevria are needed to provide adequate protection against the #DeltaVariant. #VaccinesWork #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643255249768455"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":9,"end":23,"tag":"COVIDvaccines"},{"start":172,"end":185,"tag":"VaccinesWork"},{"start":186,"end":197,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":42,"end":45,"probability":0.4867,"type":"Place","normalized_text":"ğŸ‡ªğŸ‡º"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":20,"reply_count":3,"like_count":32,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:03:48.000Z","id":"1415643255249768455","text":"The four #COVIDvaccines authorised in the ğŸ‡ªğŸ‡º provide a high protection against all the strains that are circulating, especially against severe disease and hospitalisation. #VaccinesWork #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415643141366030337"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":187,"end":203,"tag":"COVID19vaccines"},{"start":272,"end":283,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":19,"reply_count":2,"like_count":37,"quote_count":9},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:03:20.000Z","id":"1415643141366030337","text":"It is too early to confirm if and when a booster dose will be needed. There is not yet enough data from vaccination campaigns &amp; ongoing studies to understand how long protection from #COVID19vaccines will last. EMA will review data quickly once they become available. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415642970825674754"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":79,"end":95,"tag":"COVID19vaccines"},{"start":132,"end":145,"tag":"DeltaVariant"},{"start":262,"end":273,"tag":"EMAPresser"}],"mentions":{},"annotations":[{"start":204,"end":209,"probability":0.9954,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":16,"quote_count":1},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:02:40.000Z","id":"1415642970825674754","text":"EMA is continuously monitoring the virus mutations and their impact on the way #COVID19vaccines work. Given the rapid spread of the #DeltaVariant, it is extremely important to vaccinate as many people in Europe as possible according to national recommendations. #EMAPresser","referenced_tweets":[{"type":"replied_to","id":"1415642562917027842"}],"in_reply_to_user_id":"116716199"},{"entities":{"urls":[{"start":169,"end":192,"url":"https://t.co/V0BUmOwQ4T","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-2","display_url":"ema.europa.eu/en/events/ema-â€¦","status":200,"unwound_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-2"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"},{"start":156,"end":167,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":26,"reply_count":18,"like_count":43,"quote_count":4},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1415642562917027842","possibly_sensitive":false,"created_at":"2021-07-15T12:01:03.000Z","id":"1415642562917027842","text":"Watch live ğŸ”´\n\nWe are now starting our regular press briefing on #COVID19 vaccines and treatments. \n\nDonâ€™t miss our tweets during the press briefing. Follow #EMAPresser. https://t.co/V0BUmOwQ4T","referenced_tweets":{}},{"entities":{"urls":[{"start":136,"end":159,"url":"https://t.co/V0BUmOwQ4T","expanded_url":"https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-2","display_url":"ema.europa.eu/en/events/ema-â€¦"},{"start":160,"end":183,"url":"https://t.co/VpDoRzZLUO","expanded_url":"https://twitter.com/EMA_News/status/1415636715436453894/photo/1","display_url":"pic.twitter.com/VpDoRzZLUO"}],"hashtags":[{"start":35,"end":51,"tag":"COVID19vaccines"},{"start":124,"end":135,"tag":"EMAPresser"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":15,"reply_count":3,"like_count":32,"quote_count":2},"attachments":{"media_keys":["3_1415636572993695748"],"poll_ids":{}},"conversation_id":"1415636715436453894","possibly_sensitive":false,"created_at":"2021-07-15T11:37:48.000Z","id":"1415636715436453894","text":"â€¼ï¸ EMAâ€™s regular press briefing on #COVID19vaccines and treatments will be broadcast live ğŸ”´ today, 15 July 2021, 14:00 CEST #EMAPresser https://t.co/V0BUmOwQ4T https://t.co/VpDoRzZLUO","referenced_tweets":{}},{"entities":{"urls":[{"start":226,"end":249,"url":"https://t.co/jx6PFOdCln","expanded_url":"https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#safety-updates-for-authorised-covid-19-vaccines-section","display_url":"ema.europa.eu/en/human-regulâ€¦"},{"start":269,"end":292,"url":"https://t.co/eo6wn2oXt7","expanded_url":"https://twitter.com/EMA_News/status/1415317186135080970/photo/1","display_url":"pic.twitter.com/eo6wn2oXt7"}],"hashtags":[{"start":69,"end":85,"tag":"COVID19vaccines"},{"start":251,"end":268,"tag":"SafetyOfVaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":92,"reply_count":15,"like_count":149,"quote_count":7},"attachments":{"media_keys":["3_1415316998016454656"],"poll_ids":{}},"conversation_id":"1415317186135080970","possibly_sensitive":false,"created_at":"2021-07-14T14:28:07.000Z","id":"1415317186135080970","text":"â€¼ï¸ There is a lot of mis/disinformation on social media on safety of #COVID19vaccines. \nğŸ“¢ Get your information from reliable sources! Check out our latest updates on the safety of all COVID-19 vaccines authorised in the ğŸ‡ªğŸ‡º. \nğŸ‘‰https://t.co/jx6PFOdCln\n #SafetyOfVaccines https://t.co/eo6wn2oXt7","referenced_tweets":{}},{"entities":{"urls":[{"start":123,"end":146,"url":"https://t.co/7plLCoID0k","expanded_url":"https://twitter.com/EMA_News/status/1415312221752725504/photo/1","display_url":"pic.twitter.com/7plLCoID0k"}],"hashtags":[{"start":0,"end":16,"tag":"COVID19vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":40,"reply_count":19,"like_count":81,"quote_count":10},"attachments":{"media_keys":["3_1415311843309010944"],"poll_ids":{}},"conversation_id":"1415312221752725504","possibly_sensitive":false,"created_at":"2021-07-14T14:08:23.000Z","id":"1415312221752725504","text":"#COVID19vaccines where are we now? \n\nRolling reviews in progress, no new applications submitted, authorisations completed. https://t.co/7plLCoID0k","referenced_tweets":{}},{"entities":{"urls":[{"start":212,"end":235,"url":"https://t.co/qTfnajUnNA","expanded_url":"https://www.ema.europa.eu/en/news/ema-ecdc-update-covid-19","display_url":"ema.europa.eu/en/news/ema-ecâ€¦"},{"start":268,"end":291,"url":"https://t.co/C2bBbhe7tl","expanded_url":"https://twitter.com/EMA_News/status/1415305544848584704/photo/1","display_url":"pic.twitter.com/C2bBbhe7tl"}],"hashtags":[{"start":62,"end":70,"tag":"COVID19"},{"start":237,"end":249,"tag":"HealthUnion"},{"start":250,"end":267,"tag":"StrongerTogether"}],"mentions":[{"start":85,"end":93,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":76,"reply_count":12,"like_count":128,"quote_count":8},"attachments":{"media_keys":["3_1415305380104740870"],"poll_ids":{}},"conversation_id":"1415305544848584704","possibly_sensitive":false,"created_at":"2021-07-14T13:41:51.000Z","id":"1415305544848584704","text":"Complete vaccination courses are vital for protection against #COVID19. \n\nâ€¼ï¸ EMA and @ECDC_EU urge citizens in the ğŸ‡ªğŸ‡º to get vaccinated. \n\nRead the joint EMA - ECDC statement on the current COVID-19 situation: \nğŸ‘‰https://t.co/qTfnajUnNA\n\n#HealthUnion #StrongerTogether https://t.co/C2bBbhe7tl","referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1414881206085341184","possibly_sensitive":false,"created_at":"2021-07-13T09:35:41.000Z","id":"1414881206085341184","text":"RT @EU_Health: How do children deal with COVID-19?\n\nThe book â€˜My Hero is Youâ€™ helps them through storytelling to understand the pandemic beâ€¦","referenced_tweets":[{"type":"retweeted","id":"1414834477835202562"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"vonderleyen","id":"1146329871418843136"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":360,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1414880976375885830","possibly_sensitive":false,"created_at":"2021-07-13T09:34:46.000Z","id":"1414880976375885830","text":"RT @vonderleyen: More than half of all adults in the EU are now fully vaccinated!\n\nTo keep safe from variants and avoid a new wave of infecâ€¦","referenced_tweets":[{"type":"retweeted","id":"1414854064144330753"}]},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web App","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"attachments":{"media_keys":{},"poll_ids":{}},"conversation_id":"1414532762527277060","possibly_sensitive":false,"created_at":"2021-07-12T10:31:05.000Z","id":"1414532762527277060","text":"RT @EU_Health: Having the right treatments for COVID-19 patients is crucial to reduce hospitalisations &amp; save lives\n\nToday we are bringingâ€¦","referenced_tweets":[{"type":"retweeted","id":"1414532067736576005"}]}]
